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CHAPTER 4: THE CAT: RESULTS AND DISCUSSTON.
4.1 THE EFFECTS OF PSEUDO-OILS ON CAT
ERYTHROCYTES.
4.1.1 Effects of Pseudo-Oils on Cel 1 Viability.
Cat erythrocyte cultures were found to be free of any 
white blood cell or platelet contamination upon micro­
scopic examination. Most cultured erythrocytes retained 
their biconcave disc shape, although some lost this 
feature after 48 hours in culture. Further, 20% to 30% 
of erythrocytes lost their distinct 'red' colour after 2 
days in culture and hence become difficult to visualise. 
Only erythrocytes which retained their pigmentation were 
therefore regarded as viable, normal and representative 
of the situation in vivo.
Final medium albumin concentrations ranging from 0 to 
250mg/l were investigated on erythrocyte viability, and 
the results indicated that albumin had no significant 
effect, nor were any synergistic effects observed (Fig. 
4.1.1.1.). The effects induced with p-oil dosage were 
thus a result of the exogenous FA's and not the albumin 
used as FA carrier.
Erythrocytes do not divide nor require trypsinisation, 
thus no 24 hour post-trypsinisation recovery period was 
needed. Erythrocytes were dosed immediately subsequent 
to plating, thus the seeding concentration was the
cytostatic number.
The results are expressed as mean percent (%) cell 
viabi1ity±standard error of the mean (s.e.m.), where 'n‘ 
is the number of experiments. The concentrations given 
are as mg albumin or pseudo-oil per litre of growth 
medium. Fig. 4.1.1.1. shows the mean percent cell 
viability versus the albumin concentration (mg/1), and 
Figs. 4.1.1.2~4.1.1.8. depict the mean percent cell 
viability versus the pseudo-oil concentration (mg/1).
A 1 b u min 
icentration 
(mg/1 )
Mean ± s .e.m . n
0 100.0 5.2 12
25 104.9 3.7 12
50 103.1 4.8 12
75 100.0 3.5 12
100 101.2 4.0 12
125 99.0 3.4 12
150 100.7 3.4 12
175 99.4 4.3 12
200 97.7 5.0 12
225 96.0 5.8 12
250 99.1 3.7 12
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 5.7 6
10 107.1 3.8 6
20 102.6 5.4 6
30 101.1 5.9 6
40 110.5 5.8 6
50 109.4 2.5 6
60 105.3 2.5 6
70 105.1 4.9 6
80 103.9 2.7 6
90 103.9 4.0 6
100 100.8 3.4 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 4.0 6
10 93.1 5.1 6
20 81.1 3.4 6
30 60.6 3.3 6
40 53.3 4.6 6
50 53.4 5.4 6
60 52.6 2.8 6
70 45.1 2.6 6
80 35.8 1.1 6
90 29.4 1.6 6
100 31.6 0.9 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 2.8 6
10 104.5 4.0 6
20 99.5 in•▼H 6
30 101.4 3.8 6
40 107.0 4.3 6
50 103.4 2.8 6
60 97.5 3.4 6
70 72.9 2.2 6
80 35.8 2.4 6
90 12.7 1.5 6
100 6.0 1.0 " 6
pseudo-Oi1 
Concentration 
< mg/1)
Mean ±s.e.m. n
0 100.0 5.6 6
10 i'-•00 5.3 6
20 90.6 4.5 6
30 95.3 4.7 6
40 79.9 1.9 6
50 61.0 1.5 6
60 23.4 4.6 6
70 4.1 1.1 6
80 2.7 0.7 6
90 2.1 in•o 6
100 1.7 0.5 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 3.3 6
10 110.3 4.1 6
20 98.4 5.0 6
30 59.8 5.6 6
40 25.9 2.7 6
50 18.3 3.8 6
60 28.5 1.2 6
70 25.9 4.4 6
80 10.3 4.9 6
90 1.6 0.4 6
100 1.1 0.2 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 3.7 6
10 43.4 3.9 6
20 22.6 1.4 6
30 18.9 1.1 6
40 12.4 1.0 6
50 4.6 1.2 6
60 0.9 0.1 6
70 0.9 0.1 6
80 1.4 0.2 6
90 2.2 0.3 6
100 3.2 0.5 6
pseudo-Oil Mean ±s.e.m. n
Concentration 
(mg/1)
0
10
20
30
40
50
60
70
80
90
100.0 3.6 6
88.0 4.1 6
93.3 4.5 6
89.7 3.1 6
89.5 1.6 6
85.7 2.1 6
80.3 3.0 6
55.9 4.3 6
28.6 4.7 6
9.4 1.1 6
0.2 0.1 6
All p-oils, except p-CO, exhibited cytotoxic potential 
when amounts up to 100mg/l were added to erythrocytes, 
although the magnitude thereof varied with the p-oil and 
concentration dosed (Figs. 4.1.1.2-4.1.1.8.). EFA-rich 
p-oils (p-SSO, p-LO and p-EPO), however, induced the 
greatest hemolysis.
Incubation with up to 100mg/l p-CO induced no hemolysis 
(Fig. 4.1.1.2.), and both erythrocyte morphology and 
viability paralleled controls. 10, 40 and 50mg/l p-CO, 
however, appeared slightly more effective in stabilising 
erythrocyte viability in culture relative to controls. 
On the other hand, p-MO induced concentration dependent 
hemolysis such that approximately half the erythrocytes 
were viable with 40 to 60mg/l, and this was further 
reduced to 30% with 90 and 100mg/l (Fig. 4.1.1.3.).
p-00 maintained erythrocyte viability parallel to, or 
marginally better than, controls up to a concentration 
of 60mg/l, whereas extensive concentration dependent 
hemolysis was induced with greater amounts such that 
50% of cells were killed with approximately 76mg/l p-MO 
(ID5o ) and 94% with 100mg/l (Fig. 4.1.1.4.).
Erythrocyte viability decreased progressively from 95.3% 
with 30mg/l p-SS0 to 23.4% with 60mg/l p-SSO, while 
70 to 100mg/l p-SSO induced greater than 95% hemolysis 
(Fig. 4.1.1.5.). Erythrocytes were protected from lysis 
with 10 and 20mg/l p-L0, but marked hemolysis also
occured with greater concentrations, such that viability 
was 59.8% with 30mg/l p-LO and 18.3% to 28.5% with 40 to 
70mg/l p-LO (Fig. 4.1.1.6.). Practically all the cells 
were killed with 90 and 100mg/l p-LO. On the other hand, 
erythrocyte viability was reduced to 43.4% with only 
10mg/l p-EPO, and further to 22.6% with 20mg/l p-EPO, 
while at least 95% hemolysis occurred with 50 to 100mg/l 
p-EPO (Fig. 4.1.1.7.). p-EPO was the most toxic p-oil, 
followed by p-LO and p-SSO, and this correlated with the 
IDso values (about 8, 33 and 53mg/l, respectively).
Concentrations up to 40mg/l p-FO induced approximately
10% hemolysis, which increased to 20% with 60mg/l p-F0
(Fig. 4.1.1.7.). Hemolysis increased progressively with
higher concentrations dosed, and practically all cells
took up Trypan blue with 100mg/l p-F0. It was evident
that the overall effects p-F0 induced were parallel
to those of p-00 (Fig. 4.1.1.4.), although p-FO was
slightly more cytotoxic. This correlated with the ID50
values (about 73mg/l for p-F0 and 76mg/l for p-00).«
Cat erythrocytes were subsequently plated and dosed 
appropriately with 0, 20, 40 or 60mg p-oil/1 culture 
medium in sufficient quantities for all the quantitative 
and qualitative analyses to be carried out. Cell 
viabilities relative to controls were compared upon 
harvesting and found to be statistically similar to 
those in Figs. 4.1.1.1-4.1.1.8. All further biochemical 
assays were therefore performed on these samples.
4.1,2 Effects of pseudo-Qils on Total Protein.
Total protein was quantified for cat erythrocytes dosed 
with 0, 20, dO or 60mg/l p-oil, and the results shown in 
Table 4.1.2.1. as jug total protein/106 cells seeded.
Control erythrocytes contained 12.3jug total protein/10& 
cells seeded, whereas amounts in dosed erythrocytes were 
similar to, or lower than, control levels and ranged 
from 1.6 to 12.3,ug/106 cells seeded (induced with 60mg/l 
P~EP0 and 20mg/l p-LO dosage, respectively). Erythrocyte 
protein concentrations approximated to controls with 20, 
40 or 60mg/l p-CO or p-00 supplementation, but decreased 
overall with increasing amounts of other p-oils dosed. 
Cat erythrocytes incubated with 20, 40 or 60mg/l p-EPO, 
however, exhibited the lowest protein levels quantitated 
(4.2, 2.5 and 1.6jug/106 cells seeded, respect i ve 1 y ) .
The protein content of cat erythrocytes■ expressed as tig 
total protein/10& cells seeded.
pseudo-
Oil
< mg/1 )
CELLS
0
1l
20 :ii
40 60
Control 12.3
ii
ii
i
CO
i
11.6 ! 1 12.2 12.2
MO
l
i o . o  :i 7.6 6.7
00 ii.3 :i 11.9 11.3
SSO
i
ii.7 :
i
11.6 4.8
L0 12.3 :
i
3.8 3.3
EPO 4 . 2 :
i
2.5 1.6
F0 h-> O • U1 10.7 8.7
4.1.3 Effects of pseudo-Oils on the Fatty Acid
Spectrum of Cat Erythrocytes.
Table 4.1.3.1. shows the FA spectra of cat erythrocytes 
dosed with 0, 20, 40 or 60mg/l of each of the p-oils. 
FA s contributing >5.0% to the FA spectrum in control 
erythrocytes were 16:0 (11.2%), 18:0 (9.0%), 18:lu9
(7.1%), 22:4u6 (49.4%), 22:5u6 (5.1%) and 20:4u3 (9.3%). 
Overall, dosed erythrocytes contained greater 16:0, 
18:lw9 and 18:2w6 amounts than controls, 18:0 and 16:lw9 
proportions were more varied, whereras w6 PDFA and w3 
PUFA percentages were parallel to controls or decreased.
Erythrocytes dosed with p-C0 showed a marked increment 
in 16:0 levels (34.8% with 20mg/l, 46.0% with 40mg/l and 
55.9% 60mg/l p-CO, respectively vs 11.2% in controls), 
but 18:0 amounts were generally parallel to controls 
(9.0%). 24:0 and 16:lw9 were increased significantly
with 20mg/l and 40mg/l p-CO, respectively (1.8% and 7.9% 
vs 0% and 2.0% in controls, respectively), while 18:lw9 
levels increased approximately 2 fold with 20mg/l p-CO, 
and 3 fold with 40 and 60mg/l p-CO relative to controls 
(7.1%). On the other hand, p-C0 incubation decreased 
erythrocyte PUFA levels.
Dosage with 20, 40 or 60mg/l p-M0 induced increments in 
16:0 (18.5%, 31.6% and 35.5%, respectively vs 11.2% in 
controls), 18:0 (25.4%, 17.2% and 19.7%, respectively vs 
9.0% in controls) and 18:lu9 (20.3%, 27.9% and 28.3%,
All values are tabulated as relative percent total area. 
Control values are reported as mean±s.e.m., where "n" is 
the number of experiments. *Cp-OilD‘ refers to the 
pseudo-oil concentration used.
The fatty acid spectrum of cat erythrocytes»
FATTY ACID 
SPECTRUM
C4)
CONTROLS 
(n=3)
Cp-COO 
(mg/1)
20 ! 40 ! 60
tp-MOO 
(mg/1 )
20 I 40 ! 60
Cp-o o:
(mg/1 )
20 ! 40 ! 60
C p - s s o u
(mg/1)
20 1 40 ! 60
Cp-lo:
(mg/1)
20 ! 40 ! 60 20
Cp-EPOD 
(mg/1)
40 ! 60
Cp-f o:
(mg/1)
20 ! 40 ! 60
S
A
16:0 11.2±0.05 34.8 46.0 55.9 18.5 31.6 35.5 20.1 15.8 14.6 19.3 25.8 18.1 26.6 28.3 20.5 24.5 26.7 23.7 42.8 30,7 29.1
T
U
R
A
18:0 9.0+0.20 9.9 9.5 10.3 25.4 17.2 19.7 3.0 1.4 0.8 20.3 10.4 9.4 13.2 8.1 12.3 16.1 11.7 9.1 8.7 4.2 3.2
20:0 0.6+0.06 - 0.1 - - 0.2 - - - - - - - - - - - - - - - -
T 22:0 0 .5±0.00 0.1 - 0.1 - - 0.1 - - - - 0.1 - 0.2 0.2 - - 0.1 0.1 - - -
S. 24:0 — 1.8 - - — 0.3 0.1 — 0.1 0.2 - - - - - - 0.2 0.1 0.8 - - -
u9
M
16:1 2.0±0.03 0.3 7.9 - - - - 0.1 0.2 - 0.3 0.3 0.1 0.5 0.6 0.2 0.5 0.6 0.8 13.0 27.8 29.8
0M 18:1 7.1±0.25 15.2 21.4 21.3 20.3 27.9 28.2 63.2 70.5 76.3 18.5 30.8 40.1 29.2 34.5 32.8 12.3 18.8 21.3 14.9 22.5 21.8
0
S.
24:1 — — — — — — — — — — — — — - - - - - - 0.4 - -
18:2 2.4±0.05 1.7 1.0 1.2 9.7 7.1 6.5 4.2 5.5 5.1 7,5 17.9 28.4 5.8 7.6 11.8 11.6 24.9 35.8 4.0 6.5 7.4
u6
18:3 - - - - - - - - - - - - - - - 0.4 - 0.8 1.4 - - -
P 20:2
— - - — — — — 1.5 1.6 1.5 - - 0.5 - 0.1 0.7 - - - 0.4 0.7 0.8
01 20:3 0.4±0.00 0.1 0.2 0.1 0,7 0.3 0.1 0.1 0.1 - - - 0.1 - - - 0.1 - - - 0.1 -
Yc 20:4 0.510.00
- 0.2 0.4 - 0.8 0.7 0.1 0.1 - - 0.2 0.1 - 0.3 0.1 - 0.3 0.1 0.1 0.2 0.1
22:4 49.411,87 29.4 8.5 8.9 18.2 10.8 7.0 6.2 3.5 0.8 26.4 9.5 1.8 19.6 7.9 3.6 26.3 11.7 5.5 11.6 2.9 3.7
22:5 5.110.10 0.3 0.7 — 0.5 0.6 0.2 - 0.2 - 1.1 0.8 0.1 - 0.6 0.1 0.6 0.7 0.1 0.2 0.4 0.1
18:3 0.210.00 0.2 0.1 0.2 0.2 0.3 0.2 0.1 0.2 0.2 - 0.2 0.1 2.8 9.6 16.1 - 0.1 - 0.2 0.4 0.4
u3 18:4 1.810.10 0.7 1.5 0.2 1.0 1.0 0.3 0.3 0.4 0.3 1.4 1.2 0.4 0.6 1.1 0.5 1.2 1.2 0.3 0.4 0.5 0.2
P
0
L
v
20:4 9.310.20 5.5 2.7 1.4 5.5 1.7 1.6 0.7 0.6 - 5.3 1.8 0.6 0.4 1.1 1.1 6.7 2.2 0.9 2.9 0.8 0.8
20:5 0.210.00 0.2 0.2 0.1 - 0.2 - 0.2 - - - 0.9 0.1 1.0 0.1 - - - - 0.5 2.1 2.5
s . 22:5 - - - - - - 0.1 0.2 - - - - - - - - - - - - - -
22:6 0.210.00 — — 0.1 — 0.1 — 0.1 - - - 0.2 - - — - - 0.3 0.3 — 0.1 0.1
respectively vs 7.1% in controls), but not in 16:lw9 
(0% vs 2.0% in controls). PDFA levels were parallel to 
controls or decreased, despite 18:2w6 uptake.
Addition of p-00 to erythrocyte cultures induced an 
increase in 16:0 (14.6% to 20.1% vs 11.2% in controls) 
and decreases in 18:0 (0.8% to 3.0% vs 9.0% in controls) 
and 16:lu9 (SO.2% vs 2.0% in controls). Approximately 10 
fold more 18:lw9 was found in erythrocytes dosed with 
20, 40 or 60mg/l p-00 than in controls (63.2%, 70.5%, 
76.3% and 7.1%, respectively), and 18:2u6 percentages 
increased about 2 fold (4.2%, 5.5% and 5.1% vs 2.4% in 
controls). A significant increase in 20:2cj6 was found in 
dosed erythrocytes (1.5% to 1.6% vs 0% in controls), but 
w6 and w3 PDFA levels were decreased, especially 22:4w6.
16:0 levels increased with p-SSO supplementation (18.1% 
to 25.8% vs 11.2% in controls), but only 20mg/l p-SSO 
enhanced 18:0 amounts significantly (20.3% vs 9.0% in 
controls). A concentration dependent increase in 18:lw9 
and 18:2u)6 was demonstrated with 20, 40 and 60mg/l p-SSO 
(18.5%, 30.8% and 40.1%, and 7.5%, 17.9% and 28.4% vs 
7.1% and 2.4% in controls, respecti vel y) , but higher U)6, 
as well as u3, PDFA's levels were decreased overall.
Supplementation with 20, 40 or 60mg/l p-LO caused marked 
increases in 16:0 (26.6%, 28.3% and 20.5%, respectively 
vs 11.2% in controls) and 18:lu9 (29.2%, 34.5% and 
32.8%, respectively ^s 7.1% in controls), but had little
effect on 18:0 (8.1% to 13.2% os 9.0% in controls). 
18: 2u6 and 18*3u)3 percentages were increased (5.8%, 7.6% 
and 11.8%, and 2.8%, 9.6% and 16.1% with 20, 40 and 
60mg/l p-LO os 2.4% and 0.2% in controls, respectioely) , 
but this did not enhance PDFA formation.
Erythrocytes dosed with p-EPO contained 23.7% to 26.7% 
16:0 (11.2% in controls), 9.1% to 16.1% 18:0 (9.0% in 
controls), and 12.3% to 21.3% 18:lu9 (7.1% in controls). 
18:2cj6 increased from 2.4% to 11.6%, 24.9% and 35.8% 
with 20, 40 and 60mg/l p-EPO, respectioely, and up to
I. 4% 18:3u6 was found (0% in controls), but other PDFA 
levels were decreased both in the u6 and u3 series.
Significant increases in 16:0, 16:lw9 and 18:lw9 were 
demonstrated in erythrocytes supplemented with p-FO 
(29.1% to 42.8%, 13.0% to 29.8% and 14.9% to 22.5% us
II. 2%, 2.0% and 7.1% in controls, respectively), whereas 
18:0 was decreased (3.2% to 8.7% vs 9.0% in controls). 
Despite 18:2u6 and 20:5w3 uptake (4.0%, 6.5% and 7.4%, 
and 0.5%, 2.1% and 2.5% with 20, 40 or 60mg/l p-FO vs 
2.4% and 0.2% in controls, respectively), no significant 
increase in w6 PDFA s, 22:5u3 or 22:6to3 were found.
4.1.4 Effects of Pseudo-Oils on Lipid Peroxide
Formation.
The results obtained from the quantitation of lipid 
peroxides in erythrocytes dosed with 0, 20, 40 or 60mg/l 
p-oil and their corresponding spent culture media are 
shown in Table 4.1.4.1. The values are shown as nmoles 
MDA/106 cells, but in the case of the spent incubation 
media, this represents the nmoles of MDA in the volume 
of medium from which 1x10s cells were obtained.
No 1ipoperoxides were measured in control erythrocytes, 
or those dosed with p-MO, while 0.Inmoles MDA/106 cells 
was induced with 60mg/l p-CO. Erythrocytes supplemented 
with 20 or 40mg/l p-00 contained i0.2nmoles MDA/106 
cel Is, but 15.2nmoles MDA/106 cel Is with 60mg/l p—00. 
p-SSO, p-L0 and p-EPO induced 0.1 to 0.2nmoles MDA/106 
cells with 20mg/l, 0.1, 0.4 and 0.9nmoles MDA/106 cells
with 40mg/l, respectively, and 0.8 to l.Onmoles MDA/106 
cells with 60mg/l. No cellular 1ipoperoxides were found 
with 20mg/l p-F0 dosage, but 40 and 60mg/l p~F0 induced 
1.0 and 46.Onmoles MDA/106 cells, respectively.
Spent culture medium derived from cultures incubated 
with 60mg/l p-EP0 contained 0.5 nmoles MDA/106 cells, 
compared to 1.5 and 7.9nmoles MDA/106 cells with 40 and 
60mg/l p-L0, respectively, and 18.9nmoles MDA/106 cells 
with 60mg/l p-FO. Lipoperoxides were absent, however, 
from all other spent incubation media.
Lipid peroxide formation by cat erythrocyte cultures 
incubated with p-oils. expressed as nmoles MDA/10S rp>ll=;.
pseudo-
Oil
CELLS
(mg/1 ) 0 20 40 60
Control -
CO - - 0.1
MO - - -
00 - 0.2 15.2
SSO 0.1 0.1 0.8
L0 0.1 0.4 1.0
EPO 0.2 0.9 0.9
F0 - 1.0 46.0
pseudo- SPENT INCUBATION MEDIUM
Oil
(mg/1) 0 20 40 60
Control -
CO - - -
MO - -
00 - - -
SSO - - -
L0 - 1.5 7.9
EPO - - 0.5
F0 - - 18.9
4.1.5 Discussion.
Supplementation of cat erythrocytes with exogenous FA 
mixtures showed that all p-oils, with the exception of 
p-CO, induced hemolysis (Figs. 4.1.1.2-4.1.1.8.). This 
correlated with the absence of PUFA's only in p-CO
(Table 2.3.3.2.) and implied that the modulation of
hemolysis related to the presence of PUFA's in other 
p-oils. Indeed, overall hemolysis correlated with total 
p-oil PUFA levels (Table 2.3.3.2.). As the percentage of 
total p-oil PUFA's increased, so increased the extent 
of hemolysis induced, particularly with high p-oil 
concentrations. The nature and concentration of PUFA's 
present in the p-oils (Table 2.3.3.2.) also influenced 
the degree of hemolysis induced. Incubation with p-EPO 
resulted in considerably more hemolysis than p-SSO,
despite similar FA compositions, and this probably
related to the presence of GLA only in the former. It 
was also possible that interactions between GLA and 
other FA's in p-EPO enhanced the cytotoxic capability of 
this p-oil. The finding that p-EPO and p-LO induced the 
most extensive hemolysis overall correlated 'with the 
presence of linolenic acid in such. This implied that
the presence of 3 double bonds in an 18 carbon FA was
suitable to induce pronounced cytotoxicity. The fact
that p-EPO was more hemolytic than p~LO, despite a
similar complement of saturated and monounsaturated FA's 
and considerably more ALA in p-LO than GLA in p-EPO,
however, suggested that 6LA was a more potent cytotoxic 
agent than ALA. This may relate to the double bond 
positions in these FA's, and the fact that GLA is a 
PDFA. The effects reported in Figs. 4.1.1.2-4.1.1.8. 
nevertheless supported evidence indicating that FA's 
modify erythrocyte morphology, their ability to change 
shape and to resist lysis (eg. Rao et al 1979). It has 
been demonstrated that erythrocytes are susceptible to 
lysis in vitro when incubated with 0.03 to 80mg/l OA, LA 
or ALA (Csordas et al 1984). p-0ils containing large 
amounts of these moieties varied in cytotoxic capability 
depending on concentration dosed. This supported the 
mediation of synergistic and antagonistic interactions 
between p-oil FA^s, and this probably occurs in vivo 
when dietary oils are fed.
The changes reported in total erythrocyte protein (Table 
4.1.2.1.) reflected the cell viability changes (Figs. 
4.1.1.1-4.1.1.8.) induced with p-oil incubation. Most 
erythrocyte protein is attributed to its hemoglobin 
(Geigy 1984). Cel 1 lysis would therefore be consistent 
with the reduction in erythrocyte protein measured with 
hemolytic p-oil concentrations. The protein amount 
measured with p-oil concentrations inducing maximum 
hemolysis reflected erythrocyte membrane protein. This 
was shown to be 1.6Aig protein/10^ cel Is seeded (obtained 
with 60mg/l p-EPO dosage), which confirmed reports 
(Geigy 1984) indicating that only approximately 10^ of
total erythrocyte protein is membrane related, the 
remainder being hemoglobin.
MacDonald et al (1983a) showed changes in erythrocyte FA 
composition within 10 weeks of supplementing cat diets 
with 5% safflower seed oil or hydrogenated beef tallow, 
with or without 0.2% tuna oil, primarily as a result of 
accumulation of FA's in the oils fed. On the other hand, 
we have previously shown little change in erythrocyte FA 
profiles when cats were fed diets either sufficient, 
or deficient in w6, co3, or both U)6 and u3, PDFA's 
for 38 weeks (Davidson et al 1989, 1990a). With in vivo 
studies, however, erythrocyte FA profiles are dependent 
on the FA's presented to them after ingestion, in many 
instances after other tissues have metabolised these 
moieties further, unlike the situation in vitro. The 
present study demonstrated significant incorporation of 
exogenous FA's by cat erythrocytes after only 48 hours 
post-incubation with different p-oils in culture, and 
cell FA profiles were significantly modified compared to 
controls by both the amount and type of p-oil supplied 
(Table 4.1.3.1.). It was likely therefore that membrane 
physical changes (fluidity, permeability and/or osmotic 
sensitivity) occurred, which contributed to the effects 
shown in Figs. 4.1.1.2-4.1.1.8. The finding that control 
erythrocytes contained about 80% unsaturated FA's may 
well explain the maintenance of cell viability with p-CO 
incubation and the hemolysis induced when additional
unsaturated FA^s were supplied with other p-oils. This 
nevertheless indicated that the presence saturated FA's 
were important in the protection of erythrocyte lysis.
p-Oil supplementation confirmed the inability of the cat 
erythrocyte to efficiently desaturate and elongate FA's 
(Table 4.1.3.1.) due to a lack of microsomes (Lehninger 
1982). These cells in vivo are therefore dependent on 
dietary intake and/or on other tissues capable of 
desaturation as a source of PUFA's to maintain membrane 
fluidity.
Erythrocytes lack the intracel1ular organelles and 
enzymes required for FA peroxidation, although auto­
oxidation can occur (Lehninger 1982). The absence of 
1ipoperoxides in control erythrocytes (Table 4.1.4.1.), 
despite the presence of oxygen-rich hemoglobin and a 
PUFA complement of about 70% (Table 4.1.3.1.), however, 
implied that cellular PUFA's were probably components of 
complex membrane lipids and were thus unavailable for 
oxidation, particularly if the rate of PGL turnover was 
slow. The presence of vitamin E as anti-oxidant could 
also explain the data. On the other hand, saturation of 
erythrocyte anti-oxidant levels could explain the lipid 
peroxides measured in dosed cells (Table 4.1.4.1.), 
although the quantitative differences in MDA levels 
found probably related to the availability of FA's, as 
well as the number and position of double bonds in these
moieties (Table 2.3.3.2.). The absence of significant 
1ipoperoxides in erythrocytes and the corresponding 
spent medium of cultures dosed with p-CO or p-MO was
consistent with the presence of only sma11 amounts
of unsaturated FA's in these p-oi1s, uni ike the
compositions of o01a p-SSO, p-LO, p-EPO and p-FO. The
large cellular 1ipoperoxide amounts measured with 60mg/l 
p-00 incubation probably related to the well recognised 
mechanism of 0A auto-oxidation (Frankel 1984), and the 
absence of 1ipoperoxides in the corresponding spent 
medium was consistent with OA incorporation (Table 
4,1.3.1.) and the lack of membrane damage. Detection of 
small cellular 1ipoperoxide amounts with p-EPO or p-SSO 
dosage suggested that the incorporated p-oil PUFA's were 
components of complex lipids within the membrane and 
were thus not readily accessible to oxidation. The lack 
of significant 1ipoperoxides in the corresponding spent 
culture medium, despite significant hemolysis, supported 
this. Nevertheless, the 1ipoperoxides p-EPO and p-SSO 
generated probably related to oxidation of LA, although 
the presence of GLA in p-EPO only could account for the 
slightly greater 1ipoperoxide amounts p-EPO induced 
compared to p-SSO. The FA composition of p-LO indicated 
that the lipid peroxides this p-oil induced related 
largely to oxidation of free ALA, whereas the greater 
susceptibility of EPA to oxidation could explain the 
largest 1ipoperoxide amounts formed with 60mg/l p-FO 
dosage.
Cat erythrocytes were shown to incorporate dosed p-oil 
FA's (Table 4.1.3.1.), thus the 1ipoperoxides found in 
the spent incubation medium (Table 4.1.4.1. ) probably 
related to the release of cellular 1ipoperoxides. As 
most erythrocytes were viable with up to 60mg/l p-FO 
incubation, the release of cellular 1ipoperoxides into 
the medium through the plasma membrane seemed likely, 
particularly since high 1ipoperoxide levels have been 
reported to alter membrane permeability (eg. Chio et al 
1969, Mead 1976, Tappel 1975, 1980 and Frankel 1984). On 
the other hand, the extensive hemolysis p-LO and p-EPO 
induced supported the direct expulsion of cellular 
1ipoperoxides.
No clear correlation was found when 1ipoperoxide levels 
(Table 4.1.4.1.) were compared with the cell viability 
changes (Figs. 4.1.1.2-4.1.1.8.) induced with p-oil 
dosage. Thus the involvement of 1ipoperoxides in the 
modulation of cat erythrocyte viability was uncertain, 
and alterations in membrane fluidity were proposed as 
playing a more important role.
4.2 THE EFFECTS OF PSEUDO-OILS ON CAT
LYMPHOCYTES.
4.2.1 Effects of pseudo-Oils on Cell Viability.
Microscopic examination showed lymphocyte cultures to be 
free of platelet and erythrocyte contamination, and no 
morphological changes were seen between control or dosed 
lymphocytes before, during and after each experiment.
Final medium albumin concentrations ranging from 0 to 
250mg/l were shown to have no significant effect on 
lymphocyte viability (Fig. 4.2.1.1.), and no synergistic 
effects were demonstrated. The effects observed with 
p-oil dosage were therefore a result of the exogenous 
FA's alone and not the albumin used as FA carrier.
Since lymphocytes do not normally divide in culture 
without appropriate mitogen stimulation, and did not 
require trypsinisation, no 24 hour post-trypsinisation 
recovery period was required. Lymphocytes were dosed 
immediately subsequent to plating, hence the seeding 
concentration was the cytostatic number.
Figs. 4.2.1.2-4.2.1.8. depict the results obtained from 
the incubation of lymphocytes with p-oils. All p-oils 
exhibited the capability to inhibit lymphocyte viability 
dependent on the concentration dosed, but it was unclear 
whether PUFA-rich p-oils had greater cytotoxic potential
The results are expressed as mean percent (°4) cell 
viabi1ity±standard error of the mean (s.e.m.), where "n‘ 
is the number of experiments. The concentrations given 
are as mg albumin or pseudo-oil per litre of growth 
medium. Fig. 4.2.1.1. shows the mean percent cell 
viability versus the albumin concentration (mg/1), and 
Figs. 4.2.1.2-4.2.1.8. depict the mean percent cell 
viability versus the pseudo-oil concentration (mg/1).
A1bumin 
icentrat ion 
(mg/1)
Mean ±s.e.m. n
0 100.0 4.8 12
25 98.3 5.0 12
50 98.2 2.1 12
75 102.1 3.8 12
100 99.8 2.4 12
125 100.5 4.9 12
150 103.8 5.2 12
175 101.8 3.4 12
200 97.9 4.1 12
225 97.9 4.6 12
250 95.3 4.7 12
pseudo-Oi1 
Concentration 
(m g / 1 )
Mean ±s.e.m . n
0 100.0 4.8 6
10 88.1 3.1 6
20 80.9 5.4 6
30 74.0 1.9 6
40 70.4 5.1 6
50 53.2 3.3 6
60 24.6 3.2 6
70 13.5 2.3 6
80 12.2 1.9 6
90 4.7 1.7 6
100 3.8 1.2 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 4.7 6
10 100.6 5.6 6
20 99.3 6.2 6
30 100.0 5.9 6
40 94.7 5.7 6
50 75.3 3.5 6
60 50.3 4.6 6
70 27.7 3.5 6
80 20.0 3.3 6
90 11.9 2.7 6
100 6.4 2.6 6
pseudo-Oi1 
Concentration 
(m g / 1 )
Mean ±s.e.m . n
0 100.0 5.2 6
10 105.5 3.2 6
20 104.8 4.7 6
30 85.9 3.3 6
40 70.0 2.1 6
50 34.2 2.2 6
60 9.3 1.4 6
70 4.6 1.2 6
80 3.0 1.5 6
90 3.0 00•o 6
100 o 00 0.5 6
pseudo-Oil Mean ±s.e.m. n
Concentration 
(mg/1)
0
10
20
30
40
50
60
70
80
90
100.0 4.3 6
106.4 5.7 6
105.3 4.8 6
87.3 2.5 6
92.0 2.4 6
91.1 4.8 6
87.4 2.8 6
61.2 4.3 6
49.0 5.1 6
25.2 3.0 6
6.2 1.3 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±3.e.m• n
0 100.0 4.4 6
10 92.6 4.1 6
20 77.7 3.3 6
30 63.3 3.9 6
40 50.9 3.1 6
50 25.5 2.3 6
60 24.4 3.7 6
70 15.4 2.5 6
80 10.6 1.7 6
90 5.0 1.4 6
100 1.1 in•o 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 4.4 6
10 92.2 4.5 6
20 73.8 2.5 6
30 60.2 4.1 6
40 61.5 3.6 6
50 35.2 4.5 6
60 14.2 2.4 6
70 8.1 1.5 6
80 9.3 2.0 6
90 11.5 2.5 6
100 3.3 1.3 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m . n
0 100.0 3.5 6
10 76.0 2.9 6
20 60.7 4.9 6
30 58.9 4.3 6
40 28.6 3.1 6
50 11.7 2.1 6
60 3.6 1.1 6
70 1.9 00•o 6
80 1.1 0.6 6
90 0.2 0.2 6
100 0.0 0.0 6
than those abundant in saturated or monoenoic FA's.
Lymphocyte viability decreased with increasing amounts 
of p-CO dosed (Fig. 4.2.1.2.). Cell viability was 70.4% 
with 40mg/l p-CO, but this was dramatically reduced to 
2d.6% with 60mg/l p-CO and 3.8% with 100mg/l p-CO.
Incubation with up to 40mg/l p-MO induced no significant 
change in lymphocyte viability, but greater amounts 
progressively reduced the number of viable cells to 
27.7% with 70mg/l p-MO and 6.4% with 100mg/l p-MO (Fig. 
3.2.1.3.).
Relative cell viability increased approximately 5% with 
supplementation of up to 20mg/l p-00, but decreased 
almost linearly with greater amounts to 9.3% with 60mg/l 
p-00 (Fig. d.2.1.4.). More than 95% of lymphocytes were 
stained with Trypan blue with 70 to 100mg/l p-00.
Lymphocyte viability was marginally increased with up to 
20mg/l p-SSO dosage (105.3% to 106.4%) and decreased 
with 30 to 60mg/l p-SSO (87.3% to 92.0%), whereas higher 
concentrations were very cytotoxic and progressively 
reduced cell viability to 6.2% with 100mg/l p-SS0 (Fig. 
4.2.1.5.).
Incubation with up to 50mg/l p-LO reduced lymphocyte 
viability almost linearly to 25.5% (Fig. 4.2.1.6.). 
Little further change occurred with 60mg/l p~L0, but 
cytotoxicity increased with greater concentrations to
yield only 1.1% viable lymphocytes with 100mg/l p-LO. A 
concentration dependent reduction of cell viability was 
also induced with up to 60mg/l p-EPO or p-FO dosage, but 
only 14.2% and 3.6% of lymphocytes did not take up 
Trypan blue, respectively (Figs. 4.2.1.7. and 4.2.1.8., 
respectively). However, a plateau effect was observed 
with 30 to 40mg/l p-EPO (60.2% to 61.5% viability) and 
20 to 30mg/l p-FO (58.9% to 60.7% viability). Lymphocyte 
viability was further inhibited with concentrations 
greater than 60mg/l to 3.3% and 0% with 100mg/l p-EPO 
and p-FO, respectively.
Clearly, p-FO was the most cytotoxic p-oil, and this was 
supported by the low ID50 calculated (about 33mg/l). The
ID50 with incubation of p-LO was about 40mg/l, compared 
to 45mg/l with both p-EP0 and p-00. The highest ID50 
calculated was with p-SSO dosage, followed by p-MO and 
p-C0 (about 79mg/l, 60mg/l and 52mg/l, respectively).
Subsequent to these studies, cat lymphocytes were plated 
and dosed appropriately with 0, 20, 40 or 60mg p-oil/1 
culture medium in sufficient amounts for all qualitative 
and quantitative analyses to be performed. Cell numbers 
were compared upon harvesting and found not to be 
statistically different from those obtained in Figs. 
4.2.1.1—4.2•1.8, and all further biochemical assays 
were thus performed on these samples.
4*2.2 Effects of pseudo-Oils on Total Protein.
Table 4.2.2.1. shows the total lymphocyte protein 
concentrations determined for each of the three p-oil 
concentrations dosed in relation to controls.
Total protein concentrations in dosed lymphocytes were 
parallel to, or greater than, controls (6.4jug/106 cells 
seeded) and ranged from 5.9 to 105.7jug/10s cells seeded 
(obtained with 20mg/l p-LO or 60mg/l p-MO incubation). 
Cells incubated with 20mg/l p-oil contained the smallest 
protein amounts, which increased progressively with the 
concentration of p-oil dosed. The overall increment in 
cellular protein, however, was greatest with incubation 
of saturated p-oils, p~C0 and particularly p-MO (11.3 to 
46.3 and 18.3 to 105.7^9/10^ cells seeded, respectively) 
and smallest with p-oils containing 1arge PUFA amounts, 
viz. p-SSO, p-LO, p-EPO and p-FO (5.9 to 29.9jug/106 
cells seeded), while being intermediary between the two 
extremes with the monoenoic FA-rich p-00 (8.3 to 32.3 
Aig/10e cells seeded).
The protein content of cat lymphocytes. expressed as jug 
total protein/10s rells seeded.
pseudo-
Oil
(mg/1)
CELLS
0
1•
20 :
ii
40 60
Control 6.4
i
i
i
ii
CO
i
11.3 ! 1 35.1 46.3
MO
l
18.3 : 1 57.5 105.7
00
1
8.3 : 1 15.4 32.3
SSO
1
12.0 ! 1 14.1 29.9
L0
1
5.9 ! 1 21.9 24.9
EPO
1
6.2 1 l 19.2 27.7
F0 7.4 !
1
1
17.7 27.5
4*2.3 Effects of pseudo-Oils on the Fatty Acid
Spectrum of Cat Lymphocytes.
The FA spectra of cat lymphocytes dosed with 0, 20, 40 
or 60mg/l of each of the p-oils is shown in Table 
4.2.3.1.
Control lypmphocytes exhibited a FA spectrum in which 
22:4u6 was found to be present in amounts of 34.6%. 
Other FA's found in amounts of 5.0% or greater were 16:0 
(7.7%), 18:0 (6.3%), 20:0 (8.0%), 16:lu9 (7.9%), I8:lw9
(11.7%), 18:4w3 (7.3%) and 20:4u3 (6.8%).
The FA spectra of dosed lymphocytes showed significantly 
greater 16:0 and 18:lu9 amounts than controls, whereas 
relative 18:0 levels were generally increased and 16:lw9 
decreased. Also, lymphocytes dosed with p-oils generally 
contained significantly more 18:2w6 and 18:3w3 than 
controls, but PDFA levels were parallel to controls, or 
significantly decreased.
16:0 amounts increased to 42.7%, 48.8% and 57.1% with 
20, 40 or 60mg/l p-C0 incubation, respectively (7.7% in 
controls), which accounted for the largest incorporation 
of 16:0 across the spectrum of p-oils dosed. 18:0 and 
18:lu9 levels also increased (12.9%, 8.5% and 14.0%, and 
21.1%, 21.0% and 19.3% vs 6.3% and 11.7% in controls, 
respectively), but practically no 16:lu9 was found (7.9% 
in controls). PUFA levels were parallel to controls, or
Legend to Table 4,2.3.1.
All values are tabulated as relative percent total area. 
Control values are reported as mean±s.e.m., where "n* is 
the number of experiments. 'Cp-OilU' refers to the 
pseudo-oil concentration used.
The fatty acid spectrum of cat lymphocytes.
FATTY ACID 
SPECTRUM 
(*)
CONTROLS 
(n=3)
Z p - c o i
(mg/1)
20 ! 40 ! 60
Cp-MOU 
(mg/1)
20 ! 40 ! 60
Cp-003 
(mg/1)
20 ! 40 ! 60
Cp-sso:
(mg/1)
20 i 40 60
Cp-lo:
(mg/1)
20 ! 40 ! 60
Cp-EPOD 
(mg/1)
20 1 40 ! 60
Cp-FOT (mg/1)
20 ! 40 ! 60
SA 16:0 7.7±0.30 42.7 48.8 57.1 27.1 30.0 35.8 18.6 16.2 14.0 16.4 18.9 16.8 26.0 20.6 17.8 20.3 21.4 19.3 43.7 29.0 25.7
Tu 18:0 6.3±0.30 12.9 8.5 14.0 11.6 15.6 18.3 2.4 1.4 1.5 26.1 6.7 5.4 9.8 5.0 6.8 24.3 9.9 6.5 7.9 3.4 8.3
RA 20:0 8.0±0.30 - 0.1 0.1 - - - - - - - - - - - - - - - - - -
T
E
22:0 - - - - - 0.1 - - - - 0.2 - - - - 0.^ - 0.2 - - - 0.1
S. 24:0 0.5 0.3
' '
0.3 ““ — —
u9
M
16:1 7.9±0.25 - 0.3 - - - - 0.1 0.3 - 0.5 0.3 0.1 - 0.2 - 1.1 0.5 0.7 16.2 28.8 25.6
0
N
18:1 11.7±0.10 21.1 21.0 19.3 33.7 30.9 30.2 65.6 72.7 75.1 27.7 33.1 36.1 38.5 33.8 27.7 15.4 21.1 19.3 16.7 22.1 22.7
0
s.
24:1 — — — — - - - - - - - - - - - - - - -
18:2 3.7±0.10 3.6 1.5 1.0 10.7 9.7 8.9 6.3 4.9 5.5 16.3 29.9 37.5 7.0 12.4 14.0 13.1 37.6 46.8 4.2 7.1 10.5
co 6
18:3 - *S - - - - - - - - - - - - - 0.1 0.2 - 1.3 2.4 - - -
p 20:2 — - 0.2 0.3 — - - 1.5 1.3 2.2 - - - 0.4 0.1 0.4 - - - 0.5 0.6 1.8
01 20:3 3.5±0.15 - 0.3 0.2 0.1 - 0.1 - - - - 0.1 0.1 - - - - 0.5 - - 0.1 -
Y
S.
20:4 0.2±0.00 0.4 0.3 0.2 - 1.0 1.0 - - - - 0.2 0.1 - 0.2 0.1 - 0.2 0.1 - 0.1 0.1
22:4 34.6±2.50 16.0 12.8 5.6 .10.4 8.8 4.1 4.3 1.9 1.2 8.3 7.9 2.7 12.5 4.9 1.4 19.8 3.9 3.5 7.0 4.5 1.4
22:5 2.2±0.05 0.7 0.8 0.2 — 0.5 0.1 0.1 0.2 — 0.5 0.7 — 0.4 0.3 0.1 0.6 0.9 - 0.2 0.4 0.1
18:3 0.1±0.00 1.1 0.8 0.4 5.7 1.1 0.8 0.1 0.2 0.1 - 0.1 0.1 4.6 20.6 30.9 - - - 0.5 0.5 1.0
u 3 18:4 7.3+0.35 0.8 1.1 0.3 0.2 0.9 0.1 0.2 0.5 - 1.5 0.8 0.2 0.5 0.4 0.1 1.2 1.2 0.1 0.3 0.4 -
Pn 20:4 6.8+0.05 0.7 2.4 1.3 0.5 1.5 0.4 0.9 0.3 0.3 2.5 0.9 0.3 0.4 1.3 0.3 4.1 1.4 0.5 1.4 0.7 0.5
Lv 20:5 0.2±0.00 - 0.5 - 0.1 - 0.1 - - - - - - - - 0.1 - - 0.2 1.3 2.2 2.3
s. 22:5 - - 0.2 0.1 - - 0.1 - - - - - - - -0.1 - - - - - - -
22:6 — — 0.2 — — 0.1 0.1 — 0.1 — - - 0.3 — 0.2 - — — 0.4 — 0.1 0.1
significantly decreased.
Lymphocyte supplementation with 20, 40 or 60mg/l p-MO 
caused a concentration dependent increase in 16:0 and 
18:0 (27.1 %, 30.0% and 35.8%, and 11.6%, 15.6% and 18.3% 
us 7.7% and 6.3% in controls, respectively), and 18:lu9 
increased about 3 fold in relation to controls (11.7%). 
18:2co6 percentages similarly increased 2 to 3 fold (3.7% 
in controls) and 20:4w6 was slightly increased with 40 
and 60mg/l p-MO (1.0% each vs 0.2% in controls), yet 
other w6 PDFA levels, especially 22:4u6, were decreased. 
No significant increment in w3 PDFA's percentages were 
found, despite increased amounts of 18:3u3 (0.8% to 5.7% 
vs 0.1% in controls).
16:0 levels increased approximately two fold and 18:lu9 
six fold with p-00 dosage in relation to controls (7.7% 
and 11.7%, respectively), whereas 18:0 and 16:lw9 were 
significantly decreased (0% to 0.3% and 1.4% to 2.4% vs 
7.9% and 6.3% in controls, respectively). Increments in 
18:2u6 and 20:2w6 were found (4.9% to 6.3% and 1.3% to 
2.2% vs 3.7% and 0% in controls, respectively), but 
the other PUFA percentages approximated to controls, or 
were decreased.
v
p-SSO dosage increased lymphocyte 16:0 (16.4% to 18.9%
vs 7.7% in controls) and 18:lu9 (27.7% to 36.1% vs 11.7% 
in controls) levels with all concentrations, and induced 
a 4 fold increase in 18:0 with 20mg/l p-SSO (26.1% vs
6.3% in controls), although 16:lw9 levels were decreased 
(<0.5% vs 7.9% in controls). 18:2w6 amounts increased 
markedly with 20, 40 and 60mg/l p-SSO incubation (16.3%, 
29.9% and 37.5%, respectively vs 3.7% in controls), yet 
the percentages of al1 other w6 series PDFA's were 
significantly decreased, particularly 22:4w6 (8.3%, 7.% 
and 2.7%, respectively vs 34.6% in controls). w3 PUFA 
levels were also lower than, or parallel to, controls.
16:0 and 18:0 levels increased 2 to 3 fold with p-L0 
supplementation in relation to controls (7.7% and 11.7%, 
respectively), 18:0 amounts were more variable (5.0% to 
9.8% vs 6.3% in controls), but no 16:lw9 was found (7.9% 
in controls). No significant increments in PDFA levels 
were shown, despite the concentration dependent increase 
in 18:2to6 and 18:3w3 (7.0% to 14.0% and 4.6% to 30.9% vs 
3.7% and 0.1% in controls, respectively).
Cells dosed with p-EPO contained little 16:lu9 (0.5% to 
1.1% vs 7.9% in controls), but increased levels of 16:0 
(19.5% to 20.3%), 18:0 (6.5% to 24.3%) and 18:lu9 (15.4% 
to 21.1%) in relation to controls (7.7%, 6.3% and 11.7%, 
respectively). 18:2w6 incorporation increased from 3.7% 
in controls to 13.1%, 37.6% and 46.8% with 20, 40 and 
60mg/l p-EPO, respectively, while 1.3% and 2.4% 18:3w6 
was found with 40 and 60mg/l p-EPO, respectively (0% in 
controls). No significant increments in other w6 PDFA 
levels were detected, however, and this was also true
for u>3 PUFA amounts.
Cells supplemented with 20, 40 or 60mg/l p-FO exhibited 
increased levels of 16:0 (43.7%, 29.0% and 25.7%, 
respectively vs 7.7% in controls), 16:lw9 (16.2%, 28.8% 
and 25.6%, respectively vs 7.9% in controls) and 18:lu9 
(16.7%, 22.1% and 22.7%, respectively vs 11.7% in 
controls), whereas 18:0 amounts were more variable (3.4% 
to 8.3% vs 6.3% in controls). Both 18:2w6 and 20:2w6 
amounts were raised in dosed cells (4.2% to 10.5% and 
0.5% to 1.8% vs 3.7% and 0% in controls, respectively), 
but no increment in PDFA's was found. 18:3w3 levels were 
increased 5 to 10 fold (0.1% in controls), but 18:4w3 
and 20:4w3 amounts were considerably decreased (<0.4% 
and ^1.4% vs 7.3% and 6.8% in controls, respectively). 
20:5w3 was incorporated into lymphocytes dosed with 20, 
40 or 60mg/l p-F0 (1.3%, 2.2% and 2.3%, respectively vs 
0.2% in controls), but no significant changes in 22:5w3 
or 22:6w3 levels were detected.
4.2.4 Effects of pseudo-Qils on Lipid Peroxide
Formation.
Table 4.2.4.1. shows the 1ipoperoxides measured both in 
control and dosed lymphocytes, as well as the respective 
spent incubation media. The results are shown as nmoles 
MDA/106 cells, but in the case of the spent incubation 
media this represents the nmoles of MDA in the volume of 
medium from which 1x10s cells were obtained.
Lipoperoxide levels in dosed lymphocytes ranged from 0.6 
nmoles MDA/106 cells (with 20mg/l p-CO or p-MO dosage) 
to 72.4nmoles MDA/106 cells (with 60mg/l p-FO dosage), 
compared to 0.3nmoles MDA/106 control cells. Cellular 
MDA concentrations increased with the amount of p-oil 
dosed, but no clear relationship was found between lipid 
peroxide production and degree of p-oil unsaturation. 
Cells dosed with 20mg/l p-CO or p-MO formed identical 
lipoperoxide amounts (0.6nmoles MDA/106 cells), although 
concentrations were greater with 40 and 60mg/l p-CO than 
p-MO (3.3 and 6.1 vs 2.0 and 2.7nmoles MDA/106 cells, 
respectively). Similar lipoperoxide amounts were induced 
with incubation of 20, 40 or 60mg/l p-L0 or p-00 (2.0, 
5.0 and 17.9, and 2.1, 8.8 and 18.5nmoles MDA/106 cells, 
respectively), whereas p-EP0 and p-SSO induced smaller 
amounts (0.9, 2.1 and '8.4, and 1.1, 1.1 and 2.9nmoles 
MDA/106 lymphocytes, respectively). The largest overall 
increment in cellular 1ipoperoxides, however, occurred
Lipid peroxide formation by cat lymphocyte cultures 
incubated uiith p~oils. expressed as nmoles MDA/105 cells.
pseudo-
Oil
CELLS
(mg/1) 0 20 40 60
Contro1 0.3
CO 0.6 3.3 6.1
MO 0.6 2.0 2.7
00 2.1 8.8 18.5
SSO 1.1 1.1 2.9
L0 2.0 5.0 17.9
EPO 0.9 2.1 8.4
F0 1.8 16.0 72.4
pseudo- SPENT INCUBATION MEDIUM
Oil
(mg/1) 0 20 40 60
Control -
CO - - -
MO - - -
00 - - 18.1
SSO - - -
L0 - - 18.7
EPO - - -
F0 - - -
with p-FO dosage (1.8, 16.0 and 72.4nmo1es MDA/106 cells 
with 20, 40 and 60mg/l, respectively).
Spent growth medium derived from lymphocyte cultures 
supplemented with 60mg/l p-00 or p-LO contained similar 
1ipoperoxide amounts (18.1 and 18.7nmoles MDA/106 cells, 
respectively), but these compounds were absent in all 
other spent medium, including that in which control 
lymphocytes were cultured.
4.2.5 Discussion.
No reference has been found in the 1iterature in which 
the effects of exogenous FA's on the growth of cat 
lymphocytes cells has been .investigated. This study 
showed that supplementation of cat lymphocytes with 
p-oils modulated cell viability. The effects induced, 
however, were not consistent with the degree of p-oil 
unsaturation, thus it was not always clear whether 
PUFA-rich exhibited greater cytotoxic potential than 
those abundant in monoenoic or saturated FA's (Figs. 
4.2.1.2-4.2.1.8.). Such differences may relate to p-oil 
FA synergism and antagonism, which could also explain 
the different effects p-oils of similar FA composition 
induced. In the case of cells dosed with p-EPO or p-SSO, 
the effects induced reflected the abundance of LA, but 
the significantly greater cytotoxic capability of the 
former probably related to the presence of 9*4 GLA in 
such (Table 2.3.3.2.). Comparison of the cell viability 
changes p-SSO, p-EPO, p-LO and p-00 induced with the FA 
compositions of these p-oils suggested that GLA was a 
more effective cytotoxic agent than ALA and OA, whereas 
LA was least effective. This may relate to the fact that 
GLA is a PDFA, while ALA, OA and LA are J6D substrates. 
PDFA involvement in the inhibition of cat lymphocyte 
viability was therefore possible, particularly since 
p-FO contained the greatest PDFA levels (about 19*4) and 
also induced the greatest cytotoxicity. p-MO was less
effective in killing lymphocytes, but this probably 
related to the very small amount of PDFA present (about 
2% AA). The fact that lymphocyte viability was reduced 
to a greater extent with p-CO than p-MO or p-SSO 
dosage, however, also implied saturated FA involvement 
lymphocyte killing. The findings presented, therefore, 
indicated that the modulation of cat lymphocyte 
viability related to the specific combination of p-oil 
FA's and the structures of those moieties, which could 
have influenced membrane fluidity when incorporated.
The f inding that total cellular protein concentrations 
increased as greater amounts of p-oil were dosed (Table
4.2.2.1.), irrespective of the cell viability changes 
induced (Figs. 4.2.1.2-4.2.1.8.), implied FA involvement 
in the stimulation of lymphocyte protein synthesis. The 
greater enhancement of protein levels with p-oils rich 
in saturated, than monenoic or polyenoic, FA's suggested 
that the modulation of protein synthesis related partly 
to differences in FA structure, although the mediation 
of synergistic/antagonistic effects between p-oil FA's 
possibly also played a role in the effects observed. 
Increased lymphocyte protein may nevertheless reflect 
promotion of lymphocyte activation, increased enzyme 
expression to metabolise the exogenous FA's incorporated 
with p-oil dosage, and/or increased membrane protein 
synthesis to maintain plasma membrane integrity damaged 
directly by p-oil dosage or indirectly by 1ipoperoxides
(Table 4.2.4.1.), which have the capability to damage 
membrane proteins (eg. Gavino et al 1981c and Morisaki 
et al 1982b).
Comparison of the FA spectra of control and dosed cells 
(Table 4.2.3.1.) indicated that cat lymphocytes have no 
significant capability to desaturate PUFA's, and even 
the elongation steps appeared to be suppressed. This was 
consistent with the overall lack of desaturation ability 
first reported in the cat by Rivers et al (1975a) and 
Frankel et al (1978). Lack of such potential, however, 
did not appear to be due to a lack of p-oil uptake since 
FA analysis of dosed lymphocytes revealed that the p-oil 
FA components increased with the p-oil concentration 
dosed (Table 4.2.3.1.). Although 16:0 elongation to 18:0 
was suggested with 20mg/l p-SSO or p-EPO dosage, such 
seemed unlikely as one would have expected significantly 
greater amounts of 16:0 to have been elongated with p-CO 
supplementation considering the large proportions of 
this moiety incorporated (Table 4.2.3.1.). The fact that 
increased 18:0 was not detected in cells dosed with 
p-00, despite the presence of 16:0, but not 18:0, in 
this p-oil (Table 2.3.3.2.), indeed supported the lack 
of 16:0 elongation. The inability to desaturate 16:0 was 
evident; whether A9D expression occurred was unclear, 
however. All dosed cells contained increased 18:lw9 
proportions, but this could merely reflect relative PUFA 
decreases (Table 4.2.3.1.) and/or the fact that all
p-oils contained 18:lw9 (Table 2.3.3.2.). Despite large 
amounts of 16:lu9 incorporated with p-FO incubation, 
elongation of this moiety appeared to be suppressed as 
cellular 13:lw9 percentages were parallel to, or lower 
than, that in cells dosed with other p-oils.
The lack of desaturase cascade capability demonstrated 
in cat lymphocytes did not relate to p-oi1-induced 
cytotoxicity (Figs. <1.2.1.2-4.2.1.8 . ) , as desaturase and 
elongase capability did not improve even when p-oil 
supplementation induced little effect on cell viability 
compared to controls. This implied that the lack of 
desaturase cascade enzyme expression was an inherent 
property of cat lymphocytes. The alterations induced in 
lymphocyte FA profiles with p-oil incubation and the 
inability to desaturate/e1ongate FA's implied that these 
cells could not re-established membrane fluidity and 
that this contributed to the lymphocyte death reported 
(Figs. 4.2.1.2-4.2.1.8. ).
MDA measurement in control and dosed lymphocytes (Table
4.2.4.1. ) implied intact cellular enzymic and/or non- 
enzymic mechanisms for the generation of 1ipoperoxides. 
Control lymphocytes contained large PUFA proportions 
(Table 4.2.3.1.), thus the small 1ipoperoxide amounts 
quantitated could well reflect cellular anti-oxidant and 
enzymic mechanisms of protection against free radical
attack. It was also possible that cellular PUFA's were
present as components of complex membrane lipids, which 
would thus not be so readily accessible to oxidation, 
particularly if PGL cycling occurred slowly. On the 
other hand, the greater 1ipoperoxide amounts induced 
with incorporation of dosed p-oils reflected saturation 
of the cellular anti-oxidant mechanisms and increased 
FFA availability. The quantitative variations in MDA 
levels measured, however, related to the different p-oi1 
FA compositions (Table 2.3.3.2.) and FA susceptibility 
to oxidation.
The presence of 5°i OA but no PUFA's in p-CO suggested 
that the cellular 1ipoperoxides this p-oil induced 
resulted from monoenoic FFA oxidation, particularly 
since cellular OA proportions increased almost 2 fold 
with p-CO dosage (Table 4.2.3.1.) and a mechanism for 
oleate oxidation has been reported (Frankel 1984). It 
was also possible that p-CO dosage enhanced PGL cycling 
and the liberation of free PUFA's from membrane lipids. 
The significantly lower cellular 1ipoperoxide amounts 
quantified with dosage of p-MO, p-SSO or p-EPO, compared 
to p-00, p-LO or p-FO, suggested that more substrates 
for peroxidation were lipid bound and stable with 
incubation of the former group, despite all these p-oils 
containing significant amounts of unsaturated FA's. 
Alterations in PGL turnover could also account for these 
findings. The cellular 1ipoperoxides formed with dosage 
of p-SSO or p-EPO, which showed similar FA compositions,
probably related largely to oxidation of incorporated 
LA, although the greater lipoperoxide amounts found with 
p-EPO reflected the presence of GLA in this p-oil only. 
The 1arger proportions of OA found in cells with p-00, 
than ALA with p-LO, supplementation, and the greater 
susceptibility of ALA to oxidation could explain the 
similar lipoperoxide amounts these p-oils induced. On 
the other hand, measurement of the largest cellular 
lipid peroxide amounts with p-FO incubation reflected 
the availability of EPA, which is a better substrate for 
oxidation.
Cat lymphocytes incorporated p-oil FA's from the growth 
medium (Table 4.2.3.1.), thus the spent media lipid 
peroxides found with 60mg/l p-00 or p-LO supplementation 
probably reflected cellular 1ipoperoxides released upon 
cell lysis. The absence of MDA in all other spent media 
when p-oils induced cellular 1ipoperoxides and cyto­
toxicity, however, suggested lipoperoxide retention in 
the cell membranes, particularly with p-FO dosage.
The in verse correlation found between MDA levels (Table
4.2.4.1.) and cell viability (Figs. 4.2.1.2-4.2.1.8.) 
with increased p-oil dosage suggested lipid peroxide 
involvement in the modulation of lymphocyte viability. 
This was supported by the fact that p-MO and p-SSO 
generated the lowest cellular MDA amounts and the least 
reduction in cell viability, whereas p-FO induced the 
highest cellular MDA concentrations and the greatest
cytotoxicity. The finding that the 1ipoperoxide levels 
found did not always correlate quantitatively with the 
degree of cytotoxicity induced with p-oil incubation, 
however, suggested that these compounds were only partly 
involved in the modulation of cat lymphocyte viability. 
The data presented rather suggested that both 1ipid 
peroxides and membrane fluidity changes were involved in 
the modulation of the effects induced.
4.3 THE EFFECTS OF PSEUDO-OILS ON CELLS
DERIVED FROM CAT AORTIC ENDOTHELIUM.
4.3.1 Effects of pseudo-Qils on Cell Viability.
The cultured cells were examined microscopica11y before, 
during and after each experiment and at no time were any 
morphological changes observed between control or dosed 
cells, except for cytoplasmic droplets observed with 
p-oil supplementation at high concentrations in some 
instances.
The effects of albumin, with final medium concentrations 
ranging from 0 to 250mg/l, were investigated, and found 
to have no significant effect, on cell viability (Fig.
4.3.1.1.), nor were any synergistic effects induced. 
Thus, the effects induced with the p-oils dosed were a 
result of the exogenous FA's and not the albumin used as 
FA carrier.
The number of control cells, seeded at lOxlO^/ml, at the 
end of the 24 hour post-trypsinisation recovery period, 
was 10.5xl0a/ml. This equated to 80'S of the final 
control cel 1 number at the end of the 48 hour incubation 
period, and represented the cytostatic number. Hence, 
only p-oil concentrations reducing cell viability to 
significantly below 80^ were considered cytotoxic.
Figs. 4.3.1.2-4.3.1.8. show the effects of p-oil dosage
The results are expressed as mean percent (%) cell 
viabi1ity±standard error of the mean (s.e.m.), where *n‘ 
is the number of experiments. 'The concentrations given 
are as mg albumin or pseudo-oil per litre of growth 
medium. Fig. 4.3.1.1. shows the mean percent cell 
viability versus the albumin concentration (mg/1), and 
Figs. 4.3.1.2-4.3.1.8. depict the mean percent cell 
viability versus the pseudo-oil concentration (mg/1). 
Fig. 4.3.1.9. shows the mean percent cell viability 
versus the albumin concentration (mg/1) for cells dosed 
with the amount of pseudo-oil which limits cell 
viability to 50% of the controls.
A1bumin 
Concentration 
(mg/1)
Mean — s ♦ ©«m • n
0 100.0 i.i 12
25 97.8 2.1 12
50 97.8 3.6 12
75 100.0 3.1 12
100 104.3 3.3 12
125 102.6 1.0 12
150 102.6 2.6 12
175 97.8 3.0 12
200 101.2 3.0 12
225 101.7 1.9 12
250 103.0 1.8 12
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 2.8 6
10 96.9 7.0 6
20 88.2 5.1 6
30 89.0 5.1 6
40 102.5 3.9 6
50 87.9 6.6 6
60 94.2 4.1 6
70 62.8 3.0 6
80 64.0 3.3 6
.90 52.2 3.9 6
100 49.4 2.0 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m . n
0 100.0 3.5 6
10 95.7 3.1 6
20 100.9 3.6 6
30 89.3 5.6 6
40 96.3 3.2 6
50 90.0 4.2 6
60 88.4 2.2 6
70 83.9 4.3 6
80 00 »-* 4.3 6
90 79.8 5.5 6
100 85.6 4.8 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 2.8 6
10 102.1 1.6 6
20 104.8 2.3 6
30 111.4 4.4 6
40 107.9 2.6 6
50 107.3 4.6 6
60 96.8 2.5 6
70 89.5 3.7 6
80 72.4 2.5 6
90 54.0 2.8 6
100 48.9 2.5 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 3.2 6
10 111.9 5.0 6
20 113.4 6.1 6
30 111.4 5.7 6
40 137.4 1.6 6
50 110.9 3.4 6
60 115.8 4.3 6
70 106.6 5.4 6
80 121.7 4.6 6
90 105.2 4.5 6
100 98.2 4.2 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 4.5 6
10 81.6 4.9 ' 6
20 71.2 3.8 6
30 87.1 5.9 6
40 81.7 4.0 6
50 73.4 3.4 6
60 82.1 4.9 6
70 63.0 4.3 6
80 58.4 2.6 6
90 51.1 6.7 6
100 56.9 3.0 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 2.3 6
10 100.4 2.3 6
20 97.0 2.9 6
30 92.5 2.9 6
40 86.6 1.1 6
50 85.5 2.1 6
60 83.2 3.1 6
70 76.9 2.2 6
80 79.5 2.2 6
90 72.0 1.9 6
•100 64.6 4.3 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 4.0 6
10 108.1 6.1 6
20 95.4 4.0 6
30 105.4 6.9 6
40 104.4 6.0 6
50 93.7 6.8 6
60 106.0 5.3 6
70 87.7 4.1 6
80 93.7 3.8 6
90 81.2 6.8 6
100 66 • 3 2.8 6
A 1 b u min 
Concentration 
(m g / 1 )
Mean ± s .e.m . n
0 100.0 2.1 6
175 48.0 7.4 6
200 48.7 4.7 6
225 48.9 3.5 6
250 49.1 4.4 6
300 52.2 3.3 6
350 48.6 2.9 6
on cat endothelial cell viability. Growth limiting 
effects were generally induced, but some p-oils also 
stimulated and/or inhibited cell proliferation with 
particular concentrations. The magnitude of effects 
induced, however, were dependent on the p-oil and 
concentration dosed. p-SSO exhibited the greatest 
potential to stimulate cell proliferation, whereas p-CO, 
p-00 and p-LO were most growth inhibitory. ID50 values 
could, however, only be calculated for cell dosed with 
p-CO or p-00 (99mg/1 each).
No major changes in cell viability occurred overall with 
10 to 60mg/l p-CO dosage, while higher concentrations 
induced cytotoxicity such that 49.4% of cell were viable 
with 100mg/l (Fig. 4.3.1.2.).
Cell growth largely approximated to controls with up to 
40mg/l p-MO incubation (Fig. 4.3.1.3.). Growth limiting 
effects were induced with higher amounts, in a general 
concentration dependent manner, to yield a minimum of 
79.8% viable cells with 90mg/l p-MO. Cytostasis was 
induced with this concentration as the relative cell 
number approximated to the cytostatic number (80%). p-MO 
was ineffective in inhibiting cell growth.
10, 20 and 60mg/l p-00 had little effect on cell 
viability, but this was increased to 111.4%, 107.9% and 
107.3% with 30, 40 and 50mg/l p—00, respectively. 
(Table 4.3.1.4.). Cell growth was limited with 70mg/l
p-OO, while concentration dependent cytotoxicity was 
induced with concentrations of 80mg/l or greater such 
that 48.9% of cells were viable with 100mg/l p-00.
Cell proliferation was enhanced with up to 90mg/l p-SSO 
supplementation (Fig. 4.3.1.5.). An increment of 5% to 
15% was generally observed, although concentrations of 
40 and 80mg/l p-SSO enhanced cell viability to 137.4% 
and 121.7%, respectively. 100mg/l p-SSO induced little 
effect on cell growth as viability was 98.2%.
p-LO concentrations up to 60mg/l largely induced cyto- 
stasis as relative cell viability approximated to the 
cytostatic number (80%). Higher concentrations resulted 
in toxicity, but cell viability was 51.1% and 56.9% even 
with 90 and 100mg/l p-LO, respectively (Fig. 4.3.1.6.).
p-EPO induced an overal1 concentration dependent growth 
1imiting effect with concentrations up to 50mg/l, 
although cell growth was not significantly different 
from controls with concentrations up to 20mg/l (Fig. 
4.3.1.7.). 60 to 80mg/l p-EPO induced cytostasis, while 
greater amounts were cytotoxic and progressively reduced 
cell viability to a minimum of 64.6% with 100mg/l p-EPO.
Cell growth generally approximated to that of controls 
with up to 60mg/l p-FO dosage, although 108.1% viability 
occurred with a concentration of 10mg/l (Fig. 4.3.I.8.). 
70 and 80mg/l p-F0 limited pro!iferation marginally, 
90mg/l p-FO induced cytostasis, and cytotoxicity reduced
cell viability to 66.3°4 with 100mg/l p-FO.
To exclude the possibility that any of the effects 
induced with p-oil dosage were influenced by the amount 
of albumin used as FA carrier, cells were incubated with 
a fixed amount of p-00 (corresponding with its IDso, 
about 99mg/l), but varying albumin concentrations. Six 
concentrations were chosen around which to vary the 
albumin amount, viz. 2 points above, 3 points below, and
the ID50 of p-00, and the appropriate amount of albumin 
added to cultures to give the desired concentrations. 
The results are shown in Fig. 4.3.1.9., which indicated 
that the amount of p-00 dosed reduced cell viability to 
approximately 50% of controls, and that such was not 
influenced by the albumin concentration present as FA 
carrier. Hence, synergistic effects of albumin could be 
excluded, and the effects induced with the p-oils were 
solely due to the exogenous FA's.
Cat aortic endothelial cells were subsequently plated 
and dosed appropriately with 0, 20, 40 or 60mg p-oil/1 
culture medium in sufficient amounts for all qualitative 
and quantitative analyses to be carried out. Upon 
harvesting, cell viabilities were compared and found 
not to be statistically different from those in Figs. 
4.3.1.1-4.3.1.8. All further biochemical assays were 
thus performed on these samples.
4.3.2 Effects of pseudo-Qils on Total Protein.
The total cellular protein concentrations determined 
with 0, 20, 40 or 60mg/l p-oil dosage are shown in Table 
4.3.2.1. expressed as jug total protein/106 cells seeded.
424.4yg protein per 106 control cells seeded was found. 
Cells supplemented with 20mg/l p-LO contained 396.1jug 
protein per 106 cells seeded, but all other dosed cells 
contained greater amounts of total protein than control 
cells, with the highest concentration measured being 
656.3,ug per 10s cells seeded, obtained with 40rng/l p-SSO 
supplementation. The total cellular protein content 
decreased with increasing concentrations of p-MO or 
p-EPO supplemented (554.3 to 454.0 and 515.5 to 455.8 
Aig/10s cells seeded, respectively), whereas the reverse 
was demonstrated for cells incubated with p-LO or p-FO 
(396.1 to 497.7 and 501.5 to 533.4jug/10^ cells seeded, 
respectively). With p-CO, p-00 or p-SSO dosage, however, 
the protein increment was greatest with a concentration 
of 40mg/l (563.7, 524.3 and 656.3jug/10^ cells seeded, 
respectively) and least with 20mg/l (444.7, 491.3 and 
540.5/jg/106 cells seeded, respectively).
The protein content of cells derived from cat aortic 
endothelium, expressed as jug total protein/10& cella 
seeded.
pseudo-
Oil
CELLS
(mg/1) 0 20 40 60
Control 424.4
CO 444.7 563.7 475.6
MO 554.3 508.5 454.0
00 491.3 524.3 506.3
SSO 540.5 656.3 602.5
L0 396.1 491.3 497.7
EPO 515.5 463.1 455.8
F0 501.5 524.3 533.4
4.3.3 Effects of pseudo-Oils on the Fatty Acid
*
Spectrum of Cells Derived From Cat Aortic
Endothelium.
The FA spectra of cells incubated with 0, 20, 40 or 
60mg/l of each of the p-oils is depicted in Table 
4.3.3.1. Major FA's detected in control cells were 16:0 
(19.9%), 18:0 (15.8%), 18:lw9 (21.2%), 20:4u6 (5.3%), 
20:4w3 (5.4%) and 22:4w6 (15.5%). Varying amounts of 
these FA's were detected in dosed cells.
The levels of 16:0 and 18:0 were parallel to controls or 
decreased, whereas 16:lw9 and 18:lw9 levels were more 
varied. Dosed cells contained raised 18:2w6 percentages, 
and significant increments in 20:3w6 and 20:4w6, but not 
22:4w6 and 22:5w6, were noted with certain p-oils and 
concentrations. Dosed cells exhibited considerabl1y less 
18:4w3 and 20:4w3 than controls, whereas 18:3u)3, 20:5w3, 
22:5w3 and 22:6w3 levels were parallel to controls or 
increased.
Supplementation with 20, 40 or 60mg/l p-CO induced no 
marked changes in 16:0 and 18:lu9 percentages (21.7% to 
24.3% and 20.5% to 25.4% vs 19.9% and 21.2% in controls, 
respectively), whereas 18:0 levels were decreased (10.8% 
to 12.8% vs 15.8% in controls). 16:lw9 amounts were 
similar with 0 and 20mg/l p-C0, but enhanced with 40 and 
60mg/l p-CO (2.1%, 1.8%, 3.0% and 3.5%, respectively). 
20:3w6 and 20:4w6 levels were slightly increased (2.1%
All values are tabulated as relative percent total area. 
Control values are reported as mean±s.e.m., where n is 
the number of experiments. ‘Cp-OilH" refers to the 
pseudo-oil concentration used.
Table 4 ♦ 3 ♦ 3.1.
The fatty acid spectrum of cells derived from cat: 
aortic endothelium.
FATTY ACID 
SPECTRUM 
(*)
CONTROLS
(n=3)
Cp-c o:
(mg/l)
20 ! 40 ! 60
Cp-Mon 
(mg/l )
20 ! 40 ! 60
C p - o o :
(mg/l)
20 ! 40 ! 60
CP-SS03 
(mg/l)
20 ! 40 ! 60
Cp-LOH 
(mg/l)
20 ! 40 ! 60
Cp-EPOD 
(mg/l)
20 ! 40 ! 60
Cp-F03 
(mg/l)
20 ! 40 ! 60
S
A
16:0 19.9±0.35 22.0 21.7 24.3 19.6 19.8 23.9 17.2 16.4 17.5 17.8 15.9 13.9 18.5 16.6 17.3 18.2 15.8 16.1 18.6 16.8 16.6
Tu 18:0 15.8±0.40 12.8 11.8 10.8 12.6 13.1 13.7 9.0 8.0 6.9 11.5 10.3 8.5 12.0 10.7 9.6 12.0 10.5 9.5 11.4 9.2 6.8
RA 20:0 0.6+0.00 - 0.2 - - 0.2 - - - - - 0.1 - - 0.1 - - - - - - -
TF 22:0 0.9±0.00 0.1 0.1 0.2 0.1 0.2 0.1 - 0.2 - - 0.1 - - - 0.1 - 0.1 0.1 - 0.1 0.1
s . 24:0 0.2+0.00 0.2 0.1 — — 0.2 - 0.1 - - - 0.2 - - 10.1 - 0.4 0.2 — - -
u9
M
16:1 2.1±0.05 1.8 3.0 3.5 1.2 1.6 2.5 1.5 1.7 3.0 1.3 1.9 1.3 1.4 1.5 2.7 1.1 1.7 2.4 6.2 11.9 17.8
0
N
18:1 21.2±0.30 22.6 20.5 25.4 22.3 21.5 23.5 33.3 42.8 45.2 21.2 20.2 21.2 21.4 18.2 17.9 18.3 15.5 14.8 20.1 18.1 18.9
0
S.
24:1 — — — — — — — — — — — - — - - - - - 0.4 - -
18:2 3.0±0.05 ' 4.8 3.2 4.5 6.0 6.3 9.3 6.9 9.1 10.0 15.9 25.1 35.7 7.7 8.2 10.4 17.1 26.2 32.7 5.6 5.6 8.0
u6
18:3 - 0.3 - 0.3 0.3 - 0.2 0.2 - 0.2 0.2 - 0.2 0.2 - 0.2 0.4 0.5 1.3 0.2 - 0.1
p 20:2 — 0.1 0.1 0.2 0.2 0.3 0.3 0.7 1.7 1.8 0.5 1.3 1.7 0.2 0.2 0.2 0.6 1.0 1.2 0.2 0.5 0.6
01 20:3 1.8±0.05 2.3 2.4 2.1 2.4 2.6 2.1 1.8 1.7 1.1 1.9 2.1 1.7 1.9 1.7 1.2 3.7 4.5 4.2 1.8 1.8 1.2
Y S. 20:4 5.3+0.15 8.9 8.6 7.2 10.0 10.2 9.2 6.6 5.5 3.6 6.1 5.8 4.3 7.9 7.3 5.6 6.2 5.5 3.9 6.7 5.4 4.1
22:4 15.5+0.50 15.4 16.7 12.1 16.6 13.7 8.2 15.4 5.7 6.4 17.2 10.2 5.9 15.1 13.7 7.6 16.2 10.9 8.5 14.7 11.7 6.6
22:5 1.9±0.09 — 0.5 0.1 0.1 0.4 0.1 — 0.4 0.1 - 0.3 0.1 0.1 0.4 0.1 0.2 0.4 0.1 0.1 0.3 -
18:3 0.4±0.00 0.5 0.6 0.6 0.6 0.6 0.5 0.6 0.8 0.7 0.4 0.4 0.4 6.9 14.4 22.1 0.3 0.3 0.4 0.5 0.5 0.6
u3 18:4 3.0±0.10 0.4 1.1 0.3 0.3 1.3 0.2 0.2 0.9 0.2 0.2 0.6 0.2 0.3 0.9 0.2 0.3 0.8 0.2 0.4 0.5 0.3
Pn 20:4 5.4±0.05 1.3 1.6 1.2 1.6 1.9 0.4 1.6 0.5 0.5 1.4 1.0 0.4 1.6 1.6 0.8 2.1 1.3 0.7 2.8 2.3 1.3
LY 20:5 0.3±0.00 1.4 1.7 1.3 0.8 0.7 1.0 1.0 0.5 0.5 0.6 0.6 1.1 0.6 0.6 0.7 0.3 0.9 1.1 3.6 7.7 11.1
s . 22:5 1.5+0.05 3.0 2.9 2.6 3.0 2.9 2.3 2 . 2 2.0 1.3 2 . 2 2.1 1.6 2.5 2 .0 1.6 1.9 1.9 1.2 5.1 5.7 4.1
22:6 1.1±0.05 2.4 3.4 3.3 2.3 3.0 2.5 1.9 2 . 2 1.5 1.6 2.1 1.8 1.8 1.9 1.6 1.2 1.9 1.4 1.6 1.9 1.8
to 2.4% and 7.2% to 8.9% vs 1.8% and 5.3% in controls, 
respectively), but 22:4w6 levels were parallel to 
controls (15.5%) or decreased. The percentages of 18:4w3 
and 20:4u3 were significantly decreased in relation to 
controls (3.0% and 5.4%, respectively), although 20:5w3, 
22:5w3 and 22:6w3 amounts increased to a maximum of 
1.7%, 3.9% and 3.4% compared to 0.3%, 1.5% and 1.1% in 
controls, respectively.
No significant changes in 16:0 and 18:lw9 were found in 
cells dosed with p-MO, but 18:0 and 16:lu9 levels were 
parallel to controls (15.8% and 2.1%, respectively), or 
decreased. 18:2u6 incorporation increased 2 to 3 fold 
(6.0% to 9.3% vs 3.0% in controls), a small increase in 
20:3cj6 was found (2.1% to 2.6% vs 1.8% in controls), and 
20:4u6 increased approximate!y 2 fold (10.0%, 10.2% and 
9.2% with 20, 40 and 60mg/l, respectively vs 5.3% in 
controls). However, 22:4w6 levels were not significantly 
increased, and only very small amounts of 22:5w6 were 
found (<0.5% vs 1.9% in controls). p-MO decreased 18:4w3 
and 20:4u3 levels, but 20:5w3, 22:5w3 and 22:6w3 were 
significantly increased (0.8% to 1.0%, 2.3% to 3.0% and 
2.3% to 3.0% vs 0.3%, 1.5% and 1.1% in controls, 
respectively).
18:lw9 levels were increased with 20, 40 or 60mg/l p-00 
supplementation (33.3%, 42.8% and 45.2%, respectively vs 
21.2% in controls), whereas 16:0, 18:0 and 16:lw9 were
decreased relative to controls (19.9%, 15.8% and 2.1%, 
respectively). 18:2u6 percentages increased 2 to 4 fold 
(3.0% in controls), and a significant increase in 20:2u6 
was found, especially with 40 and 60mg/l p-00 (1.7% and 
1.8%, respectively vs 0% in controls). Except for 6.6% 
20:4w6 found with 20mg/l p-MO (5.3% in controls), other 
uj6 PDFA percentages were decreased, particularly with 
increasing amounts of p-00 dosed. p-00 induced similar 
changes in the u3 PUFA's as reported with p-CO and p-MO.
p-SSO incubation had little effect on cellular 18:lw9 
levels, induced a decrease in 16:0, 16:lw9 and 18:0 
(21.2%, 19.9%, 2.1% and 15.8% in controls, respectively) 
and resulted in a concentration dependent increase in 
18:2w6 (15.9%, 25.1% and 35.7% with 20, 40 and 60mg/l 
p-SSO, respectively vs 3.0% in controls). 20:2w6 was 
significantly increased with 40 and 60mg/l p-SSO (1.3% 
and 1.7%, respectively vs 0% in controls), but this was 
not found for other w6 PDFA's. The changes induced in 
w3 PUFA's were as reported above.
Saturated and monounsaturated FA levels approximated to 
controls or were decreased with p-LO incubation. 18:2w6 
amounts increased 2 to 4 fold (3.0% in controls) and a 
small increase in 20:4w6 was induced, but other u6 PDFA 
levels were not significantly increased. A concentration 
dependent increase in 18:3w3 was detected with 20, 40 or 
60mg/l p-LO dosage (6.9%, 14.4% and 22.1%, respectively 
vs 0.4% in controls). 18:4w3 and 20:4u3 levels, however,
were at least 3 fold lower than controls (3.0% and 5.4%, 
respectively), but there was a 2 fold increase in 20:5w3 
over the range dosed (0.6% to 0.7% vs 0.3% in controls). 
Increased levels of 22:5w3 and 22:6w3 were also found 
(1.6% to 2.5% and 1.6% to 1.9% vs 1.5% and 1.1% in 
controls, respectively), but these increments were not 
greater than shown with other p-oils.
16:0, 16:lu9, 18:0 and 18:lw9 amounts were parallel to 
controls (19.9%, 2.1%, 15.8% and 21.2%, respectively) or 
decreased in cells dosed with p-EPO. On the other hand, 
18:2w6 levels increased markedly (3.0%, 17.1%, 26.2% and 
32.7% with 0, 20, 40 and 60mg/l p-EP0, respectively), 
while smaller increments were found for 20:2w6 and 
18:3w6 (0.6%, 1.0% and 1.2%, and 0.4%, 0.5% and 1.3%, 
respectively vs 0% each in controls). 20:3w6 percentages 
increased 2 to 3 fold (3.7%, 4.5% and 4.2% with 20, 40 
and 60mg/l p-EPO, respectively vs 1.8% in controls), but 
concentration dependent decreases in 20:4w6 and 22:5w6 
were found (6.2%, 5.5% and 3.9%, and 16.2%, 10.9% and 
8.5% vs 5.3% and 15.5% in controls, respectively). p-EPO 
decreased 18:4w3 and 20:4w3 levels, but induced small 
increments in 20:5u3, 22:5w3 and 22:6w3 with certain 
concentrations.
16:0, 18:0 and 18:lw9 levels were parallel to controls 
or decreased when cells were dosed with 20, 40 or 60mg/l 
p-FO relative to controls (19.9%, 15.8% and 21.2%,
respectiuely) , but a concentration related increment in 
16:lu9 was found (6.2%, 11.9% and 17.8%, respectively us 
2.1% in controls). 18:2w6 incorporation was less marked 
(5.6% to 8.0% us 3.0% in controls), and PDFA leuels were 
parallel to controls or decreased. Significant increases 
in 20:5u3 and 22;5w3 were detected with 20, 40 and 
60mg/l p-FO (3.6%, 7.7% and 11.1%, and 5.1%, 5.7% and 
4.1% us 0.3% and 1.5% in controls, respectiuely), but 
the increment in 22:6w3 was smaller (1.6%, 1.9% and 
1.8%, respectiuely us 1.1% in controls).
4.3.4 Effects of pseudo-Qils on Lipid Peroxide
Format i on .
The 1ipoperoxides measured in control and dosed cells 
and their their respective spent culture media are shown 
in Table 4.3.4.1. The concentrations are expressed as 
nmoles MDA/106 cells, but in the case of the spent media 
this represent the nmoles of MDA in the volume of medium 
from which lxlO6 cells were obtained.
Lipoperoxide amounts generated by dosed cells ranged 
from a low of 0.9nmoles MDA/106 cells (obtained with 
20mg/l p-SSO, 20mg/l p-EPO or 60mg/l p-CO dosage) to a 
high of 2.4nmoles MDA/106 cells (induced with 60mg/l 
P~L0), compared to 0.8nmoles MDA/106 control cells. p-CO 
had little overall effect on lipoperoxide formation over 
the range dosed (0.9 to 1.Inmoles MDA/106 cells), while 
20, 40 and 60mg/l p-MO induced greater amounts (2.0, 1.5 
and 1.2nmoles MDA/106 cells, respectively). Dosage with 
20, 40 or 60mg/l p-L0 or p-FO generated similar levels 
of 1ipoperoxides (1.3, 1.7 and 2.4 vs 1.7, 1.6 and 2.1 
nmoles MDA/106 cells, respectively), whereas smaller 
amounts were induced with p-SSO (0.9, 1.3 and 1.Inmoles 
MDA/106 cells, respectively), p-EPO (0.9, 0.9 and 1.6 
nmoles MDA/106 cells, respectively) and p-00 (1.1, 1.0 
and 1.7nmoles MDA/106 cells, respectively).
Lipoperoxides were absent in spent control medium, while 
concentrations were greatest for medium dosed with
Lipoperoxide formation by cat aortic endothelial cultures 
incubated with p-oils, expressed as nmoles MDA/106 cells.
pseudo-
Oil
CELLS
(m g / 1 ) 0 20 40 60
Control 0.8
CO 1.0 1.1 0.9
MO 2.0 in• 1.2
00 1.1 1 . 0 1.7
SSO 0.9 1.3 1.1
L0 1.3 1.7 2.4
EPO 0.9 0.9 1.6
F0 1.7 1.6 2.1
pseudo- SPENT INCUBATION MEDIUM
Oil
(m g / 1 ) 0 20 40 60
Control -
CO - - 0 . 1
MO - - 0.3
00 - 0.1 0.1
SSO - 0.4 -
L0 0.1 0.4 1.1
EPO - 0 . 1 0.2
F0 o CO in•o 1.2
20, 40 or 60 p-FO (0.3, 0.5 and 1.2nmoles MDA/106 cells, 
respectively) or p-LO (0.1, 0.4 and 1.Inmoles MDA/106 
cells, respectively). Spent media from all other dosed 
cultures, however, contained fewer 1ipoperoxides (i0.4 
nmoles MDA/106 cells), or none at all.
4.3.5 Discussion.
Dosing primary cultures of cat endothelial cells with 
p-oils modulated the viability of such cells, although 
the effects induced were not consistent with the degree 
of p-oil unsaturation (Figs. 4.3.1.2-4.3.1.8.). Even 
p-oils of similar FA compositions induced different 
effects, suggesting that the particular p-oil FA 
composition (Table 2.3.3.2.) was important in the 
modulation of the effects reported. It was apparent that 
the presence of GLA only in p-EPO induced growth 
limiting and inhibitory effects, whereas its absence in 
p-SSO modulated extensive cell proliteration which could 
be largely related to an abundance of LA. GLA was thus 
a potent agent preventing the proliteration of these 
cells, unlike LA which promoted cell growth. ALA seemed 
less effective than GLA in this regard as the extent 
of growth inhibition induced with p~L0 was not 
significantly greater than with p-EPO incubation,
despite more ALA in p-LO than GLA in p-EPO (about 63‘4 vs 
9%, respectively). Such differences may relate to the 
different double bond positions in each trienoic FA and 
the fact that GLA is a PDFA, unlike ALA which requires 
prior delta-6-desaturation to become biologically active 
in the cat (Frankel et al 1978). On the other hand, 
counteraction between inhibitory and proliferative
effects modulated between different FA's in p-FO could 
account for the overall absence of marked cell viability
changes induced with supplementation of this p-oil. This 
may relate to the more even balance of saturated, 
monounsaturated and polyunsaturated FA's in p-FO. The 
involvement of p-oil FA synergism/antagonism could also 
partly account for the cell viability changes other 
p-oils induced. This phenomemon could explain the 
enhancement of cell pro 1iferation with low, and 
inhibition thereof with high, p-00 concentrations as a 
result of interations between OA with 'other FA's, as 
well as the particularly extensive capability of 40mg/l 
p-SSO to stimulate cell growth. It was nevertheless 
apparent from comparison of the p-oil FA spectra (Table 
2.3.3.2.) with the cell viability changes the p-oils 
induced (Figs. 4.3.1.2-4.3.1.8.) that different FA's, or 
combinations thereof, had the capability to stimulate, 
limit and/or inhibit cell proliferation to a greater or 
lesser extent.
The incorporation of p-oils and modification of the FA 
profiles of dosed cells in relation to controls (Table 
4.3.3.1.) could have modulated membrane fluidity and be 
an important mechanism whereby the p-oils induced cell 
viability changes. The greater complement of saturated 
FA s in p—CO than in p—MO, for example, may have shifted 
membrane fluidity to a less stable state by causing 
rigidification when dosed at high concentrations, thus 
inducing cell death. The presence of PUFA's and a 
greater complement of monoenoic FA's in p-MO, however,
may have been able to maintain membrane fluidity, and 
therefore cell viability, more effectively than p-CO. 
Despite the possible mechanisms by which cell viability 
was mediated, none of the p-oils and concentrations 
supplemented induced marked cytotoxicity (Figs. 4.3.1.2- 
4.3.1.8.). The ability of these cells to tolerate 
relatively large amounts of p-oil FA's possibly relates 
to fact that the endothelium in vivo is continuously 
exposed to FA's in the circulation and may therefore be 
relatively resistant to the effects thereof.
Supplementation of cultures with p-oils resulted in 
total cellular protein changes (Table 4.3.2.1.) which 
generally reflected the cell viability changes induced 
(Figs. 4.3.1.2-4.3.1.8.). However, the finding that cell 
numbers alone were unable to quantitatively explain the 
increased protein amounts found when cell proliferation 
was enhanced or limited implied FA involvement in the 
stimulation of cellular protein biosynthesis. The extent 
of protein stimulation varied with supplementation of 
identical concentrations of different p-oils, even when 
this yielded similar cell numbers, suggesting that FA's 
of different chain lengths and degrees of unsaturation 
vary in their capability to modulate protein synthesis. 
It was also likely that synergistic/antagonistic 
interactions between p-oil FA's played a role in this 
process. Alterations in the absolute amount of protein 
per cell could nevertheless reflect appropriate changes
in the expression of 1ipid metabolising enzymes as a 
result p-oil FA incorporation.
Increased PDFA formation in dosed cat endothelial cells 
compared to controls (Table 4.3.3.1.) suggested the 
capability for desaturation and elongation. However, the 
low 18:3u6 and 18:4w3 amounts formed, despite pronounced 
uptake of 18:2u6 with p-SSO or p-EPO and 18:3u3 with 
p-LO dosage, indicated impaired A6D capability in these 
cells. It was suggested therefore that 20:3w6 formation 
could have related to limited 18:2u6 elongation and 
J8-desaturation, although direct elongation of 18:3u6 
incorporated with p-EPO dosage could also account for 
the 20:3u6 increment found with this p-oil. Formation of 
small amounts of 20:4w6 was nevertheless consistent with 
limited J5D activity. This enzyme was also expressed 
with u3 PUFA's, although the inability to efficiently 
desaturate 18:3w3 incorporated with LA dosage implied 
utilisation of endogenous 18:4w3 and 20:4w3 as A5D 
substrates. This would indeed explain the significantly 
decreased 18:4w3 and 20:4u3 levels found in dosed cells. 
w3 PUFA profiles supported the potential for significant 
20:5u3 elongation and J4D expression, whereas the 
inability to efficiently elongate 20:4cj6 could account 
for the lack of 22*5w6 formation via .44D. This supported 
the greater activity of desaturase cascade enzymes with 
U)3 than w6 PUFA's (Brenner et al 1966, Mead et al 1976 
and Kanau et al 1977) and the potential of u3 PDFA^s to
suppress/inhibit further w6 PDFA formation (eg. Garcia 
et al 1965 and Sprecher 1981).
The above suggested a mechanism whereby cat endothelial 
cells could metabolise circulating PDFA's, but not 
EFA's. This was consistent with the in vivo studies 
of Rivers et al (1975a) and Frankel et al (1978) who 
demonstrated that the cat lacks the ability for A6~ 
desaturation, but not elongation, of FA's. Other in vivo 
studies also showed that the cat exhibits J5D capability 
(Sinclair 1979 and Davidson et al 1989, 1990a), although 
the presence or absence of J4D was not confirmed. 
None of the studies, however, investigated the potential 
for desaturation and elongation in cat endothelium. As 
the endothelium plays a central role in eicosanoid bio­
synthesis for vascular homeostasis (Moncada et al 1976a, 
1976b, 1984), its capability to desaturate and elongate 
PDFA's to generate eicosanoid precursors may partially 
explain the results we obtained. No consistent evidence 
to support desaturation or elongation of saturated and 
monounsaturated FA's was found, however, and this could 
reflect a 1ack/suppression of enzyme expression, or 
competitive inhibition by cellular polyenoic FA's which 
has been demonstrated in EFA/PDFA-sufficient states 
(eg. Brenner et al 1965a, 1965b, 19866, 1969, Brenner 
1977, Sprecher 1981 and Holman 1986a, 1986b).
The cell viability changes induced with p-oil dosage
(Figs. 4.3.1.2-4.3.1.8. ) had no significant effect on 
the desaturase cascade enzyme capability of these cells 
(Table 4.3.3.1.), and it was more likely that the 
relative amounts of cellular FA's, both of the same and 
different families, modulated enzyme expression by 
competitive interactions which have been well documented 
(eg. Mohrhauer et al 1963a, 1963b, Garcia et al 1965, 
Brenner et al 1966, Brenner 1974, Sprecher 1981, de 
Schriver et al 1982 and Nassar et al 1986). Evidence 
suggests that dietary FA's alter the lipid composition 
of microsomal membranes and that such is involved in the 
modulation of desaturase enzyme activity (Nervi et al 
1968, Kurata et al 1980, Garda et al 1984, 1985 and 
Garg et al 1988a, 1988b, 1988c). This probably occurred 
when p-oil incorporation modified the FA profiles of the 
dosed cells in relation to controls (Table 4.3.3.1.). It 
was theoretically possible that incubation of cells with 
saturated FA-rich p-oils induced a relative EFA/PDFA 
deficiency which enhanced desaturation and elongation of 
endogenous PDFA's in an attempt to restore membrane 
fluidity. This could well explain the greater 22j6w3 
amounts formed with supplementation of p-CO or p-MO than 
with p-oils abundant in unsaturated FA's.
MDA detection in cat endothelial cells both in the 
presence and absence of dosed p-oils (Table 4.3.4.1.) 
supported the ability of these cells to oxidise FA's 
enzymatically and/or via auto-oxidation when the
mechanisms of protection against free radical attack 
were saturated. Control cell lipid peroxides implied 
oxidation of endogenous unsaturated FA's released 
during the continuous cycling of PGL's, whereas enhanced 
lipid peroxide measurement in dosed cells additionally 
reflected oxidation of unsaturated p-oil FA's. This 
related to the p-oil concentration incubated, p-oil FA 
composition (Table 2.3.3.2.), and FA availability and 
susceptibility to oxidation.
The finding that cellular 1ipoperoxide formation with 
p-CO supplementation approximated to that of controls 
reflected the overall dearth of double bonds in the FA's 
comprising this p-oil. Quantitation of small cellular 
1ipoperoxide amounts also with dosage of p-SSO, 20 or 
40mg/l p-00 and 20 or 40mg/l p-EPO, despite these p-oils 
containing significant levels of unsaturated FA's which 
were incorporated (Table 4.3.3.1.), however, implied 
that the substrates for peroxidation were largely lipid- 
bound and stable, although oxidation of free LA and OA 
probably accounted for the significant increment in 
1ipoperoxide formation found with 60mg/l p-EPO or p-00 
dosage. The fact that cells incubated with 20 or 40mg/l 
p-MO exhibited the greatest AA levels (Table 4.3.3.1.) 
and induced similar or greater cellular 1ipoperoxide 
amounts than other p-oils at these concentrations could 
have related to the utilisation of free AA as a direct 
endoperoxide substrate. The reason why 1ipoperoxide
production decreased with increasing concentrations of 
p-MO supplemented was unclear, but may relate to the 
availability of unsaturated FA's for peroxidation. The 
amount and susceptibility of ALA in p-LO and EPA in p-FO 
could largely account for the fact that these p-oils 
induced the highest 1ipoperoxide concentrations overall, 
although the smaller amount of EPA in p-FO compared to 
ALA in p-LO (about 18% and 63%, respectively) supported 
the greater susceptibility of the former to peroxidation 
due to its greater chain length and number of double 
bonds.
The abundance of saturated FA^s in new growth medium 
(Table 2.3.3.3.), the capability of these cells to 
incorporate exogenous FA's (Table 4.3.3.1.), and the 
lack of p-oi1-induced cytotoxicity with concentrations 
of 20, 40 or 60mg/l (Figs. 4.3.1.2-4.3.1.8.) supported 
the likelyhood that the spent medium 1ipoperoxides 
(Table 4.3.4.1.) originated intracel1ular1y and were 
transfered into the incubation medium through the plasma 
membrane. This correlated with studies which implicated 
1ipoperoxides in increasing membrane permeability (Chio 
et al 1969, Mead 1976, Tappel 1980, Gavino et al 1981b, 
Morisaki et al 1982a and Frankel 1984). It was also 
possible that these spent medium 1ipoperoxides reflected 
released cellular FFA^s which were oxidised extra- 
cel lularly by released cellular peroxidising enzymes.
No correlation between 1ipoperoxide formation and growth
inhibition could be established due to the lack of 
cytotoxicity induced with 20, 40 or 60mg/l p-oil (Figs. 
4.3.1.2-4.3.1.8. ) , although these compounds should not 
be overlooked as a mechanism involved in the modulation 
of cell death at higher concentrations. Quantitative 
changes in 1ipoperoxide production (Table 4.3.4.1.) did 
not always reflect the alterations in cell viability 
induced with p-oil dosage (Figs. 4.3.1.2-4.3.1.8.), and 
membrane fluidity changes were proposed as playing a 
1arger role in the modulation of cat endothelial cell 
proliferation.
4.4 THE EFFECTS OF PSEUDO-OILS ON CELLS
DERIVED FROM CAT SKELETAL MUSCLE.
4.4.1 Effects of pseudo-Qi1s on Cell Viability.
Control cells were examined microscopically before, 
during and after each experiment and no .morphological 
changes were seen at any time. Cells dosed with p-oils 
were morphologically similar to controls, although 
cytoplasmic droplets were observed with p-oil incubation 
at high concentrations in some instances.
Final medium albumin concentrations ranging from 0 to 
250mg/l were found to induce no significant effect on 
cell viability (Fig. 4.4.1.1.), nor were any synergistic 
effects demonstrated. The effects induced with the dosed 
p-oils were therefore solely due to the exogenous FA's 
and not of the albumin used as FA carrier.
The number of control cells, seeded at 10xl04/ml, at the 
end of the 24 hour post-trypsinisation recovery period, 
was 11.5xl04/ml. This equated to approximately 674 of 
the final control cell number at the end of the 48 hour 
incubation period and represented the Cytostatic number. 
Only p-oil concentrations reducing cell viability to 
significantly below 674 were thus considered cytotoxic.
The results of the incubation of cells with p-oils are 
shown in Figs. 4.4.1.2-4.4.1.8. Low concentrations of
The results are expressed as mean percent (%) cell 
viabi1ityistandard error of the mean (s.e.m.), where *n‘ 
is the number of experiments. The concentrations given 
are as mg albumin or pseudo-oil per litre of growth 
medium. Fig. 4 . 4 . 1.1. shows the mean percent cell 
viability versus the albumin concentration (mg/1), and 
Figs. 4.4.1.2-4.4.1.8. depict the mean percent cell 
viability versus the pseudo-oil concentration (mg/1).
AT bumin 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 3.5 12
25 97.4 3.3 12
50 98.8 3.9 12
75 95.2 4.4 12
100 100.4 3.0 12
125 97.5 3.0 12
150 97.6 3.9 12
175 101.1 3.5 12
200 99.3 5.5 12
225 96.3 4.4 12
250 100.4 3.9 12
Pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 1.8 6
10 90.7 3.1 6
20 88.9 2.4 6
30 82.8 2.2 6
40 84.9 2.0 6
50 - 75.1 2.3 6
60 66.3 3.8 6
70 36.3 3.1 6
80 25.2 1.7 6
90 19.1 1.4 6
100 11.7 1.6 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 2.6 6
10 97.1 2.1 6
20 103.4 2.1 6
30 103.7 2.7 6
40 102.4 2.8 6
50 96.8 2.3 6
60 89.8 3.7 6
70 88.6 3.2 6
80 95.1 3.1 6
90 84.9 3.0 6
100 84.2 3.2 6
pseudo-Oi1 
Concentration 
(mg/1 )
Mean ± s .e.m . n
0 100.0 1.7 6
10 96.5 1.9 6
20 99.5 2.5 6
30 97.3 2.4 6
40 96.8 3.0 6
50 97.0 2.5 6
60 96.5 1.5 6
70 60.8 2.4 6
80 36.0 3.0 6
90 12.0 1.7 6
100 2.5 o in 6
pseudo-Oi1 
Concentration 
(m g / 1 )
Mean ± s.e.m . n
0 100.0 2.8 6
10 98.9 2.5 6
20 97.9 3.6 6
30 88.1 3.6 6
40 96.6 1.7 6
50 87.1 1.5 6
60 85.5 3.1 6
70 78.1 4.1 6
80 82.9 1.9 6
90 78.6 4.0 6
100 75.2 2.0 6
pseudo-Oi1 
Concentration 
(m g / 1 )
Mean ± 3 .e.m . n
0 100.0 3.5 6
10 103.4 4.1 6
20 104.5 2.5 6
30 102.4 2.8 6
40 109.9 3.4 6
50 99.3 2.8 6
60 98.0 3.6 6
70 95.2 2.5 6
80 95.9 4.3 6
90 79.1 2.7 6
100 63.0 2.6 6
pseudo-Oi1 
Concentration 
(m g / 1 )
Mean ±s.e.m . n
0 100.0 5.6 6
10 114.7 3.7 6
20 116.0 3.2 6
30 89.6 3.7 6
40 89.6 4.6 6
50 81.3 5.4 6
60 74.8 6.0 6
70 44.5 3.4 6
80 26.3 2.3 6
90 4.6 1.9 6
100 o CD 0.5 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m . n
0 100.0 2.6 6
10 100.6 3.6 6
20 101.7 3.5 6
30 HinCN 3.1 6
40 93.5 3.6 6
50 89.5 4.6 6
60 75.6 4.2 6
70 73.9 2.3 6
80 65.3 3.3 6
90 62.5 3.6 6
100 35.8 2.6 6
p-EPO and p-LO enhanced cell proliferation, whereas all 
p-oils were growth limiting, although this potential 
varied greatly in magnitude, depending both on the p-oil 
and concentration dosed. High concentrations of p-EPO, 
p-00, p-CO and p-FO, however, were cytotoxic. p-EPO 
induced the most dramatic overall changes in cell 
growth, while p-MO and p-SSO were the least effective.
p-CO supplementation induced growth limitation with 
concentrations up to 50mg/l and cytostasis with 60mg/l 
(Fig. 4.4.1.2.). Approximately 65mg/l p-CO reduced cell
viability by half (IDgo), whereas higher concentrations 
became progressive!y more cytotoxic such that 88.3% of 
cells took up Trypan blue with 100mg/l p~CO.
Dosage with up to 50mg/l p-MO had little effect on cell 
proliferation (96.8% to 103.7% viability), and greater 
concentrations induced some growth limitation (Fig.
4.4.1.3.). No ID50 could be calculated, however, since
even with 100mg/l p-MO, 84.2% of cells were viable.
Supplementation with up to 60mg/l p-00 also had little 
effect on cell viability (Fig. 4.4.1.4.). Concentrations 
of 70mg/l p-00 or greater, however, induced extensive 
cytotoxicity and reduced the number of viable cells in a 
concentration dependent fashion to 50% with 75mg/l. p-00
(ID5 0) and only 2.5% with 100mg/l p-00.
No significant changes in cell proliferation were found 
with 10, 20 or 40mg/l p-SSO incubation, whereas other
concentrations limited cell growth slightly to a minimum 
of 75.2% with 100mg/l (Fig. 4.4.1.5.). p-SSO did not 
induce cytostasis or cytotoxicity with any concentration 
dosed, thus no ID50 could be calculated.
Dosage with up to 80mg/l p-LO induced no marked changes 
in cell proliferation, although such was enhanced to 
109.9% with 40mg/l p-LO (Fig. 4.4.1.6.). Cell growth was 
limited to 79.1% with 90mg/l p-LO and 63.0% with 100mg/l 
p-LO, hence no ID50 could be determined.
Cell proliferation was enhanced to 114.7% and 116.0% 
with 10 and 20mg/l p-EPO, respectively, whereas 30 and 
40mg/l p-EPO both limited cell growth to 89.6%, compared 
to 74.8% with 60mg/l p-EP0 and 50% with approximately
68mg/l p-EPO (ID5 0 ) (Fig. 4.4.1.7.). Cytotoxicity was 
induced with higher concentrations, which reduced cell 
viability progressively to 4.6% with 90mg/l p-EPO and 
practically 100% of cells took up the Trypan blue with 
100mg/l p-EPO.
Dosage with up to 30mg/l p-FO induced little effect on 
cell viability, but this was progressively limited from 
93.5% to 73.9% with 40 to 70mg/l p-EPO, respectively 
(Fig. 4.4.1.8.). 80mg/l p-FO induced cytostasis as cell 
viability (65.3%) approximated to the cytostatic number 
(about 67%), but higher concentrations were cytotoxic. 
The number of viable cells yielded with 90mg/l p-FO was 
62.5%, compared to 50% with 95mg/l p-FO (IDSO), but this
was reduced markedly to 35.8% with 100mg/l p-FO.
Subsequent to these studies, cells derived from cat 
skeletal muscle were plated and dosed appropriate1y with 
0, 20, 40 or 60mg p-oil/1 culture medium in sufficient 
quantities for all the quantitative and qualitative 
analyses to be performed. Cell viabilities were compared 
upon harvesting and found to be statistically similar to 
those in Figs. 4.4.1.1-4.4.1.8. All further biochemical 
assays were therefore performed on these samples.
4.4.2 Effects of Pseudo-Oils on Total Protein.
The results in Table 4.4.2.1. show the total protein 
concentrations determined for dosed cells compared to 
contro1s.
Total protein concentrations in dosed cells ranged from 
271.6 to 418.9,ug/106 cells seeded (obtained with 60mg/l 
P~CO and 20mg/l p-EPO incubation, respectively) compared 
to 300. l,ug/106 control cells seeded. Cells supplemented 
with 60mg/l p-CO or p-FO contained slightly less protein 
than controls, but all other dosed cells exhibited more 
protein than controls. Protein concentrations decreased 
across the range dosed with p-CO, p-MO, p-EPO and p-FO 
(330.4 to 271.6, 383.1 to 348.5, 418.9 to 314.6 and 
376.5 to 285.8;ug/10& cells seeded, respectively), but 
increased slightly with p-SSO supplementation (348.2 to 
353.8,ug/106 cells seeded). p-LO induced more protein 
with a concentration of 40 than 20 or 60mg/l (377.5, 
368.1 and 363.2,ug/10G cells seeded), while the converse 
occurred with p-00 dosage (372.1, 383.6 and 383.3jug/10G
cells seeded).
The protein content of cells derived from cat skeletal 
muscle, expressed as jug total protein/106 cells seeded.
pseudo-
Oil
CELLS
(mg/1 ) 0 20 40 60
Control 300.1
CO 330.4 319.9 271.6
MO 383.1 352.8 348.5
00 383.6 372.1 383.3
SSO 348.2 350.6 353.8
L0 368.1 377.5 362.4
EPO 418.9 351.1 314.6
F0 376.5 348.6 285.8
4.4.3 Effects of Pseudo-Oils on the Fatty Acid
Spectrum of Cells Derived From Cat 
Skeletal Muscle.
Table 4.4.3.1. shows the FA spectra of cells incubated 
with 20, 40 or 60mg/l of each of the p-oils in relation 
to controls.
The greatest proportion of any single FA in control 
cells was 18:lu9 (21.1%). Significant amounts of 16:0, 
18:0 and 22:4w6 were also found (15.3%, 14.5% and 17.1%, 
respectively), whereas smaller percentages of 16:lu9 and 
20:4w6 were detected (5.8% and 8.2%, respectively).
The relative amounts of 16:0, 16:lw9 and 18:0 were
generally lower in dosed cells than in controls. The 
converse was true for 18:lu9 and 18:2w6, yet PDFA levels 
were generally lower in dosed cells. Similarly, w3 PUFA 
levels were generally parallel to controls or decreased.
Cellular 16:0 and 18:lu9 levels increased with 20, 40 or 
60mg/l p-C0 supplementation (20.3%, 24.6% and 25.7%, and 
23.9%, 25.4% and 27.5% vs 15.3% and 21.1% in controls, 
respectively), 18:0 decreased over the same range 
(13.7%, 12.5% and 11.2%, respectively vs 14.5% in
controls), and an increase in 16:lw9 was detected only 
with 60mg/l p—CO (8.5% vs 5.8% in controls). PUFA levels 
were parallel to controls or decreased, although 22:6w3 
was slightly increased (3.6%, 3.2% and 2.9% with 20, 40
All values are tabulated as relative percent total area. 
Control values are reported as mean±s.e.m., where "n* is 
the number of experiments. "Cp-OilU" refers to the 
pseudo-oil concentration used.
The fatty acid spectrum of cells derived from cat 
skeletal muscle.
FATTY ACID 
SPECTRUM 
(*)
CONTROLS 
(n =3 )
Cp-COZI 
(mg / 1)
20 ! 40 ! 60
Cp -MOD 
(mg/ 1)
20 ! 40 ! 60
Cp - 003  
(m g / 1 )
20 1 40 ! 60
Cp -SSOD
(mg/ 1 )
20 ! 40 ! 60 20
Cp-LCG 
(mg/ 1) 
! 40 : 60
Cp -EPOII 
(mg/ 1)
20 ! 40 ! 60
Cp -f o :
(mg/ 1)
20 ! 40 ! 60
S
A
16:0 1 5 .3 ±0 .30 2 0 . 3 2 4 . 6 2 5 . 7 20 . 1 2 1 . 0 2 2 . 8 11 . 7 1 3 . 3 1 4 . 6 7 . 4 12 . 6 13 . 5 1 3 . 4 1 2.7 !13 . 6
l1
5 .9113 . 0 1 3 . 3 7 . 7 15 . 9 11 . 2
T
u
18:0 1 4 .5 ±0 . 29 1 3 . 7 1 2 . 5 1 1 . 2 16 . 1 1 4 . 4 12.1 2 0 . 2 6 . 0 5 . 5 2 9 . 6 9 . 1 8 . 7 1 3 . 3 9 .6 ! 8 . 4 3 1 .3 ! 9 . 7 9 . 3 2 9 . 5 8 . 4 14 . 3
R
A
20:0 0 .3 ±0 .00 - 0 . 1 - - 0 . 1 - - - - - - - - 0 .1 ! -
!_ i __i - - - 0 . 4
TE 22:0 0 .1±0 . 0 0 0 . 3 0 . 2 0 . 2 0 . 1 0 . 2 0 . 2 - - - - 0 . 1 - 0 . 1
!
0 .1 ! o.i - ! 0 . 2 - - 0 . 1 -
S . 24:0 0 .3 ±0 . 0 0 0 . 1 0 . 4 — — — 0 . 1 - . - - - 0 . 3 - - 0 .1 !111
0 . 1 - ! 0 . 5  1 1 i
0 . 4 - - -
u9
M
16:1 5 .8 ±0 . 06 3 . 9 5 . 1 8 . 5 1 . 6 1 . 9 3 . 6 0 . 8 1 . 5 2 . 1 0 . 4 1 . 6 2 . 0 1 . 7
!
1 .4 ! 2 . 4
11
0 .3 ! 1 . 6 1 . 5 4 . 3 17 . 8 1 4 . 3
0
N
18:1 2 1 .1±0 .10 2 3 . 9 2 5 . 4 2 7 . 5 2 4 . 5 2 4 . 6 2 6 . 4 4 1 . 9 4 9 . 9 5 5 . 1 2 5 . 9 2 0 . 9 2 2 . 6 2 0 . 5 1 7 .8 !16. 9 2 3 .9 114 . 7 1 4 . 9 3 0 . 7 19 . 8 2 2 . 2
0
S .
24:1 — — — — — — — . - - - - - - - 1_ 111111
-
!__ i _ iiii
- - - -
18:2 3 .3 ±0 .10 4 . 8 2 . 6 3 . 6 7 . 6 8 . 0 1 0 . 7 6 . 4 9 . 2 1 0 . 4 20 . 0 3 2 . 7 3 7 . 4 10 . 4
11
1 1 .0 !12.1
j
1 8 .8 134 . 5 4 1 . 1 1 2 . 3 6 . 9 11 . 5
u6
18:3 - o:4 0 . 1 0 . 4 0 . 3 0 . 1 0 . 3 0 . 1 0 . 1 0 . 3 1 . 9 0 . 2 0 . 9 0 . 7 0 .1 ! 0 . 3 5 .7 ! 1 . 2 2 . 3 - 0 . 1 1 . 2
P 20: 2 0 .2 ±0 .00 0 . 1 - - 0 . 3 0 . 6 0 . 3 2 . 9 1 . 8 1 . 8 1 . 0 1 . 6 1 . 4 0 . 2 0 .3 ! 0 . 2
l
1 .1 ! 1 . 4 1 . 2 - 0 . 5 3 . 5
0
L
20: 3 2 .9±0 .05 2 . 3 2 . 1 1 . 8 2 . 5 2 . 6 2 . 2 1 . 5 1 . 6 1 . 1 1 . 3 2 . 5 2 . 0 1 . 7 1 .5 ! 1 . 0 2 .1 ! 5 . 9 5 . 1 0 . 9 1 . 5 1 . 6
Y
S .
20: 4 8 .2 +0 . 1 0 7 . 8 7 . 2 5 . 9 9 . 1 9 . 5 8 . 5 4 . 0 3 . 6 2 . 6 2 . 8 4 . 4 2 . 9 7 . 3 6 .9 ! 4 . 9
1
2 .4 ! 4 . 5 3 . 0 2 . 5 4 . 7 2 . 3
22: 4 1 7 .1±0 .30 12 . 1 9 . 0 7 .0? 8 . 8 6 . 7 6 . 9 5 . 1 7 . 1 3 . 0 4 . 3 7 . 9 5 . 0 1 2 . 3 6 .7 ! 4 , 9 4 .5 ! 6 . 7 3 . 7 4 . 0 6 . 3 2 . 5
22: 5 0 .5 ±0 .00 — 0 . 5 — 0 . 1 0 . 7 — 0 . 1 0 . 2 - 0 . 1 0 . 3 - -
I
0 .3 !111
-
!
0 .1 ! 0 . 4111
0 . 1 0 . 1 0 . 4 0 . 1
18:3 0 .8 ±0 . 03 0 . 9 0 . 7 0 . 8 1 . 0 0 . 7 0 . 4 0 . 7 0 . 8 0 . 7 1 . 9 0 . 5 0 . 4 11 . 4
11
2 4 .5 !3 0 . 6
11
- ! 0 . 3 0 . 4 1 . 4 0 . 5 2 . 7
u3 18:4 0 .7±0 . 05 0 . 5 0 . 9 0 . 5 0 . 5 1.1 0 . 3 - 0 . 4 - 0 . 5 0 . 3 0 . 2 0 . 3 0 .5 ! 0 . 2
s
1 .0 ! 0 . 4 0 . 2 0 . 1 0 . 2 -
P
0
20:4 2 .1±0 .00 1 . 2 1 . 7 0 . 6 0 . 9 2 . 5 0 . 4 1 . 3 1 . 3 0 . 3 0 . 9 0 . 9 0 . 5 1 . 4 2 .3 ! 1 . 2 1 .2 ! 0 . 9 0 . 6 1.1 0 . 8 0 . 9
L
Y
20: 5 1 .2 ±0 . 0 5 1 . 0 1 . 0 1 . 1 0 . 6 0 . 4 0 . 6 0 . 2 0 . 4 0 . 3 0 . 1 0 . 7 0 . 3 0 . 6 0 .5 ! 0 . 5 0 .1 ! 0 . 7 0 . 4 2 . 4 8 . 5 7 . 2
S . 22: 5 3 .2 ±0 .00 3 . 1 2 . 7 2 . 4 3 . 0 2 . 5 2 . 0 1 . 7 1 . 4 1 . 0 1 . 1 1 . 7 1 . 2 2 . 9 -i.9 ; 1 . 3 0 .9 ! 1 . 7 1 . 2 2 . 5 6 . 0 2 . 9
22: 6 2 .4+0 . 1 0 3 . 6 3 . 2 2 . 9 3 . 0 2 . 5 2 . 2 1 . 6 1 . 6 1 . 2 0 . 9 1 . 7 1 . 3 2 . 0 1 .8 !
!ii
1 . 4 0 .7 ! 1 . 7  1 1j
1 . 3 0 . 7 1 . 9 1 . 3
and 60mg/l p-CO, respectively vs 2.4% in controls).
Incubation with 20, 40 or 60mg/l p-MO enhanced 16:0 and 
18:lu9 levels (20.1%, 21.0% and 22.8%, and 24.5%, 24.6% 
and 26.4% vs 15.3% and 21.1% in controls, respectively), 
had little overall effect on 18:0, but induced a marked 
reduction in 16:lu9 (1.6%, 1.9% and 3.6%, respectively 
vs 5.8% in controls). 18:2w6 increased significantly 
(7.6%, 8.0% and 10.7%, respectively vs 3.3% in controls) 
and little change occurred in 20:4u6 (9.1%, 9.5% and 
8.5%, respectively vs 8.2% in controls), whereas other 
to6 PDFA levels were parallel to controls or decreased. 
Dosed cells generally contained lower w3 PUFA amounts 
than controls, although 22:6w3 was slightly increased 
with 20mg/l p-MO (3.0% relative to 2.4% in controls).
18:lto9 was incorporated in a concentration dependent 
manner when cells were dosed with 20, 40 or 60mg/l p-00 
(41.9%, 49.9% and 55.1%, respectively vs 21.1% in 
controls). 16:0, 18:0 and 16:lw9 levels were lower than 
controls (15.3%, 14.5% and 5.8%, respectively), although 
18:0 was slightly increased with 20mg/l p-00 (20.2%). A 
concentration dependent increase in 18:2w6 was also 
demonstrated over the range dosed (6.4%, 9.2% and 10.4%, 
respectively vs 3.3% in controls), and there was a 
significant increase in 20:2w6 (2.9%, 1.8% and 1.8%, 
respectively vs 0.2% in controls). However, the levels 
of 20:3u6, 20:4w6, 22:4w6 and 22:5w6 were 1ower than 
controls (2.9%, 8.2%, 17.1% and 0.5%, respectively), as
were those of u3 PUFA's.
16:0 and 16:lu9 percentages were decreased with 20, 40 
or 60mg/l p-SSO incubation (7.4% to 13.5% and 0.4% to 
2.0% us 15.3% and 5.8% in controls, respective!y), 18:0
was increased only with 20mg/l p-SSO (29.6% vs 14.5% in 
controls), while little change occurred in 18:lw9 levels 
(21.1% in controls). 18:2w6 amounts increased in a 
concentration dependent fashion (3.3%, 20.0%, 32.7% and 
37.4% with 0, 20, 40 and 60mg/l p-SSO, respectively), a 
significant amount of 18:3w6 was found with 20mg/l p-SSO 
(1.9% vs 0% in controls), and 20:2w6 levels increased 
significantly over the range dosed (1.0%, 1.6% and 1.4%, 
respectively vs 0.2% in controls). All other u6 PDFA 
levels, however, were decreased with p-SSO dosage, and 
this was also demonstrated with w3 PDFA's.
Cells supplemented with p-L0 exhibited decreased amounts 
of 16:0 (12.7% to 13.6% vs 15.3% in controls), 16:lw9 
(1.4% to 2.4% vs 5.8% in controls), 18:0 (8.4% to 13.3% 
vs 15.4% in controls), and 18:lu9 (16.9% to 20.5% vs 
21.1% in controls). 18:2w6 levels increased 3 to 4 fold 
(10.4% to 12.1% vs 3.3% in controls) and 18:3w3 was 
markedly enhanced (11.4%, 24.5% and 30.6% with 20, 40 
and 60mg/l p-LO, respectively vs 0.8% in controls), but 
PDFA levels were not significantly raised.
p-EPO dosage decreased cellular 16:0, 16:lu9 and 18:0 
levels in relation to controls (15.3%, 5.8% and 14.5%,
respectively), although 18:0 increased approximately 2 
fold with 20mg/l p-EPO (31.3%). 18:lw9 percentages 
approximated to controls (21.1%) with 20mg/l p-EPO 
(23.9%), but were decreased with 40 and 60mg/l p-SSO 
(14.7% and 14.9%, respectively. A concentration related 
increment in 18:2w6 was demonstrated (3.3%, 18.8%, 34.5% 
and 41.1% with 0, 20, 40 and 60mg/l p-EPO, respectively 
vs 3.3% in controls), and 20:2w6 increased significantly 
(1.1% to 1.4% vs 0.2% in controls), as did 18:3w6 (5.7%, 
1.2% and 2.3%, respectively vs 0% in controls). Despite 
more 20:3w6 detected with 40 and 60mg/l p-EPO than in 
controls (5.9%, 5.1% and 2.9%, respectively), 20:4w6 
percentages decreased significantly (2.4%, 4.5% and 
3.0%, respectively vs 8.2% in controls) as did those of 
22:4w6 (4.5%, 6.7% and 3.7%, respectively vs 17.1% in 
controls). w3 PUFA levels approximated to, or were 
below, their respective control levels.
Cells enriched with p-FO exhibited 16:0 levels parallel 
to, or lower than, controls (15.3%). Increments in 18:0 
and 18:lw9 were detected with 20mg/l p-FO (29.5% and 
30.7%, respectively), while percentages were parallel to 
or lower than controls (14.5% and 21.1%, respectively) 
with 40 and 60mg/l p—FO. 16:lw9 proportions, however, 
increased significantly with 40 and 60mg/l p-FO (17.8% 
and 14.3%, respectively vs 5.8% in controls). 2 to 4 
fold more 18:2w6 was found (6.9% to 12.3% vs 3.3% in 
controls), and 20:2u)6 was significantly increased with
60mg/1 p—FO (3.5% vs 0.2% in controls), but this did 
not induce an enhancement in U)6 PDFA levels. p-FO dosage 
resulted in 20:5u)3 incorporation (2.4% with 20mg/l , 8.5% 
with 40mg/l and 7.2% with 60mg/l vs 1.2% in controls), 
yet 22:5w3 was increased only with 40mg/l p-FO (6.0% vs 
3.2% in controls), and 22i6u3 levels were decreased with 
all concentrations (0.7% to 1.9% vs 2.4% in controls).
4.4.4 Effects of Pseudo-Oils on Lipid Peroxide 
Format i on.
Table 4.4.4.1. shows the 1ipoperoxides measured both in 
control and dosed cells, as well as their respective 
spent growth media. The results are shown as nmoles 
MDA/106 cells, but in the case of the spent incubation 
medium, this represents the nmoles of MDA in the volume 
of medium from which lxlO6 cells were obtained.
Lipoperoxide production ranged from 0,5 to 1.8nmoles 
MDA/106 dosed cells (0.6nmoles MDA/106 control cells), 
and increased in an overal1 concentration dependent 
manner. Relatively little lipid peroxidation was induced 
when cells were supplemented with 20, 40 or 60mg/l p-CO, 
p-MO or p-00 (0.5 to 1.Inmoles MDA/106 cells). This was 
also found with p-SSO or p-EPO dosage (0.5, 0.7 and 1.0, 
and 0.7, 0.8 and 1.Inmoles MDA/106 cells, respectively), 
whereas greater amounts were induced with 40 and 60mg/l 
p—L0 (1.3 and 1.8nmoles MDA/106 cells, respectively) and 
P —F0 (1.1 and 1.8nmoles MDA/106 cells, respectively).
Lipoperoxides were absent in spent control medium, while 
concentrations were greatest for medium incubated with 
40 or 60mg/l p-LO (0.5 and l.Onmoles MDA/106 cells) or 
P —FO (1.1 and 1.2nmoles MDA/106 cells). Spent media from 
all other dosed cultures, however, contained fewer lipo­
peroxides (<0.4nmoles MDA/106 cells), or none at all.
Lipoperoxide formation by cat skeletal muscle cultures 
incubated uiith p-oils. expressed as nmoles MDA/10£ rells.
pseudo- 
Oi 1
CELLS
< mg/1 ) 0 20 40 60
Contro1 0.6
CO 0.6 0.6 0.7
MO 0.6 0.8 0.9
00 0.6 0.6 0.9
SSO 0.5 0.7 1. 0
L0 in•o 1.3 1.8
- EPO 0.7 0.8 1.1
F0 in•o 1.1 1.8
pseudo- SPENT INCUBATION MEDIUM
Oil
(mg/1) 0 20 40 60
Contro1 -
CO 0.2 0.2 0.2
MO - - -
00 - - * 0 . 1
SSO - - 0.4
L0 0.2 0.5 1. 0
EPO - - 0 . 1
FO 0 . 1 1.1 1.2
4.4.5 Discussion.
Supplementation of cat skeletal muscle primary cultures 
with p-oils modulated the viability of those cells 
in a p~oi1-specific manner (Figs. 4.4.1.2-4.4.1.8.), 
dependent on p-oil FA composition (Table 2.3.3.2.) and 
concentration dosed rather than the degree of p-oil un­
saturation or p-oil EFA/PDFA levels. The cell viability 
changes p-00, p-SSO and p-LO induced related primarily 
to the high OA, LA and ALA contents of these p-oils, 
respectively, and it was apparent that ALA was more 
effective than LA in reducing cell viability only at 
very high concentrations in the range dosed, although 
OA was more effective. The pronounced cell viability 
differences mediated with p-EPO or p-SSO dosage, which 
exhibited similar FA compositions, probably related to 
the presence of small amounts of GLA (about 9°4) in the 
former only. This FA appeared to be involved in the 
stimulation of cell proliferation with low, growth 
limitation with intermediate, and cytotoxicity with 
high, p-EPO concentrations in the range dosed. However, 
the finding that cell viability was unchanged or merely 
limited in the absence of GLA with p—SSO incubation 
implied that LA had no stimulatory or inhibitory effect 
on the proliferation of these cells. Comparison of the 
FA spectra of p-EPO and p-LO with the cell viability 
changes these p-oils mediated upon dosage also indicated 
that GLA (in p-EPO) exhibited greater capability to
modulate cell prol iferation than ALA (in p-LO). These 
differences could relate to the double bond positions in 
these trienoic C18 FA's. The fact that cell growth 
was significantly enhanced only with p-EPO or p-LO 
supplementation nevertheless suggested that the presence 
of 3 double bonds in an 18 carbon FA exhibited greater 
potential to stimulate the proliteration of these cells 
than FA's with other structures. Although the cell 
viability changes the dosed p-oils induced reflected the 
presence of particular exogenous FA's, it was also 
likely that synergistic and antagonistic interactions 
between p-oil FA's amplified or deminished certain 
effects. This could explain, for example, the dramatic 
cell viability changes p-EPO induced, the absence of 
marked alterations in cell viability overall with p-MO 
supplementation, as well as the capability of OA in p-00 
to alter cell viability only at high concentrations. The 
cell viability changes observed could nevertheless be 
the result of alterations in membrane fluidity induced 
as a result of differential p-oil FA incorporation 
(Table 4.4.3.1.). Rigidification of the plasma membrane 
could account for the progressive reduction in cell 
viability found with dosage of increasing amounts of 
p-CO, whereas the converse was suggested with p-FO, p-00 
and p-EPO.
p-Oil dosage induced alterations in total cellular 
protein (Table 4.4.2.1.) which generally reflected the
cell viability changes found (Figs. 4.4.1,2-4.4.1.8.). 
The measurement of increased cellular protein with 
20mg/l p-EPO incubation correlated with the greatest 
stimulation of cell viability reported, and possibly 
represented increased cell number with constant, or 
increased, protein per cell. The latter seemed more 
likely as consistent, but increased, protein levels were 
measured in cells dosed with p-00, despite the fact that 
cell viability was parallel to controls. Cells incubated 
with other p-oils which did not alter cell viability 
significantly in relation to controls, eg. 20mg/l p-MO, 
p-SSO, p~LO and p-FO, exhibited numerically different 
protein levels, but such were also increased in relation 
to controls. Increased cellular protein was even found 
when p-oils induced growth limitation, eg. 40mg/l p-CO, 
p-EPO and p-FO. On the other hand, the decreased protein 
found with 60mg/l p-CO or p-FO dosage implied decreased 
cell, number with constant or decreased protein per cell. 
It was apparent from these findings that exogenous FA's 
have the capability to modulate protein synthesis in cat 
skeletal muscle cells. Such varied with different p-oils 
and this may relate to differences in FA structure and 
the mediation of synergistic and antagonistic effects 
between p-oil FA's. Absolute changes in cellular protein 
could nevertheless reflect alterations in the production 
of enzymes required for the metabolism of incorporated 
p-oil FA's.
The literature does not describe the desaturation 
capability of cultured cat skeletal muscle cells. In 
vivo studies in our laboratory, however, showed that 
feeding cats diets either sufficient in all PDFA's, or 
deficient in u3, w6, or all PDFA^s, induced changes in 
the FA spectra of their skeletal muscle (Davidson et al 
1989, 1990a). Such indicated that A6D activity was 
absent, while evidence for J5D activity was found. As 
the diets were made more PDFA deficient, the proportion 
of 18:2w6 increased and a concommitant decrease was 
generally found for both w3 and w6 post-J5D FA's. The 
presence or absence of J4D, however, could not be proven 
(Davidson et al 1989, 1990a). The present study showed 
that the overall desaturation and elongation capability 
of cultured cat skeletal muscle cells was also poor, 
despite significant incorporation of the p-oil FA's 
supplemented (Table 4.4.3.1.). This implied that the 
increased cellular protein levels reported with p-oil 
incubation (Table 4.4.2.1.) did not reflect enhanced 
expression of desaturase cascade enzymes.
The finding that 16:0 percentages were significantly 
decreased and 18:0 increased only with 20mg/l p-SSO, 
P-EP0 or p-FO dosage suggested the capability for 16:0 
elongation. However, 18:0 desaturation via A9D seemed 
unlikely since 18:lu9 levels were not significantly 
enhanced, except with 20mg/l p-FO incubation. This could 
have related to elongation of 16:lw9 incorporated with
20mg/l FO dosage, although such activity was impaired 
with higher p-FO concentrations, despite cellular uptake 
of large amounts of this moiety from the medium. Little 
significant A6D capability was shown with incubation of 
18:2w6-rich p—oils (p—SSO or p-EPO). 20:2w6 formation 
thus resulted primarily from a build up of 18:2to6, some 
of which was elongated due to the lack, or suppression, 
of A6D activity. On the other hand, the small 18:3u6 
levels detected could have reflected extramicrosoma 1 
retroconversion of endogenous 20:3u6, which could 
account for the decreased levels of this moiety. 18:3w6 
incorporated with p-EPO dosage was elongated to 20:3u6, 
but J5- or ,44-desaturation of w6 PDFA's was not found in 
cells enriched with any p-oil. Elongation of 20 : 5u)3 
occurred with 40mg/l p-FO supplementation, but no 
evidence of J4~desaturation to 22:6w3 was found, nor 
was 18:3w3 incorporated with p-LO dosage significantly 
desaturated or elongated to PDFA's. Evidence to support 
desaturation and elongation of w3 PDFA's, however, was 
found with p-CO incubation. This p-oil did not contain 
PUFA's (Table 2.3.3.2.), thus the elevated 22:6w3 levels 
detected must represent desaturation/elongation of 
cellular w3 PUFA's. The finding that 18:3u3 and 18:4w3 
levels were similar to controls, whereas 20:4w3 amounts 
were decreased, suggested desaturation and elongation of 
endogenous 20:4u)3 to 22:6w3. This supported the absence 
of A6D, but not of J5D, elongase and ^4D, expression.
It was possible that supplemention of cells with p-CO 
increased the requirement for PDFA's, and this may have 
enhanced 22:6u3 production in a rather poor attempt to 
re-establish a more even balance between saturated and 
unsaturated FA's in the membranes. However, the level 
of 16:0 in the cells could still have been too high 
to maintain normal membrane fluidity, and the known 
inhibitory/suppressive effects of saturated FA's on A6D, 
J5D and J4D activities (eg. Brenner et al 1966) may also 
have limited the extent to which the desaturases were 
stimulated. Such factors could explain the decreased 
cell viability shown with p-CO incubation. In contrast, 
cells dosed with p-oils abundant in unsaturated FA's may 
already have achieved an optimum FA balance for 
maintaining membrane fluidity and other cell functions. 
Suppression of further desaturation would thus be 
consistent with maintenance of the existing FA balance, 
and such has been reported to occur via complex 
mechanisms, including feedback inhibition (Brenner 
1965a, 1965b, Holman et al 1964, Garcia et al 1965, 
Brenner et al 1966, 1967, 1969 and Actis Dato et al 
1970). Such control mechanisms may explain the lack of 
22:5w6 and 22:6w3 formation with p-MO or p-FO dosage in 
particular.
The poor desaturase/elongase capability reported overall 
in these cells (Table 4.4.3.1.) did not appear to 
relate to the cell viability changes induced with p-oi1
supplementation (Figs. 4.4.1.2-4.4.1.8.) as poor enzyme 
activity was found even when cell viability was parallel 
to, or greater than, controls. The overal1 FA balance in 
the cells, as well as competitive interactions between 
cellular FA's appeared to be more important factors 
explaining the desaturase cascade capability we reported 
for these cel Is.
The results obtained from MDA measurement following the 
48 hour incubation period showed that even in the 
absence of any exogenously added p-oil, control cells 
produced 1ipoperoxides (Table 4.4.4.1.). This was not 
surprising, since the FA spectra (Table 4.4.3.1.) showed 
FA's that were potential candidates to act as substrates 
for the formation of 1ipoperoxides. This could have 
occurred enzymatically and/or or via auto-oxidation of 
endogenous unsaturated FA's released during PGL cycling 
once the anti-oxidant defenses were saturated. Enhanced 
MDA formation with p-oil dosage additionally reflected 
oxidation of unsaturated p-oil FA's. The quantitative 
variations in MDA levels measured, however, related to 
differences in p-oil FA composition (Table 2.3.3.2.) and 
concentration supplemented, as well as FA availability 
and susceptibility to oxidation. The overall lack of 
double bonds in the FA's comprising p-CO could indeed 
explain why cellular lipoperoxide formation approximated 
to that of controls with incubation of this p-oil. On 
the other hand, the finding that p-MO, p-00, p-SSO or
p-EPO dosage induced small, or no increments in cellular 
1ipoperoxides, despite significant levels of unsaturated 
FA's in these p-oils which were incorporated (Tables 
2.3.3.2. and 4.3.3.1.), implied that the substrates for 
peroxidation were largely lipid-bound and stable. In 
contrast, the greatest lipoperoxide amounts measured 
overall with p-LO or p-FO dosage both in the cells and 
spent medium reflected the amount and susceptibility of 
ALA in p-LO and EPA in p-FO to oxidation, dependent not 
only on the number and position of double bonds in such 
FA's, but also on the availability of these moieties in 
the free form. However, the abundance of saturated FA's 
in new culture medium (Table 2.3.3.3.), the ability of 
these cells to incorporate p-oi1 FA's (Table 4.4.3.1.), 
the lack of cytotoxicity induced with 20, 40 or 60mg/l 
p-oil dosage (Figs. 4.4.1.2-4.4.1.8.), and the ability 
of 1ipoperoxides to increase membrane permeability (Chio 
et al 1969, Mead 1976, Pryor 1976, Tappel 1975, Gavino 
et al 1981c, Morisaki et al 1982b and Frankel 1984) 
suggested that most spent media 1ipoperoxides originated 
intracel1ular1y via passage through the plasma membrane.
Supplementation of cat skeletal muscle cells with 20, 40 
or 60mg/l p-oil stimulated and/or limited, but never 
inhibited, cell viability (Figs. 4.4.1.2-4.4.1.8), thus 
no correlation between lipoperoxide formation (Table 
4.4.4.1.) and cytotoxicity could be established; these 
compounds should, however, be considered -as a possible
mechanism involved in the modulation of cell death with 
higher p-oil concentrations. On the other hand, the 
inverse correlation found between MDA levels and cell 
viability with p-SSO, p-EPO or p-FO dosage suggested 
1ipoperoxide involvement in the modulation of growth 
limitation. The finding that the MDA levels found did 
not always correlate quantitatively with the degree of 
growth limitation the p-oils induced, however, indicated 
that 1ipoperoxides were only partly responsible for 
modulating the viability of these cells, and it was 
proposed that alterations in membrane fluidity were 
additionally involved.
4.5 THE EFFECTS OF PSEUDO-OILS ON CELLS
DERIVED FROM CAT BRAIN.
4.5.1 Effects of pseudo-Oils on Cell Viability.
Microscopic examination of control cells before, during 
and after each experiment showed no changes in cel 1 
morphology at any time, and p-oil dosed cells were 
morphologically similar to controls, except for cyto­
plasmic droplets observed with p-oil supplementation at 
high concentrations in some instances.
The effects of 0 to 250mg albumin/1 culture medium were 
investigated on cell viability and shown to have no 
significant effect (Fig. 4.5.1.1.), nor were synergistic 
effects induced. Hence, the effects induced with the 
dosed p-oils were a result of the exogenous FA's and not 
the albumin utilised as FA carrier.
The number of control cells, seeded at 10xl04/ml, at the 
end of the 24 hour post-trypsinisation recovery period, 
was 10.2xl04/ml. This equated to about 88% of the final 
control cel 1 number at the end of the 48 hour incubation 
period, and represented the cytostatic number. Only 
p-oil concentrations limiting cell viability to 
significantly below 88% were thus considered cytotoxic.
The results of the incubation of cells with p-oils are 
depicted in Figs. 4.5.1.2-4.5.1.8. Cell proliferation
The results are expressed as mean percent (%) cell 
viabi1ity±standard error of the mean (s.e.m.), where 'n' 
is the number of experiments. The concentrations given 
are as mg albumin or pseudo-oil per litre of growth 
medium. Fig. 4.5.1.1. shows the mean percent cell 
viability versus the albumin concentration (mg/1), and 
Figs. 4.5.1.2-4.5.1.8. depict the mean percent cell 
viability versus the pseudo-oil concentration (mg/1).
A1bumin 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 3.3 12
25 100.3 5.2 12
50 99.4 4.7 12
75 98.0 3.4 12
100 99.2 4.0 12
125 101.6 3.6 12
150 99.4 5.0 12
175 101.6 4.8 12
200 103.0 6.0 12
225 96.5 3.6 12
250 101.6 5.0 12
pseudo-Oi1 
Concentration 
. (mg/1 )
Mean ±s.e.m. n
0 100.0 4.0 6
10 94.6 5.0 6
20 87.0 3.2 6
30 94.6 5.7 6
40 66.5 4.3 6
50 52.2 2.7 6
60 47.0 3.8 6
70 42.4 4.2 6
80 35.9 5.0 6
90 27.2 4.6 6
100 12.0 3.9 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 4.3 6
10 105.0 4.7 6
20 99.2 4.4 6
30 97.5 4.2 6
40 90.1 6.3 6
50 83.3 4.8 6
60 71.9 3.8 6
70 64.5 4.1 6
80 57.0 4.9 6
90 47.1 3.2 6
100 26.5 3.3 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 5.1 6
10 103.3 4.0 6
20 103.3 1.8 6
30 113.1 2.3 6
40 104.1 3.7 6
50 95.0 4.1 6
60 67,3 1.5 6
70 44.1 1.6 6
80 2.5 1.0 6
90 00'iH 1.0 6
100 0.7 0.7 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 2.7 6
10 100.8 3.4 6
20 103.8 3.3 6
30 108.3 7.8 6
40 109.8 4.0 6
50 111.3 6.0 6
60 101.5 5.7 6
70 90.2 7.8 6
80 75.2 4.3 6
90 37.6 5.4 6
100 13.5 2.6 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m . n
0 100.0 3.3 6
10 100.3 3.2 6
20 95.5 2.1 6
30 93.1 1.7 6
40 99.7 2.8 6
50 88.1 2.6 6
60 72.6 2.1 6
70 47.3 3.2 6
80 11.9 1.7 6
90 2.5 1.4 6
100 2.5 1.2 6
pseudo-Oi 1 
Concentration 
(mg/1 )
Mean ±s.e.m. n
0 100.0 4.4 6
10 95.0 4.1 6
20 89.0 3.2 6
30 98.3 inin 6
40 89.0 4.9 6
50 84.2 3.8 6
60 63.6 4.4 6
70 54.8 in• 6
80 31.6 2.8 6
90 15.2 2.1 6
100 6.6 2.6 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 4.9 6
10 97.8 5.3 6
20 96.5 3.4 6
30 95.8 5.4 6
40 94.0 5.5 6
50 81.6 5.3 6
60 63.4 4.3 6
70 43.8 4.9 6
80 23.5 3.2 6
90 3.5 1.3 6
100 0.4 0.4 6
was significantly enhanced with certain concentrations 
of p-00 and p-SSO, but all p-oils were growth inhibitory 
with the cytotoxic potential varying in magnitude 
dependent on the nature of the p-oil and concentration 
dosed. Overall, p-CO was most, and p-SSO was least, 
effective in reducing the viability of these cells.
10 and 30mg/l p-CO had little effect on cell growth 
(Fig. 4.5.1.2.), but cytostasis was induced with 20mg/l 
p-CO as relative cell viability (87.0%) approximated to 
the cytostatic number (about 88%). Higher p-CO amounts 
induced concentration dependent cytotoxicity, and cell 
viability was reduced to 50% with 55mg/l p-CO (ID50) and 
to 12.0% with 100mg/l p-CO.
Cell proliferation was not significantly different from 
controls with up to 30mg/l p-MO dosage, cytostasis was 
induced with 40mg/l p-MO, but greater amounts of p-MO 
were increasingly cytotoxic in an almost 1 inear manner 
(Fig. 4.5.1.3.). Cell viability was 50% of controls with
about 88mg/l P-M0 (ID5 0), and this was reduced to 26.5% 
with 100mg/l p-MO.
Supplementation of cells with p-00 induced a sigmoidal-
like response (Fig. 4.5.1.4.). 10, 20, 40 and 50mg/l
p-00 had little effect on cell viability, but such was
enhanced to 113.1% with 30mg/l p-00. Concentrations
greater than 50mg/l p-00 were increasingly cytotoxic,
%and approximately 68mg/l p-00 reduced cell viability to
50% of controls (ID5 0 ). Only 2.5% of cells were viable 
with 80mg/l p-00, and practically all cells incorporated 
Trypan blue with 100mg/l p-00 dosage.
10, 20 and 60mg/l p-SSO had little effect on cell growth 
but such was enhanced to 108.3%, 109.8% and 111.3% with 
30, 40 and 50mg/l p-SSO, respectively (Fig. 4.5.1.5.). 
70mg/l p-SS0 induced cytostasis, whereas cytotoxicity 
reduced cell viability to 50% with 87mg/l p-SS0 (ID5 0 ) 
and only 13.5% of the cells survived after incubation 
with 100mg/l p-SSO.
Supplementation with up to 40mg/l p-L0 did not affect 
cell growth markedly (Fig. 4.5.1.6.), and cytostasis was 
induced with 50mg/l p-LO as relative cell viability 
(88.1%) and the cytostatic number (88%) were alike. 
Higher p-LO concentrations progressively inhibited cell 
growth to 50% with 69mg/l p-LO (ID50), 11.9% with 80rng/l 
p-LO and 2.5% with both 90 and 100mg/l p-LO.
10 and 30mg/l p-EP0 had little effect on cell viability, 
but this was reduced to 89.0% with both 20 and 40mg/l 
p-EPO such that cytostasis was induced (Fig. 4.5.1.7.). 
Concentrations of 50mg/l p-EP0, or greater, induced 
concentration dependent cytotoxicity, reducing cell 
viability almost linearly to 50% of controls with about 
74mg/l (ID5 0) and to 6.6% with 100mg/l.
Cell proliteration was not significantly altered with 
supplementation of up to 40mg/l p-F0 (Fig. 4.5.1.8.).
Higher concentrations, however, were increasingly toxic, 
and linearly reduced cell viability to 3.5% with 90mg/l 
p-FO and almost completely with 100mg/l p-FO. The ID50 
for p-FO, p-00 and p~LO were similar (approximately 
67mg/l, 68mg/l and 69mg/l, respectively), although the 
effects p-FO induced resembled those modulated by p-LO 
more closely than those for p-00.
Cells derived from cat brain were subsequently plated 
and dosed appropriate 1y with 0, 20, 40 or 60mg p-oil/1 
growth medium in sufficient amounts for all quantitative 
and qualitative analyses to be carried out. Cell numbers 
were compared upon harvesting with controls and found to 
be statistically similar to those obtained in Figs. 
4.5.1.1-5.5.1.8., thus all further biochemical assays 
were performed on these samples.
4.5.2 Effects of pseudo-Oils on Total Protein.
Table 4.5.2.1. shows the total cellular protein contents 
determined at each of the 3 p-oil concentrations dosed, 
compared to controls.
The amount of total protein found in dosed cells ranged 
from 106.4 to 220.7/jg/10s cells seeded (obtained with 
60mg/l p-CO and 40mg/l p-SSO dosage, respectively) in 
relation to 175.1,ug/10& control cells seeded. Cellular 
protein levels were parallel to controls or increased 
with supplementation of 20 or 40mg/l p-oil, but the 
converse was generally true with 60mg/l p-oil. Protein 
concentrations decreased across the range dosed with 
p-CO (205.7 to 106.4jug), p-MO (216.1 to 164.2,ug), p-00 
(219.5 to 142.7jug), p-EPO (198.1 to 139.8^g) and P-F0 
(209.6 to 153.9^g), but p-SSO and p-LO induced more 
protein with a concentration of 40 than 20 or 60mg/l 
(220.7, 186.1 and 216.9, and 216.1, 205.3 and 189.8/jg 
per 106 cells seeded, respective1y).
The protein content of cells derived from cat brain. 
expressed as ug total protein/lO5 cells seeded.
pseudo-
Oil
CELLS
(mg/1) 0 20 40 60
Control 175.1
CO 205.7 172.4 106.4
MO 216.1 201.8 164.2
00 219.5 215.3 142.7
SSO 186.1 220.7 216.9
L0 205.3 216.1 189.4
EPO 198.1 187.1 139.8
F0 209.6 182.9 153.9
4.5.3 Effects of Pseudo-Oils on the Fatty Acid
Spectrum of Cells Derived From Cat Brain.
Table 4.5.3.1. shows the FA spectra for cells incubated 
with 0, 20, 40 or 60mg/l p-oil.
The greatest proportion of any single FA in controls was 
18: lu)9 (33.7%), but significant levels of 16:0 (20.4%), 
18:0 (11.5%), 18:2u6 (7.2%) and 22:4w6 (10.0%) were also 
found. Dosed cells contained varying proportions of 
these FA's.
16:0 and 16:lw9 percentages were generally lower in 
dosed cells than in controls, while the converse was 
found for 18:0. 18:lu9 and 18:2(*)6 levels were more
variable, but more 20:3w6 was generally found in dosed 
cells, unlike 20:4u6, 22:4w6 and 22:5w6. In most
instances, however, dosed cells contained lower amounts 
of w3 PUFA's than controls.
Cel 1 ular 16:0 and 18:0 levels were decreased with dosage 
of 20 or 40mg/l p-CO, but increased with 60mg/l p-C0 
(9.8%, 2.2% and 32.3%, and 0%, 0.4% and 17.7% vs 20.4% 
and 11.5% in controls, respectively). A significant 
increment in 22:0 was detected with 60mg/l p-CO (1.2% vs 
0.5% in controls), 16:lw9 was considerably decreased 
with all concentrations dosed (0.2% to 1.3% vs 4.8% in 
controls), whereas 18:lio9 was greatly increased with 20 
and 40mg/l p-CO, but decreased with 60mg/l p-CO (77.5%,
All values are tabulated as relative percent total area. 
Control values are reported as meanis.e.m., where "n" is 
the number of experiments. ‘Cp-OilD* refers to the 
pseudo-oil concentration used.
The fatty acid spectrum of cells derived from cat brain.
FATTY ACID 
SPECTRUM 
(*)
CONTROLS 
(n=3)
Cp-c o:
(mg/1)
20 ! 40 ! 60
Cp-MOU 
< mg/1)
20 ! 40 ! 60
Lp-001 
(mg/1)
20 ! 40 1 60
Cp-SSOH 
(mg/1)
20 ! 40 1 60
Cp-LOII 
(mg/1)
20 ! 40 ! 60
Cp-EPOD 
(mg/1)
20 ! 40 ! 60
Cp-FOD 
(mg/1)
20 ! 40 ! 60
S
A
16:0 20.4±0.15 9.8 2.2 32.3 16.4 17.8 24.3 17.2 14.8 14.0 8.8 12.0 10.6 7.1 10.6 10.7 7.0 12.6 15.0 11.7 13.0 21.5
Tu 18:0 11.5±0.30 - 0.4 17.7 24.7 31.3 15.8 4.5 1.4 - - 17.3 20.7 13.5 21.1 21.2 12.7 20.7 34.4 38.5 25.9 15.8
RA 20:0
- - - - 0.3 - - - - - - - - - - - - - - - - -
TP 22:0 0.5±0.00 0.3 - 1.2 0.4 0.2 0.1 0.4 0.1 - - - - - - 0.1 - - - - - -
S. 24:0 0.1±0.00 — — 0.3 1.0 - 0.1 - - - - - - - - 0.1 0.3 1.7 - - -
w9
M
16:1 4. 8±0.10 0.8 0.2 1.3 0.1 0.3 0.6 2.9 - - 0.4 - - 1.1 - - 0.8 - - 4.3 10.8 17.4
0
N
18:1 33. 7±0.35 77.5 95.6 28.3 39.0 23.6 26.5 52.8 60.0 61.0 55.2 24.9 20.6 43.0 26.3 17.2 39.1 22.2 15.7 26.8 22.0 17.9
0
S.
24:1 — — — — — — - - - - - - - - - - - - - - -
18:2 7.2±0.00 - 0.1 1.8 2.0 3.7 7.0 3.1 4.2 8.2 16.2 22.2 32.5 20.9 11.7 9.8 16.9 20.9 20.8 1.8 3.6 6.1
u6
18:3 - - - - - 0.3 0.3 0.5 0.6 2.3 2.1 1.1 - 0.1 - - 2.2 1.4 - - -
P 20:2
- - - - 0.4 - - 0.4 0.9 1.4 - 0.8 0.6 - 0.3 - - 0.7 - - - -
0
L
20:3 1.1±0.10 - - 1.4 2.6 2.9 4.2 2.5 3.5 2.6 4.7 9.0 3.7 0.4 1.3 0.4 10.5 10.6 1.4 1.5 1.9 0.9
Y
S.
20:4 3.6±0.15 2.6 1.3 3.7 5.5 7.1 7.8 4.6 3.2 1.8 3.5 3.7 1.7 0.7 3.2 2.4 5.3 3.3 1.7 3.2 1.9 1.2
22:4 10.0±0,65 4.4 0.2 7.3 ,,3.4 6.7 8.7 6.0 7.3 7.2 5.8 4.4 5.8 1.0 4.1 4.6 3.4 4.3 5.2 5.1 8.4 7.4
22:5 0.3±0.03 — — —* 0.5 — — - - - - - - 0.1 0.2 - - 0.1 - - - 0.1
18:3 0.7±0.00 - - 0.7 - 0.4 0.5 0.6 0.8 0.5 - - 0.1 10.3 17.8 28.3 - - - — 0.2 0.4
u3 18:4 1.1±0.10 1.1 - 0.7 0.2 1.1 1.0 1.5 1.3 0.7 0.6 0.4 0.3 0.1 - 1.1 0.7 0.1 0.6 0.7 0.4 0.5
P
o
20:4 2.2±0.00 1.6 0.1 0.5 1.4 0.6 0.4 0.4 0.3 0.6 1.2 1.1 0.9 1.1 0.7 2.6 2.0 0.4 0.7 0.8 2.1 1.6
L
Y
20:5 0.1±0.00 - - 0.1 0.2 0.7 0.1 0.3 0.1 - - - - 0.1 0.3 - - - - 1.2 4.5 6.7
S. 22:5 0.9±0.09 0.3 0.1 0.9 0.6 0.8 0.7 0.8 0.4 0.4 0.3 C. 6 0.5 0.3 0.9 0.5 0.5 0.6 0.3 3.1 4.2 1.9
22:6 2.2±0.09 1.5 0.2 2.4 2.0 2.1 2.2 1.6 1.2 1.1 1.0 1.5 1.0 0.2 1.4 1.1 1.1 1.1 1.2 1.5 1.2
i
0.7
95.6% and 28.3%, respectively vs 33.7% in controls). 
PUFA percentages, however, were generally parallel to, 
or significantly lower than, controls.
p-MO supplementation had no significant effect on 16:0 
levels, but resulted in decreased 16:lw9 (0.1% to 0.6% 
vs 4.8% in controls) and increased 18:0 (15.8% to 31.3% 
vs 11.5% in controls), detection. On the other hand, 
18:lw9 levels were greater than controls (33.7%) with 
20mg/l p-MO, but were decreased with 40 and 60mg/l p-MO 
(39.0%, 23.6% and 26.5%, respectively). 18:2w6 amounts 
were parallel to controls (7.2%) or decreased (i7.0%), 
but 20:3w6 was significantly increased (2.6%, 2.9% and 
4.2% with 20, 40 and 60mg/l p-MO, respectively vs 1.1% 
in controls). Raised levels of 20:4u)6 were also found 
over the range dosed (5.5%, 7.1% and 7.8%, respectively 
vs 3.6% in controls), yet 22:4w6 and 22:5w6 percentages 
were parallel to controls (10.0% and 0.3%, respectively) 
or decreased. This was also found with io3 PUFA's.
Incubation with 20, 40 or 60mg/l p-00 induced marked 
increases in cellular 18:lw9 (52.8%, 60.0% and 61.0%, 
respectively vs 33.7% in controls), but 16:0, 16:lu9 and 
18:0 levels were decreased relative to controls (20.4%, 
4.8% and 11.5%, respectively). 20:2w6 was significantly 
increased with 60mg/l p-00 (1.4% vs 0% in controls) and 
20:3w6 percentages were raised at least 2 fold (2.5% to 
3.5% vs 1.1% in controls), but no marked increments in 
20:4u6, 22:4w6 or 22:5u6 were found. u3 PUFA percentages
were parallel to controls or decreased.
16:0 and 16:lw9 levels were significantly decreased with 
p-SSO supplementation (112.0% and 10.4% vs 20.4% and 
4.8% in controls, respectively). 18:0 levels increased 
over the range dosed (0%, 17.3% and 20.7%, respectively 
vs 11.5% in controls), but the converse was found for 
18:lw9 (55.2%, 24.9% and 20.6%, respectively vs 33.7% in 
controls). 18:2w6 increased in a concentration dependent 
manner (16.2%, 22.2% and 32.5% with 20, 40 and 60mg/l 
p-SSO, respectively vs 7.2% in controls) and significant 
increases in 18:3w6 and 20:3w6 were found with 20, 40
and 60mg/l p--sso (2.3%, 2.1% and 1.1%, and 4.7%, 9.0%
and 3.7% vs 0% and 1.1% in controls, respective!y).
However, subsequent desaturase and elongase product 
levels were parallel to controls or decreased. In every 
instance, the proportion of u3 PUFA's were decreased in 
dosed, compared to control, cells.
Considerably less 16:0 and 16:lu9 were detected in cells 
supplemented with p-LO than in controls (20.4% and 4.8%, 
respectively), while 18:0 was increased (13.5% to 21.2% 
vs 11.5% in controls). 18:lw9 increased significantly 
with 20mg/l p-LO dosage, but was decreased with 40 and 
60mg/l p-LO (43.0%, 26.3% and 17.2%, respectively vs 
33.7% in controls). 18:2to6 levels were significantly 
raised with 20mg/l p-LO (20.9% vs 7.2% in controls), and 
18:3w3 increased in a concentration dependent manner
with 20, 40 or 60mg/l p-LO supplementation (10.3%, 17.8% 
and 28.3%, respectively vs 0.7% in controls), yet PDFA 
levels were not significantly raised.
p-EPO supplementation decreased cellular 16:0 and 16:lu)9 
levels (7.0% to 15.0% and SO.8% vs 20.4% and 4.8% in 
controls, respectively), and 24:0 amounts were slightly 
increased with 60mg/l (1.7% vs 0.1% in controls). p-EPO 
increased 18:0 percentages in a concentration dependent 
manner (11.5%, 12.7%, 20.7% and 34.4% with 0, 20, 40 and 
60mg/l, respectively), whereas the converse occurred for 
18:lu9 (33.7%, 39.1%, 22.2% and 15.7%, respectively).
p-EPO dosage raised cellular 18:2u6 levels (16.9%, 20.9% 
and 20.8% with 20, 40 and 60mg/l, respectively vs 7.2% 
in controls), and 18:3w6 was significantly increased 
with 40 and 60mg/l p-EPO (2.2% and 1.4%, respectively vs 
0% in controls). 20:3u6 levels were raised about 10 fold 
with 20 and 40mg/l p-EP0 (10.5% and 10.6%, respectively 
vs 1.1% in controls), and 20:4w6 was only increased with 
20mg/l p-EPO (5.3% vs 3.6% in controls), but 22:4u6 and 
22:5u6 levels were decreased. All w3 PUFA levels were 
decreased in dosed cells compared to controls.
p-FO supplementation decreased cellular 16:0 and 18:lu9 
percentages overall, but induced increases in 16:lu9 
(4.8%, 4.3%, 10.8% and 17.4% with 0, 20, 40 and 60mg/l, 
respectively) and 18:0 (11.5%, 38.5%, 25.9% and 15.8%, 
respectively). 20*3u6 levels were nearly 2 fold greater 
than controls (1.1%) with 40mg/l p-F0 (1.9%), but other
u6 PUFA levels were not significantly increased. 20:5w3 
levels increased with addition of 20, 40 and 60mg/l p-FO 
(1.2%, 4.5% and 6.7%, respectively vs 0.1% in controls), 
and this was also found for 22:5w3 (3.1%, 4.2% and 1.9%, 
respectively vs 0.9% in controls), yet 22:6u3 levels 
were decreased (1.5%, 1.2% and 0.7%, respectively vs 
2.2% in controls).
4.5.4 Effects of Pseudo-Oils on Lipid Peroxide
Format i on.
The 1ipoperoxides measured both in control and dosed 
cells, and in their respective growth media are shown in 
Table 4.5.4.1. as nmoles MDA/106 cells. In the case of 
the spent incubation media, however, this represents the 
nmoles of MDA in the volume of medium from which lxlO6 
cells were obtained. The MDA amounts measured varied 
with the p~oil dosed, but increased in an overall 
concentration dependent manner.
Lipoperoxide production in dosed cells ranged from 0.1 
to 3.Inmoles MDA/106 cells compared to 0.Inmoles MDA/10& 
control cells. The p-oils abundant in saturated FA's 
(p-CO and p-MO) consistently induced small lipoperoxide 
amounts (0.1 to 0.2nmoles MDA/106 cells), which were 
parallel to controls, but slightly greater amounts were 
generated by cells incubated with p-00, p-SSO or p-EPO 
(0.1 to 0.6nmoles MDA/106 cells), particularly with a 
concentration of 60mg/l. Smal1 1ipoperoxide amounts were
induced by cells dosed with 20 or 40mg/l p-|_0, but 
production was considerably greater with 60mg/l p-LO 
(0.2, 0.3 and 2.Inmoles MDA/106 cells, respectively).
p-F0, however, induced the largest cellular lipoperoxide 
levels at every concentration dosed (0.4, 0.4, 3.Inmoles 
MDA/106 cells with 20, 40 and 60mg/l, respectively).
Spent incubation medium obtained from control cultures
Table 4.5.4.1
Lipoperoxide formation by cat brain cultures incubated 
with p-oils. expressed as nmoles MDA/106 cells.
P s e u d o -
Oil
< m g / 1 )
CELLS
0 20 40 60
Control 0.1
CO 0.1 0.2 0.2
MO 0.1 0.2 0.2
00 0.2 0.3 0.6
SSO 0.1 0.3 0.4
L0 0.2 0.3 2.1
EPO 0.1 0.1 0.5
F0 0.4 0.4 3.1
p s e u d o - SPENT INCUBATION MEDIUM
Oil
( m g / 1 ) 0 20 40 60
Control -
CO 0.2 0.3 ino
MO 0.1 0.3 0.6
00 - 0.3 0.7
SSO 0.2 0.4 1.6
L0 0.8 o CO 7.2
EPO 0.2 0.4 1.4
FO 1.1 3.2 14.5
contained no MDA, but this was measured in spent medium 
derived from dosed cultures. As with the cells, the 
smallest 1ipoperoxide amounts measured in spent media 
occurred with p-CO or p-MO incubation (0.1 to 0.6nmoles 
MDA/106 cells), although similar concentrations were 
measured in spent media with p-00 dosage. Larger amounts 
of spent medium 1ipoperoxides were measured when p-oils 
containing significant levels of PUFA's, especially of 
the w3 series, were dosed. Lipoperoxide concentrations 
were similar in medium enriched with 20, 40 or 60mg/l 
p-SSO or p-EPO (0.2, 0.4 and 1.6 vs 0.2, 0.4 and 1.4 
nmoles MDA/106 cells, respectively). Considerably 1arger 
lipoperoxide amounts were measured in spent medium 
dosed with 20, 40 or 60mg/l p-LO (0.8, 0.8 and 7.2nmoles 
MDA/106 cells, respectively), although p-FO induced the 
largest amounts (1.1, 3.2 and 14.5nmoles MDA/106 cells, 
respectively). Clearly, the pattern of 1ipoperoxides 
found in the cells and spent medium of dosed cultures 
were similar, despite numerical variations.
4.5.5 D i scuss i on.
No reference has been found in the 1iterature in which 
the effects of FA's on the growth of cat brain cells has 
been found. This study showed that primary cultures 
deriued from cat brain were susceptible to alterations 
in cell viability as a result of p-oil supplementation. 
The results reported (Figs. 4.5.1.2-4.5.1.8.) indicated 
that exogenous FA's modulated the proliteration of these 
cells to a greater or lesser extent, dependent on p-oil 
FA composition (Table 2.3.3.2.) and concentration dosed. 
The 1arge amounts of OA, LA and ALA present in p-00, 
p-SSO and p-LO., respectively could probably account for 
the cell viability changes these p-oils induced. It was 
apparent that OA and ALA exhibited greater cytotoxic 
potential than LA, although the increased cell viability 
induced with low to intermediate concentrations of p-00 
and p-SSO only also suggested the involvement of OA and 
LA in the stimulation of cell proliferation. On the 
other hand, the inability of p-EPO to stimulate cell 
proliferation, despite a similar FA composition to 
p-SSO, could have related to the presence GLA in p-EPO 
only. The presence of this moiety could also explain the 
more extensive growth inhibition p-EPO induced compared 
to p-SSO. This indicated that GLA exhibited no potential 
to stimulate cell proliferation, but was more effective 
than LA in mediating growth inhibition. Comparison of 
the extent of growth reduction p-EPO and p-LO induced
with the amount of GLA in p-EPO and ALA in p-LO (about 
9% and 63%, respectively) also implied that GLA was more 
potent than ALA in mediating cytotoxicity. The different 
effects OA, LA, GLA and ALA appeared to induce could 
have related to variations in the number and position of 
double bonds between these C18 FA's. While the data 
suggested that specific FA's within p-oils were largely 
responsible for certain cell viability changes, it 
was also possible that synergistic and antagonistic 
interactions between p-oil FA's enhanced or diminished 
particular effects of individual FA's. Such may explain, 
for example, the stimulation of cell pro 1iferation only 
with certain concentrations of p-00 and p-SSO, or the 
similar cell viability changes p-LO and p-FO induced, 
despite considerable differences in the FA profiles of 
these p-oils.
Comparison of FA spectra between control and dosed cells 
(Table 4.5.3.1.) supported the ability of cat brain 
cells in culture to incorporate exogenous FA's. A 
possible mechanism whereby the p-oils modulated cell 
viability could thus have related to differential uptake 
of exogenous FA's from the growth medium and alterations 
in membrane fluidity. Substancial evidence indeed exists 
showing that dietary FA supplementation induces changes 
in membrane physical properties (eg. King et al 1971, 
Ginsberg et al 1981, Simon et al 1982 and Stubbs et al 
1984). The greatest cytotoxicity induced with p-CO
incubation could thus have related to the abundance of 
saturated FA's and lack of PUFA's in this p-oil. Such 
would have decreased the membrane unsaturation index to 
a greater extent than with dosage of other p-oils, thus 
increasing membrane rigidification and the susceptib1ity 
to cell lysis. The low PUFA levels found in cells dosed 
with p-CO (Table 4.5.3.1.) would indeed support this. On 
the other hand, the greater unsaturated FA content of 
p-MO may have been able to maintain membrane fluidity 
more effectively than with p-CO dosage, accounting for
the lower higher ID50 calculated with p-MO than p-CO. It
was also possible that incorporation of large amounts of
»
unsaturated and polyunsaturated FA's from other p-oils, 
particularly at high concentrations dosed, increased 
membrane fluidity and instability to such an extent that 
cell viability could not continue.
Supplementation of cultures with p-oils induced changes 
in the amount of cellular protein (Table 4.5.2.1.) which 
generally paralleled changes mediated in cell viability 
(Figs. 4.5.1.2-4.5.1.8.). When p-oils stimulated cell 
pro 1iferation, a concommitant increase in total protein 
was found, which indicated increased cell numbers with 
constant, or increased, protein per cell. The latter 
possibility seemed more likely, however, as increased 
protein was also found when cell viability was limited 
with incubation of certain p-oils and concentrations. 
p-Oi1-induced cytotoxicity generally decreased cellular
protein levels, although the protein amounts found were 
higher than expected considering the number of viablel
cells reported; this was also consistent with increased 
protein per cell. These findings implied the involvement 
of p-oil FA's in the stimulation of protein synthesis, 
and the numerical variations in such even when different 
p-oils yielded similar cell numbers could relate to 
differences in FA structure. An absolute increment in 
cellular protein could nevertheless reflect enhanced 
expression of 1ipid metabolising enzymes induced as a 
result of p-oil FA incorporation.
p-Oil incorporation by cultured brain cells (Table 
4.5.3.1.) significantly modified the FA profiles of the 
dosed cells compared to controls, dependent upon p-oil 
FA composition. In vivo studies have also reported 
changes in the spectra of brain FA's when cats were fed 
diets either sufficient in all PDFA's, or deficient in 
u3, w6, or all PDFA's (Davidson et al 1989, 1990a). 
Generally, the changes in saturated and monounsaturated 
FA's were slight, but more striking differences were 
apparent in the PUFA profiles between dietary groups. 
The data nevertheless supported the absence of J6D 
activity, and presence of an active .45D, but could not 
prove whether AdD was present or not. However, it 
confirmed the earlier in vivo findings of other workers 
(Sinclair 1979, Sinclair et al 1981) showing that 18:2u6 
was not metabolised to more unsaturated derivatives in
cat brain, despite incorporation, thus indicating a 
lack or suppression of 46D expression. This was 
confirmed in the present study (Table 4.5.3.1) since 
gj3 PUFA profiles indicated that cultured cat brain cells 
exhibited no significant capability for 46-desaturation. 
The small increment in ce'llular 18:3w6 with p-SSO dosage 
could thus reflect retroconversion of 20:3u)6 formed via 
18:2u6 elongation and 48-desaturation. This sequence 
could account for the increased 20:3w6 levels found in 
most p-oil dosed cells, although the large increment in 
20:3w6 with p-EPO incubation could also have related to 
elongation of incorporated 18:3w6. However, the finding 
that 20:4w6 levels were slightly increased only with 
20mg/l p-00 or p-EPO incubation implied very 1imited or 
suppressed 45D capability, which w3 PDFA profiles 
supported. In addition, no 20:4w6 elongation occurred, 
but the potential to elongate 20:5u3 was demonstrated 
with p-FO dosage. However, it was apparent that 44D was 
not expressed.
The FA spectra of dosed cells were consistent with the 
lack or suppression of 16:0 desaturation and 16:lw9 
elongation (Table 4.5.3.1.). The finding that the levels 
of 16:0 were generally lower and 18:0 higher in dosed 
than in control cells supported elongation of the 
former. The presence or absence of 49D, however, could 
not be proven as the FA profiles of cells dosed with 
p-FO were consistent with the lack of 49D expression,
while elevated 18:lw9 levels with p-CO incubation 
suggested the opposite. The formation of 18:lu9 by cells 
fed p-CO, however, could have reflected enhancement of 
J9D expression in an attempt to maintain membrane 
fluidity altered with incorporation of saturated FA's.
The findings we presented clearly indicated that the 
overall capability for desaturase cascade enzyme 
expression was poor in cat brain cells (Table 4.5.3.1.). 
The possibility that such enzyme expression was 
suppressed by the growth limiting and/or cytotoxic 
effects the p-oil FA's induced (Figs. 4.5.1.2-4.5.1.8.) 
seemed unlikely, as desaturase cascade enzyme activity 
was not improved even when p-oils had little effect on, 
or stimulated, cell pro 1iferation. It was more likely 
that the overall FA balance in the cells was more 
important in modulating enzyme expression by competitive 
interations which have been documented (eg. Garcia et al 
1965, Brenner et al 1966, Brenner 1974, Ullman et al 
1971a, de Schriver et al 1982 and Nassar 1986), although 
the poor capability for desaturase cascade enzyme 
expression may also be a characteristic of these cells. 
This would imply a requirement for preformed PDFA's in 
the diet to maintain normal cell physiology.
MDA detection in cat brain cultures both in the presence 
and absence of dosed p-oils (Table 4.5.4.1.) supported 
the ability of these cells to oxidise FFA's by enzymic
and/or non-enzymic mechanisms. However, measurement of 
only small lipoperoxide amounts in control cells, 
despite detection of potential FA substrates for the 
formation of these compounds in such (Table 4.5.3.1.), 
implied efficient mechanisms of protection against free 
radical formation, eg. peroxidase, superoxide dismutase 
and/or vitamin E. It was also possible that most 
cellular unsaturated FA's in control cells were present 
as components of complex lipids, eg. membrane PGL^s, 
which would thus not be readily accessible to oxidation. 
Enhanced lipoperoxide formation as a result of p-oil 
dosage, however, reflected saturation of the cellular 
anti-oxidant mechanisms due to exogenous unsatur&ted FA 
incorporation and/or increased cellular unsaturated FA 
availability for oxidation. This supported the increased 
concentrations of 1ipoperoxides found overall with the 
amount of p-oil supplemented (Table 4,5.4.1.).
The ability of these cells to incorporate exogenous FA's 
(Table 4.5.3.1.), the presence of albumin as FA carrier 
and abundance of saturated FA's in culture medium (Table 
2.3.3.3.), supported the probability that most lipid 
peroxides found in the spent media of dosed cultures 
originated intracel1ularly. The capability of cellular 
1ipoperoxides to increase membrane permeability and even 
to disrupt biological membranes (Chio et al 1969, Mead 
1976, Tappel 1975, 1980, Gavino et al 1981b, Morisaki et 
al 1982b and Frankel 1984) implied their leakage through
the plasma membrane of intact cells when p-oil dosage 
did not induce cell lysis at the concentrations studied, 
or as a direct result of p-oi1-induced cytotoxicity. 
Cellular peroxidising enzymes and FFA's could well have 
been released into the culture medium in this process, 
particularly since superoxide radicals have been shown 
to mediate an increase in the permeability of the cat 
brain to albumin (Uei et al 1986). Thus, the possiblity 
that further FFA oxidation occurred extracel1ular1y, and 
contributed to the 1ipoperoxides measured in the spent 
medium, could not be overlooked. Such may well account 
for the greater 1ipoperoxide amounts found in the spent 
medium of cultures enriched with p-CO, p-SSO, p-EPO, 
P~LO, p-FO, 60mg/l p-MO or 60mg/l p-00 than in the cells 
themselves. In vivo studies by Kontos et al (1985) found 
that the metabolism of exogenous or endogenous AA in cat 
brains resulted in the appearance of superoxide anions 
in the extracel1ular space. Their studies suggested that 
these superoxides emerged from the interior of undamaged 
cells via existing membrane channels. Such a mechanism 
could also explain the higher levels of medium than 
cellular 1ipoperoxides measured in our study when dosed 
p-oils did not induce cytotoxicity.
The quantitative variations in MDA levels reported with 
p-oil supplementation at a particular concentration 
reflected differences in p-oil FA composition (Table 
2.3.3.2.). This related not only to the amount of
unsaturated FA's present in any p-oil, but also to their 
susceptibility to oxidation, dependent on the number and 
position of double bonds in a FFA. The lowest lipid 
peroxide amounts induced with p-CO or p-MO incubation 
reflected the abundance of saturated FA's in these 
p-oils, and probably related to oxidation of their small 
amounts of unsaturated FA's and/or FFA's released during 
PGL turnover. On the other hand, the small 1ipoperoxide 
amounts measured with p-00 dosage, despite the abundance 
of OA in the cells (Table 4.5.3.1.) and the capability 
of OA to undergo oxidation (Frankel 1984), implied that 
such was largely lipid-bound. This could also explain 
the small cellular 1ipoperoxide concentrations measured 
with p-SSO or p-EPO supplementation, although such could 
partly relate to 1ipoperoxide release into the medium, 
which was significantly increased. The fact that p-EPO 
and p-SSO induced similar MDA amounts nevertheless 
reflected their similar FA compositions; the lipid 
peroxides formed probably related mainly to oxidation 
of free LA. On the other hand, the availability and 
susceptibility of free ALA and EPA could explain the 
large 1ipoperoxide concentrations measured with p-LO or 
p-FO dosage, respectively. The greater susceptibility of 
EPA to oxidation than ALA was consistent with the 
greatest MDA levels measured with p-FO dosage, despite 
more ALA in p-LO than EPA in p-FO (approximately 63% 
and 18%, respectively). Such could also reflect a faster 
rate of PGL cycling and therefore FFA release into the
cellular pool from membrane lipids with p-FO incubation. 
EPA incorporated with p-FO dosage could also have been 
utilised directly as an endoperoxide substrate, whereas 
ALA could not, particularly since these cells did not 
express A6D (Table 4.5.3.1.).
Lipoperoxides have been implicated in affecting vital 
cell functions by damaging proteins, membranes, and even 
inhibiting cell division, amoungst others (Ohio et al 
1969, Mead 1976, Miller at al 1980, Tappel 1980, Frankel 
1984 and Beppu et al 1987). Furthermore, oxygen radicals 
have been shown to damage cerebro-vascular tissue in 
cat brain (Christman et al 1984). In the light of this, 
and the finding that the MDA concentrations reported 
both in the dosed cells and corresponding spent culture 
medium (Table 4.5.4.1.) were generally inversely related 
to the cell viability changes induced with p-oil dosage 
(Figs. 4.5.1.2-4.5.1.8.), 1ipoperoxide involvement in 
the modulation of cell proliferation was possible. The 
fact that the 1ipoperoxide concentrations did not always 
correlate quantitatively the with cell numbers, however, 
indicated that other mechanisms were also involved in 
the modulation of cell viabi1ity, such as alterations in
membrane fluidity.
4.6 THE EFFECTS OF PSEUDO-OILS ON CELLS
DERIVED FROM CAT LUNG.
4.6.1 Effects of pseudo-Qils on Cell Viability.
Microscopic examination of cells before, during and 
after each experiment showed no morphological changes 
between control or p-oil dosed cells at any time, 
although cytoplasmic droplets were observed with p-oil 
incubation at high concentrations in some instances.
Investigation of the effects of albumin with final 
medium concentrations ranging from 0 to 250mg/l showed 
no significant effect on cell viability (Fig. 4.6.1.1.). 
The effects induced with the dosed p-oils were therefore 
a direct result of the exogenous FA's and not the 
albumin used as FA carrier.
The control cell number, seeded at 10xl04/ml, at the end 
of the 24 hour post-trypsinisation recovery period, was 
12.3xl04/ml. This equated to about 66% of the control 
cell number at the end of the 48 hour incubation period, 
and represented the cytostatic number. Only p-oil 
concentrations reducing cell viability to significantly 
below 66% were thus considered cytotoxic.
The results of the incubation of cells with p-oils are 
shown in Figs. 4.6.1.2-4.6.1.8. p-MO, p-LO, p-FO and 
p-00 enhanced cell proliferation with low concentrations
The results are expressed as mean percent (.%) cell 
viabi1ity±standard error of the mean (s.e.m.), where ‘n* 
is the number of experiments. The concentrations given 
are as mg albumin or pseudo-oil per litre of growth 
medium. Fig. 4.6.1.1. shows the mean percent cell 
viability versus the albumin concentration (mg/1), and 
Figs. 4.6.1.2-4.6.1.8. depict the mean percent cell 
viability versus the pseudo-oil concentration (mg/1).
A1bumin 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 4.0 12
25 99.3 6.3 12
50 98.4 4.2 12
75 102.8 5.4 12
100 96.9 5.0 12
125 98.3 3.8 12
150 99.2 4.8 12
175 103.3 3.9 12
200 98.8 3.4 12
225 99.2 5.4 12
250 98.2 3.8 12
pseudo-Oi1 
Concentration 
(mg/1 )
Mean ±s.e.m. n
0 100.0 3.2 6
10 92.1 3.0 6
20 90.6 1.5 6
30 91.0 1.5 6
40 92.9 2.8 6
50 88.7 2.2 6
60 90.5 2.5 6
70 87.1 1.9 6
80 84.7 2.0 6
90 76.8 2.7 6
100 82.6 4.0 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 2.2 6
10 99.0 3.6 6
20 102.9 2.8 6
30 103.9 2.7 6
40 109.9 1.8 6
50 97.4 3.7 6
60 93.6 3.2 6
70 97.4 3.3 6
80 91.7 2.6 6
90 89.1 1.7 6
100 86.2 2.0 6
pseudo-Oi1 
Concentration 
(mg/1 )
Mean ±s.e.m. n
0 100.0 4.6 6
10 104.8 3.3 6
20 121.3 3.2 6
30 115.6 4.0 6
40 113.1 1.4 6
50 61.4 2.6 6
60 20.2 4.0 6
70 5.5 1.4 6
80 o CD 0.3 6
90 0.0 o • o 6
100 o•o 0.0 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean is.e.m. n
0 100.0 1.9 6
10 93.2 2.0 6
20 86.7 2.7 6
30 83.4 3.2 6
40 82.4 4.1 6
50 81.5 2.5 6
60 78.0 2.4 6
70 68.4 1.8 6
80 53.2 1.4 6
90 40.8 2.4 6
100 21.3 1.8 6
Fig. 4.6.1.6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 3.9 6
10 104.1 2.8 6
20 112.3 3.9 6
30 107.9 5.2 6
40 98.8 3.6 6
50 89.2 3.3 6
60 94.8 4.8 6
70 86.1 4.4 6
80 76.8 2.6 6
90 60.2 3.0 6
100 42.0 2.0 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 2.8 6
10 79.8 2.3 6
20 83.5 2.8 6
30 82.7 2.0 6
40 81.3 2.5 6
50 71.1 3.1 6
60 68.3 2.4 6
70 47.0 2.9 6
80 2.4 1.1 6
90 0.2 0.2 6
100 0.0 0.0 6
pseudo-Oi1 
Concentration 
(mg/1 )
Mean ±s.e.m. n
0 100.0 4.3 6
10 87.3 5.8 6
20 97.0 1.5 6
30 113.7 4.2 6
40 92.9 1.5 6
50 90.6 4.6 6
60 81.3 2.9 6
70 77.3 3.5 6
80 68.7 3.7 6
90 56.8 0.8 6
100 48.9 2.4 6
in the range dosed, all p-oils caused growth limitation, 
whereas cytotoxicity was only induced with p-oils rich 
in monoenoic and/or polyenoic FA's. The effects induced, 
however, varied in magnitude dependent on the p~oil and 
concentration dosed.
Cell viability was not adversely affected when dosed 
with p-CO or p-MO (Figs. 4.6.1.2. and 4.6.1.3.) as these 
p-oils were at most only marginally growth limiting, and 
40mg/l p-MO enhanced cell pro 1iferation to 109.9%. The 
minimum yield of viable cells found was 76.8% and 86.2% 
with 90mg/l p-CO and 100mg/l p-MO, respectively, thus no 
ID50 could be determined.
p-00 induced the most dramatic cell viability changes, 
manifested by a sigmoidal-type growth curve (Fig. 
4.6.1.4.). Cell viability was enhanced to 121.3%, 115.6% 
and 113.1% with 20, 30 and 40mg/l p-00, respectively, 
but higher concentrations were cytotoxic. Half the cells 
were killed with 53mg/l p-00, representing the lowest
ID50 found. 60mg/l p-00 reduced cell viability to 20.2%, 
and all cells practically took up Trypan blue with p-00
concentrations of 80mg/l or greater.
Cell pro 1iferation was progressively limited with dosage 
of up to 70mg/l p-SSO, at which concentration cytostasis 
was induced (Fig. 4.6.1.5.). Higher amounts dosed 
caused cytotoxicity, yielding 21.3% viable cells with 
100mg/l p-SSO. Cell growth was limited by approximately
20% with 10 to 40mg/l p-EPO and 30% with 50mg/l p-EPO, 
whereas 60mg/l p-EPO induced cytostasis (Fig. 4.6.1.7.). 
Higher concentrations were cytotoxic, and reduced cell 
viability to 47.0% with 70mg/l p-EPO, while practically 
100 % Trypan blue uptake was observed with p-EPO amounts 
of 80mg/l or greater. p-EP0 was thus more effective in 
reducing cell growth than p-SS0, and this was supported 
by the ID50 values (68mg/l and 83mg/l, respectively).
p-L0 and p-F0 elicited similar effects on cell growth 
(Figs. 4.6.1.6. and 4.6.1.8.). Cell proliferation was 
enhanced to 112.3% and 107.9% with 20 and 30mg/l p-L0, 
respectively, compared to 113.7% with 30mg/l p-FO. 
Higher p-oil concentrations progressive1y limited cell 
growth such that 76.8% viable cells were found with 
80mg/l p-L0 and 68.7% with 80mg/l p-F0. Cytotoxicity was 
induced with 90mg/l p-L0 or p-F0, but 42.0% and 48.9% of 
cells were still viable 100mg/l p-L0 or p-F0 incubation, 
respectively, and similar ID50 values were calculated 
(95mg/l and 98mg/l, respectively).
Subsequent to these studies, cells derived from cat lung 
were plated and dosed appropriately with 0, 20, 40 or 60 
mg p-oil/1 culture medium in sufficient quantities for 
all quantitative and qualitative analyses to be carried 
out. Upon harvesting, cell viabilities were compared and 
found not to be statistically different from those 
obtained in Figs. 4.6.1.1-4.6.1.8., thus all further 
biochemical assays were performed on these samples.
4.6.2 Effects of pseudo-Oils on Total Protein.
The total cellular protein concentrations determined at 
each of the 3 p-oil concentrations dosed are shown in 
Table 4.6.2.1. in relation to controls.
Cells dosed with 60mg/l p-00 exhibited significantly 
less total protein than controls (169.2 vs 230.4/jg/lO6 
ce11s 'seeded). With this exception, total protein levels 
in p-oil dosed cells were parallel to controls or 
significantly increased, and the greatest increment was 
induced with 20mg/l p-00 incubation (337.2^9 protein/106 
cells seeded). Cellular protein levels were greater in 
cells enriched with 20 than with 60mg/l p-oil, and 
concentrations decreased across the range dosed with 
p-00 (337.2 to 169.2,ug), p-SSO (240.1 to 236.5jug) and 
p~L0 (317.3 to 261.3jug). On the other hand, more protein 
was found in cells dosed with 40 than with 20 or 60mg/l 
p-CO (263.4, 243.6 and 233.6jug, respectively), p-MO 
(304.4, 286.0 and 262.2jug, respectively), p-EPO (255.5, 
245.3 and 228.3,ug, respective! y) or p-FO (283.8, 271.1 
and 242.7jug, respectively).
The protein content of cells derived from cat lung. 
expressed as jug total protein/106 rells seeded.
pseudo-
Oil
CELLS
(mg/1) 0 20 40 60
Control 230.4
CO 243.6 263.4 233.6
MO 286.0 304.4 262.2
00 337.2 315.8 169.2
SSO 240.1 237.0 236.5
L0 317.3 281.5 261.3
EPO 245.3 255.5 228.3
F0 271.1 283.8 242.7
3.6.3 Effects of Pseudo-Oils on the Fatty Acid
Spectrum of Cells Derived From Cat Lung.
FA spectra of cells incubated with 0, 20, 40 or 60mg/l 
of each of the p-oils is shown in Table 4.6.3.1.
Control cells exhibited a FA spectrum in which 18:lw9 
comprised 21.7% of all FA's, compared to 14.4% 16:0, 
18.6% 18:0, 8.1% 20:4w6 and 14.1% 22:4u6, whereas other 
FA's were detected in smaller proportions.
Dosed cells generally contained less 18:0 and 16:lw9 
than controls, while 16:0 and 18:lu9 levels approximated 
to controls, or were increased. 18:2w6 percentages were 
generally greater in dosed than in control cells, while 
the converse was true for 20:3u6, 20:4w6, 22:4u6 and 
22:5w6. Furthermore, 20:3u6, 20:4w6 and 22:4w6 amounts 
generally occurred in progressively smaller proportions 
with increments in p-oi1 concentration dosed. 18:3w3 
levels were similar between control and dosed cells, but 
w3 PDFA levels were generally decreased in dosed cells.
Cells supplemented with 20, 40 or 60mg/l p-C0 exhibited 
increased levels of 16:0 (21.4%, 25.3% and 30.4%,
respectively vs 14.4% in controls), 16:lu9 (4.2%, 8.1%
and 3.1%, respectively vs 2.5% in controls) and 18:lw9 
(24.2%, 27.8% and 29.2%, respectively vs 21.7% in
controls), but 18:0 was decreased (16.0%, 13.1% and 
11.7%, respectively vs 21.7% in controls). 22:6w3 was
All values are tabulated as relative percent total area. 
Control values are reported as mean±s.e.m., where "n“ is 
the number of experiments. "Cp-OilD" refers to the 
pseudo-oil concentration used.
The fatty acid spectrum of cells derived from cat lung.
FATTY ACID 
SPECTRUM
m
CONTROLS
(n=3)
Cp-COD 
(mg/1)
20 ! 40 ! 60
Cp-mo:
(mg/l)
20 40 ! 60
Cp-oo:
(mg/1)
20 : 40 : 60
Cp-sso:(mg/1)20 ! 40 ! 60 20
Cp-LOH (mg/1)
! 40 ! 60
Cp-EPOU 
(mg/1)
20 ! 40 ! 60
Cp-FOD 
(mg/1)
20 ! 40 ! 60
sA 16:0 14.4±0.05 21.4 25.3 30.4 19.9 20.8 21.7 13.2 13.0 16.3 12.2 11.4 14.3 9.3 10.6 11.8
11
10.1110.8 14.7 15.2 14.8 36.1
Tu 18:0 18.6±0.25 16.0 13.1 11.7 16.2 14.2 12.3 8.7 6.0 6.0 12.7 9.8 9.1 24.9 9.2 24.4 26.7110.1 10.9 12.5 9.9 10.2
R
A
20:0 0.4±0.00 - 0.2 - - 0.1 - - - 0.7 - - - - 0.1 -
1_ 1 _ 1 - - - -
T 22:0 0.H0.00 0.4 0.3 0.2 0.1 0.2 0.2 - - - - - - - - - !ii - - 0.1 -
S. 24:0 0.410.00 0.2 0.2 — — 0.3 0.1 0.1 0.2 - - 0.1 0.6 - 0.9 - 0.2! 0.3 
ii
0.5 - - -
u9
M
16:1 2.510.10 4.2 8.1 3.1 1.3 1.5 2.9 1.5 1.4 2.1 1.0 1.3 1.2 0.6 1.0 0.5
ii
0.4! 1.0 1.8 10.8 17.5 15.4
0N 18:1 21.710.05 24.2 27.8 29.2 23.5 25.1 27.7 46.1 53.2 56.0 21.0 20.1 21.7 21.8 15.8 25.3 18.1113.4 14.8 20.4 19.6 19.1
0
S.
24:1 — — — — — — — - - - - - - - - !iiiii
- - - -
18:2 2.910.07 3.6 2.4 2.9 8.1 10.6 13.6 9.3 11.4 10.3 28.1 39.1 40.6 11.0 12.0 15.2
i
23.6142.0 40.6 6.4 7.9 5.6
u6 18:3
_ a.i - 0.1 0.2 0.2 0.3 0.1 0.1 - 0.1 0.1 0.3 0.8 0.1 - 10.4! 1.4 1 2.8 0.1 0.1 0.1
p 20:2 — — — — 0.3 0.5 0.4 1.5 2.0 1.5 1.7 1.8 0.9 0.3 0.4 - 1.2! 1.8 0.4 0.6 1.0 0.7
01 20:3 2.610.03 2.2 1.8 1.5 2.5 2.4 2.0 1.6 1.5 0.8 2.7 2.2 1.2 1.1 1.1 0.9
1
4.6! 6.3 2.9 1.7 1.4 0.5
Y
S.
20:4 8.H0.20 8.2 5.7 5.3 9.9 8.5 8.4 4.6 3.3 1.6 5.3 3.2 2.1 5.5 6.6 1.1 4.2! 3.3 2.2 5.2 3.2 1.3
22:4 14.110.20 9.5 6.1 7 ,3 9.4 7.0 5.1 6.8 3.0 2.2 9.0 5.8 4.4 4.6 4.0 3.5 5.5! 4.8 4.8 8.2 4.3 4.6
22:5 1.010.00 — 0.4 — — 0.4 0.1 — 0.1 — — 0.2 — 0.1 0.1 0.1 0.2! 0.2 1 11I
0.1 - 0.3 0.1
18:3 0.610.00 0.7 0.6 0.6 0.8 0.6 0.4 0.9 0.8 0.3 0.5 0.4 0.3 13.6 32.8 11.0
J
0.2! 0.3 0.3 0.7 0.6 0.5
u3 18:4 2.H0.05 0.6 1.1 0.5 0.3 0.7 0.2 0.2 0.4 0.3 0.2 0.4 0.2 0.8 0.4 4.5
1
0.4! 0.3 0.2 0.2 0.8 0.3
Pn 20:4 3.310.12 0.9 1.3 1.2 0.8 1.3 0.5 0.3 0.7 0.4 0.5 0.9 0.8 2.2 1.7 0.8
1
0.8! 0.8 1.0 0.9 1.4 0.7
Lv 20:5 1.310.10 1.2 1.1 1.1 0,5 0.8 0.9 0.9 0.3 0.1 0.4 0.3 0.4 0.3 0.3 -
1
0.2! 0.3 0.3 6.7 10.3 3.3
S. 22:5 3.310.03 3.1 2.1 2.2 3.0 2.2 1.7 2.0 1.3 0.7 2.3 1.4 0.9 1.7 1.5 0.5 1.7! 1.3 0.9 7.7 5.1 1.0
22:6 2.610.03 3.7 2.7 2.7 3.4 2.6 2.0 2.2 1.5 0.8 2.3 1.6 1.1 1.6 1.5 0.4 1.8! 1.6
1l
1.1 2.5 1.9 0.7
slightly increased with 20mg/l p-CO dosage (3.7% vs 2.6% 
in controls), but no significant increment in other 
PUFA's were detected.
16:0 and 18:lw9 percentages increased slightly with 20, 
40 or 60mg/l p-MO dosage (19.9%, 20.8% and 21.7%, and 
23.5%, 25.1% and 27.7% vs 14.4% and 21.7% in controls, 
respectively), whereas 16:lu9 and 18:0 were parallel to 
controls (2.5% and 18.6%, respective!y) or decreased. A 
concentration dependent increase in 18:2w6 was detected 
(8.1%, 10.6% and 13.6% with 20, 40 and 60mg/1 p-MO, 
respectively vs 2.9% in controls), and 20:4u6 was 
slightly increased only with 20mg/l p-MO (9.9% vs 8.1% 
in controls), yet 22:4u6 and 22:5w6 levels were lower 
than those of controls (14.1% and 1.0%, respectively).
Dosage of cells with 20, 40 or 60mg/l p-00 had little 
effect on 16:0 levels (13.0% to 16.3% vs 14.4% in 
controls), but decreased 18:0 and 16:lw9 percentages 
(6.0% to 8.7% and 1.4% to 2.1% vs 18.6% and 2.5% in 
controls, respectively). On the other hand, increased 
amounts of 18:lw9 (46.1%, 53.2% and 56.0%, respectively 
vs 21.7% in controls) and 18:2w6 (9.3%, 11.4% and 10.3%, 
respectively vs 2.9% in controls) were detected, as well 
as a significant increment in 20:2w6 (1.5% to 2.0% vs 0% 
in controls). However, w6 PDFA proportions were parallel 
to controls or significantly decreased.
Enrichment of cells with p-SSO induced little change in
16:0 and 18:lu9 levels, but 18:0 and 16:lw9 were 
decreased (9.1% to 12.7% and 1.0% to 1.3% vs 18.6% and 
2.5% in controls, respectively). A marked increment in 
18:2to6 was detected (28.1%, 39.1% and 40.6% with 20, 40 
and 60mg/l p-SSO, respectively vs 2.9% in controls), and 
20:2w6 inc reased slightly over the same range (1.7%, 
1.8% and 0.9%, respectively vs 0% in controls). However, 
u6 and u3 PDFA levels were parallel to controls or 
significantly decreased.
16:0 and 16:lu9 percentages were decreased with 20, 40 
or 60mg/l p-L0 dosage (9.3% to 11.8% and 0.5% to 1.0% vs 
14.4% and 2.5% in controls), whereas 18:0 and 18:lu9 
levels were more variable (24.9%, 9.2% and 24.4%, and 
21.8%, 15.8% and 25.3% vs 18.6% and 21.7% in controls, 
respectively). p-LO induced an increment in 18:2u)6 
(11.0% to 15.2% vs 2.9% in controls), and 18:3u3 (13.6%, 
32.8% and 11.0% with 20, 40 and 60mg/l, respectively vs 
0.6% in controls), and 18:4w3 increased approximately 2 
fold with 60mg/l p-L0 (4.5% vs 2.1% in controls). No 
significant increments in other u3, and all U)6, PDFA's 
were detected, however.
p-EPO incubation had little effect on 16:0, increased 
18:0 only with 20mg/l (26.7% vs 18.6% in controls), but 
decreased 16:lw9, 18:lw9 and all w3 PUFA's levels. A 
marked increase in 18:2w6 was induced (23.6%, 42.0% and 
40.6% with 20, 40 and 60mg/l p-EPO, respectively vs 2.9% 
in controls). 18:3w6 was significantly increased with 40
and 60mg/l p-EPO (1.4% and 2.8%, respectively vs 0% in 
controls), and such was also found for 20:2u6 and 20:3u6 
with 20 and 40mg/l p-EPO (1.2% and 1.8%, and 1.8% and 
6.3% vs 0% and 2.6% in controls, respectively). However, 
lower amounts of 20:4w6, 22:4w6 and 22:5w6 were detected 
in dosed cel Is.
Supplementation of cells with p-FO increased 16:0 levels 
only with 60mg/l (36.1% vs 14.4% in controls), decreased 
18:0 levels, had little effect on 18:lu9 percentages, 
but increased 16:lw9 amounts significantly (10.8%, 17.5% 
and 15.4% with 20, 40 and 60mg/l, respectively vs 2.5% 
in controls). No significant increment in u6 PDFA's 
were detected, despite approximately 2 fold more 18:2u6 
than in controls (2.9%). p-FO dosage induced an increase 
in 20:5w3 (6.7%, 10.3% and 3.3% with 20, 40 and 60mg/l, 
respectively vs 1.3% in controls) and 22:5w3 (7.7% and 
5.1% with 20 and 40mg/l, respectively vs 3.3% in 
controls), but not in 22:6w3 (2.5%, 1.9% and 0.7% with 
20, 40 and 60mg/l, respectively vs 2.6% in controls).
4.6.4 Incorporation of Radiolabel1ed C18 Fatty
Acids into Cells Derived from Cat Lung.
Table 4.6.4,1. shows the radioactivity recovered from 
cultures incubated with 2juCi C 14C3-18:1 w9, C1 4C3-18:2u6, 
or C14CD-18:3u3.
The total counts recovered in the spent incubation media 
ranged from 2.4 to 2.9xl06Cpm. Only 0.3 to 0.4xl06cpm 
were recovered from the pooled buffers after washing the 
cells, and this accounted for non-specific binding. For 
both C14C3-18: 1uj9 and C14CU-18:3w3, the equivalent of 
4.3xl0&cpm were dosed to cultures, and total recovery of 
each was approximately 84% and 86%, respectively. For 
C14C3-18:2w6 the equivalent of 4.8xl06cpm were dosed to 
the incubation medium, and total recovery of this 
radioisotope amounted to about 85%. However, the total 
amount of each of these radioisotopes incorporated into 
the cells approximated to 18% for C 14C!]-18: lw9, 18% for
C14CD-18:2w6 and 15% for C14C3-18:3u3.
Table 4.6.4.2. shows the percentage of each incorporated 
radiolabel1ed C18 FA converted to u9, u6 or w3 series 
products after incubation with cat lung fibroblasts.
28.3% of the total C14CD-18:lu9 counts derived upon 
GLC analysis (1034cpm) remained unchanged, while the 
proportions of 20:lw9, 22:lw9 and 24:lw9 detected were 
33.6%, 29.9% and 8.2%, respectively.
The radioactivity (cpm) recovered from cat Tung cultures 
incubated with radio!abel1ed C18 fatty acids. expressed as 
mean (±s.e.m.). n=3♦
SPENT
MEDIA
(M)
POOLED
WASHINGS
(W)
TOTAL
(M+U)
CELLS TOTAL
xlQ6
Total 18:1 counts dosed to incubation medium = 4.3 x 10s
2350080
(±3340)
427440
(±6060)
2777520 769494
(±1308)
3.6
Total 18:2 counts dosed to incubation medium = 4.8 x 106
2866720
(±7200)
387300
(±6300)
3254020 862419
(±1728)
4.1
Total 18:3 counts dosed to incubation medium = 4.3 x 106
2817320
(±11320)
278700
(±4440)
3096020 644634
(±1428)
3.7
The counts detected for the radio!abel1ed fatty acids 
dosed and their resulting metabolites formed after 
incubation with cells derived from cat lung, expressed 
as a percentage of the total counts recovered upon GLC 
analysis.
u9
MONOS.
CiaCT- 
18:lu9 u6POLYS. C14C3- 18:2u6 u3POLYS. c 1 4 c o -18:3u3
18:1 28.3 18:2 23.4 18:3 27.1
20:1 33.6 18:3 8.1 18:4 10.0
22:1 29.9 20:2 36.1 20:3 24.6
24:1 8.2 20:3 14.3 20:4 19.6
20:4 5.7 20:5 7.4
22:4 6.9 22:5 8.1
22:5 5 . 5 22:6 3.3
TOTAL
CPM 1034
TOTAL
CPM 1998
TOTAL
CPM 1484
23.4% of the total C14CH-18:2w6-derived counts measured 
(1998cpm) remained unchanged, and 36.1% 20:2w6 was 
detected. 8.1% and 14.3% of total counts recovered were 
found as 20:2w6 and 20:3w6, respectively, compared to 
5.7% 20:4u6, 6.9% 22:4w6 and 5.5% 22:5w6.
The total counts derived following GLC analysis of cells 
incubated with C14CD-18:3w3 were 1484cpm, of which 27.1% 
was detected for 18:3w3, 10.0% for 18:4w3, 24.6% for 
20:3w3 and 19.6% for 20:4u3. Smaller proportions of 
post-,450 FA's were found, amounting to 7.4% 20:5w3, 8.1% 
22:5w3, and only 3.3% 22:6w3.
46D represents the first enzyme in the desaturase enzyme 
cascade, thud total activity of this enzyme is reflected 
by the sum of all subsequent desaturase and elongase 
products.
4.6.5 Effects of pseudo-Oils on Lipid Peroxide
Format i on.
The 1ipoperoxides quantified in dosed cells and their 
respective growth media are presented in Table 4.6.5.1. 
in relation to controls. Values are reported as nmoles 
MDA/106 cells, but in the case of the spent incubation 
media, this represents the nmoles of MDA in the volume 
of medium from which lxlO6 cells were obtained. The 
lipoperoxide amounts measured in dosed cultures varied 
with p-oil, but increased in an overall concentration 
dependent manner.
Cat lung fibroblasts dosed with p-oils contained 0.3 to 
6.9nmoles MDA/106 cells, compared to 0.3nmoles MDA/106 
control cells. p-CO and p-MO induced the smallest lipid 
peroxide amounts over the range dosed (0.3 to 0.4nmoles 
MDA/106 cells), and p-00 generated 1arger concentrations 
only with 60mg/l (1.3nmoles MDA/106 cells), compared to 
increments with 40 and 60mg/l p-FO (0.9 and l.Onmoles 
MDA/106 cells). p-SSO and p-EPO induced similar lipid 
peroxide levels with concentrations of 20 and 40mg/l 
(0.4 to 0.5nmoles MDA/106 cells), but 1arger amounts 
were formed with 60mg/l p-EPO than p-SSO (2.8 vs 1.7 
nmoles MDA/106 cells, respectively). However, cellular 
lipid peroxide levels were greatest with 40 and 60mg/l 
p—LO (1.2 and 6.9nmoles MDA/106 cells, respectively).
No MDA was measured in spent control medium or in that
Lippperoxide formation by cat lung cultures incubated 
uiith p-oils. expressed as nmoles MDA/106 cells.
pseudo-
Oil
CELLS
(mg/1 ) 0 20 40 60
Control 0.3
CO 0.3 0.4 0.3
MO 0.4 0.4 0.4
00 0.3 0.3 1.3
SSO 0.5 0.4 1.7
L0 0.4 1.2 6.9
EPO 0.4 0.5 2.8
F0 0.5 0.9 1.0
pseudo- SPENT INCUBATION MEDIUM
Oil
(mg/1) 0 20 40 60
Control -
CO 0.2 0. 1 0.2
MO - - -
00 - - 0.6
SSO 0.1 (N♦O 1.6
L0 0.3 o CD 00
EPO 0 . 1 0.3 1.7
F0 CO•o 0.6 1.0
derived from cultures incubated with p-MO. Small lipid 
peroxide amounts were detected in the spent medium with 
p-CO supplementation (0.1 to 0.2nmoles MDA/106 cells), 
and p-00 only induced an increment with a concentration 
of 60mg/1 (0.6nmoles MDA/106 cells). Higher 1 ipoperoxide 
levels were detected with addition of 20, 40 or 60mg/l 
p-FO to the incubation medium (0.3, 0.6 and l.Onmoles 
MDA/106 cells, respectively). Spent media derived from 
cultures incubated with 20, 40 or 60mg/l p-EPO or p-SSO 
contained similar 1ipoperoxide levels (0.1, 0.3 and 1.7 
vs 0.1, 0.2 and 1.6nmoles MDA/106 cells, respectively), 
although amounts were greatest overall with p-LO dosage 
(0.3, 0.8 and 1.8nmoles MDA/106 cells, respectively).
4.6.6 The Eicosanoid Profile of Cells Derived
from Cat Lung.
The eicosanoids positively detected in control and dosed 
cat lung fibroblasts are presented in Table 4.6.6.1. as 
a percentage of the total area detected. However, an 
indication of the total eicosanoid amounts quantified 
is given for controls in *( )', expressed as pmoles/106
cel  I s .
Total eicosanoid formation amounted to only 32.9pmoles 
per 106 control cells, of which 15.6% could be 
positively identified with the prostanoid standards 
available. Approximately half this proportion was
composed of TXB2 (7.3%), whereas PGFfc and PGI2 comprised 
smaller amounts (5.4% and 2.9%, respectively). However,
no PGEit PGE2 or PGD2 were found.
Total percentages for the prostanoids detected in dosed 
cells varied significantly with p-oil concentration, but 
levels were greater than in control cells (15.6%). The 
increment was least with dosage of 40mg/l p-oil (16.8% 
to 25.2%), but significantly greater both with 20mg/l 
P-oil (31.2% to 40.0%) or 60mg/l p-oil (33.1% to 40.5%). 
These differences were reflected by appropriate changes 
in the amount of individual prostanoids. PGI2 levels 
were decreased with 20mg/l p-CO or p-LO dosage (2.1% and 
1.5%, respectively), but enhanced with all other p-oils 
and concentrations supplemented (3.2% to 7.7% vs 2.9% in
Values are tabulated as relative percent of the total 
area detected, and as pmoles total eicosanoids/106 
control cel Is.
The profile of the eicosanoids detected in extracts of 
cells derived from cat lung.
Pseudo-
Oil
(mg/1)
EICOSANOIDS C4)
TOTAL pgi2 TXB2 (1+2*5 PGE2 PGEi PGD2
CONTROL 15.6 2.9 7.3 5.4 _ _ _
(32.9)
20 34.1 2.1 17.2 14.8 0.3 — —
CO 40 17.8 3.5 8.1 6.2 - - -
60 40.5 7.7 18.1 14.2 in•o — —
20 33.4 4.9 17.4 9.7 1.4 — —
MO 40 21.6 5.5 11.6 4.5 - - -
60 33.1 3.2 19.7 8.7 1.5 — —
20 36.6 4.1 20.3 11.1 1.1 — —ooo 22.8 7.2 9.5 6.1 - - -
60 39.1 5.9 21.0 11.0 1.2 — —
20 40.0 5.7 19.9 12.5 — 1.9 —
SSO 40 22.6 5.6 9.6 5.2 2.2 - -
60 39.9 6.3 20.7 10.5 0.8 1.4 0.2
20 31.2 1.5 17.5 11.1 1.1 — —
LO 40 16.8 4.5 8.2 4.1 - - -  -
60 38.4 4.3 20.4 11.1 2.6 — -
20 35.3 5.1 17.2 9.6 1.2 2.2 _
EPO 40 25.2 4.6 10.1 7.3 3.2 - -
60 35.9 4.4 18.3 9.1 1.9 2.2 -
20 39.4 5.9 19.5 12.4 0.8 in•o 0.3F0 40 22.5 3.7 11.9 6.9 - - —
60 33.5 4.8 18.0 9.5 1.2 — —
controls). TXB2 percentages were marginally greater than 
controls (7.3%) with 40mg/l p-oil incubation (8.1% to 
11.9%), but these amounts increased 2 to 3 fold with 20 
or 60mg/l p-oil supplementation (17.2% to 21.0). PGFq. 
levels were parallel to controls (5.4%) with dosage of 
40mg/l p-oil (4.1% to 7.3%), but production was enhanced 
to a similar extent with 20 or 60mg/l p-oil incubation 
(8.7% to 14.8%). Dosed cells contained small amounts of
both PGE2 (0% to 3.2% us 5% in controls) and PGEi 
(0% to 2.2% us 0% in controls), but neither control nor 
dosed cells formed significant amounts of PGD2,
4.6.7 D i scussi on.
The results obtained from the incubation of cultured cat 
lung fibroblasts with p-oils indicated that exogenous 
FA's have the capability to modulate the proliferation 
of these cells to a greater or lesser extent (Figs. 
4.6.1.2-4.6.1.8. ) , dependent on p-oil FA composition 
(Table 2.3.3.2.) and concentration dosed. The finding 
that all p-oils, except p-CO, could inhibit and/or 
enhance cell proliteration implied that unsaturated 
rather than saturated FA's were primarily responsible 
for the cell viability changes the p-oils induced. The 
significantly greater amount'of unsaturated FA's in p-MO 
than in p-CO (21.6% vs 5.3%, respectively) could well 
account for the increased cel 1 growth p-MO induced. The 
fact that both saturated FA-rich p-oils, p-CO and p-MO, 
could not induce cytotoxicity at the concentrations 
dosed, unlike those p-oil abundant in monoenoic and/or 
polyenoic FA's, supported unsaturated FA involvement in 
the modulation of growth inhibition in these cells. 
Alternatively, saturated FA's may be more protective 
against growth inhibition than unsaturated FA's. The 
finding that the extent of growth inhibition induced did 
not always correlate with the unsaturated FA content of 
the p-oils, however, suggested that cytotoxic potential 
varied between unsaturated FA's. The abundance of OA, LA 
and ALA in p-00, p-SSO and p-LO, respectively probably 
accounted for the cell viability changes these p-oils
induced, and it was apparent that OA exhibited greater 
cytotoxic potential than LA, whereas ALA was less 
effective. However, the increased cell viability induced 
with low concentrations of p-00 and p-LO also suggested 
OA and ALA involvement in the stimulation of cell 
proliferation. LA did not exhibit this capability since 
no increment in cell viability was observed with p-SSO 
or p-EPO incubation. The greater capability of p-EPO to 
limit and inhibit cell viability than p-SSO, despite 
similar FA compositions, could nevertheless have related 
to the presence of GLA in p-EPO only. This indicated 
that GLA was more effective than LA in mediating growth 
inhibition. Comparison of the extent of growth reduction 
p-EPO and p-LO induced with the amount of GLA in p-EPO 
and ALA in p-LO (approximately 9% and 63%, respectively) 
also indicated that GLA was more potent than ALA in 
mediating growth limitation and inhibition.
The different cell viability changes which p-oil FA's 
appeared to induce could have related to variations in 
FA structure between different moieties, although it 
was also likely that the effects induced by individual 
FA's were enhanced or diminished by synergistic and 
antagonistic interactions between p-oil FA's. Such could 
explain, for example, any non-linear relationships 
between cell viability and p-oil concentration dosed, 
the greater stimulation of cell proliferation with 
40mg/l p-MO, 20mg/l p-00, 20mg/l p-LO and 30mg/l p-FO
than with other concentrations, as well as the similar 
cell liability changes p~LO and p-FO induced, despite 
pronounced differences in p-oil FA spectra. The ability 
of these cultured cat lung fibroblasts to incorporate 
exogenous FA's (Table 4.6.3.1.) nevertheless suggested 
that the modulation of cell viability related to 
differential uptake of exogenous FA's from the growth 
medium and alterations in membrane fluidity.
p-Oil supplementation of cat lung fibroblast cultures 
influenced the total protein content of those cells 
(Table 4.6.2.1.), and this generally reflected the cell 
viability changes induced (Figs. 4.6.1.2-4.6.1.8. ) . The 
lowest and highest protein amounts measured with p-00 
dosage indeed corresponded with the greatest cytotoxic 
and proliterative effects induced, respectively. Cell 
numbers alone, however, did not correlate quantitatively 
with the increments in total protein found when cell 
viability was enhanced or limited with p-oil dosage, and 
the 80% cytotoxicity which 60mg/l p-00 caused also could 
not justify the 30% reduction in total protein found. 
These findings indicated that while measurement of total 
protein may reflect cell growth in terms of actual cell 
numbers, p-oil FA's were involved in the stimulation of 
protein biosynthesis. The extent of protein stimulation 
varied numerically with incubation of identical amounts 
of different p—oils, even when similar cell numbers were 
yielded, and suggested that the capability to modulate
protein synthesis varied with FA structure; it was also 
possible, however, that FA synergism and antagonism 
played a role in this process. Increments in the amount 
of protein per cell could nevertheless reflect enhanced 
expression of enzymes to metabolise incorporated p-oil 
FA's.
The lung has been implicated a primary eicosanoid 
biosynthetic site (Mathe et al 1977, Hyman et a 1 1978 
and Harper et al 1984), thus any ability of this tissue 
to desaturate and elongate PUFA's would be of major 
importance in the provision of eicosanoid precursors. 
Whether cat lung has desaturase cascade capability, 
however, has not been described in the literature. The 
results obtained from the supplementation of cat lung 
fibroblasts with p-oils showed that such cells exhibited 
very litt-le potential to desaturate or elongate PUFA's 
(Table 4.6.3.1.). The findings were consistent with 
an overall lack or suppression of J6D, J5D and J4D 
expression, although certain elongation steps seemed 
possible. The presence of small 20:2w6 amounts in most 
dosed cells reflected limited elongation of incorporated 
18:2w6 which could not be further metabolised via A6D. 
20:3w6 formation only in cells supplemented with p-EPO 
supported impaired A6D expression, but was consistent 
with elongation of incorporated 18:3w6; the lack of 
further 20:3u>6 metabolism, however, supported impairment 
of J5D expression. Limited elongation of 20:5w3
incorporated with p-FO dosage also occurred, but no 
desaturation to 22:6w3 via J4D was found. On the other 
hand, the small increment in 18:4w3 found only with 
60mg/l p-LO dosage was consistent with extramicrosomal 
retroconversion of 20:4w3. The data could not exclude 
the potential for 16:0 elongation (suggested with 20 or 
60mg/l p-LO dosage) or 16:0 desaturation/18:lw9 retro- 
conversion (suggested with 20 or 40mg/l p-CO dosage), 
but 18:0, 16:lw9 and 18:lw9 were neither desaturated nor 
elongated. Nevertheless, it was unlikely that desaturase 
cascade enzyme activity was impaired by the growth 
limiting and/or cytotoxic effects mediated with p-oil 
dosage (Figs. 4.6.1.2-4.6.1.8.), as desaturation was not 
improved even when p-oils had little effect on, or 
stimulated, cell proliferation. This phenomenon may 
rather be a characteristic of this tissue type, implying 
a requirement of preformed PDFA's from the diet or other 
tissues from which to generate eicosanoids.
To assess whether the pattern of desaturation reported 
above was modulated by FA mixtures, p—oil desaturation 
(Table 4.6.3.1.) was compared with that of individual 
FA s (Table 4.6.4.2.). As with p-oil desaturation, cat 
lung fibroblasts were unable to desaturate C1aC3-18:lw9. 
The pathway for L14C3—18:lw9 elongation was shown, 
however, and such was possibly suppressed with p-oil, or
enhanced with L14C3 —18:lw9, supplementation. On the 
other hand, evidence for C14C3-18:3w3 and C14CU-18:2oo6
desaturation and elongation were found. Detection of 
large proportions of 20:3w3 and 20:2w6, but only small 
percentages of 18:4w3 and 18:3w6, suggested direct 
elongation of C1^ CH-IS:3w3 and C14CD-18:2u6 as a result 
of impaired J6D expression. Thus it was possible that 
20:4w3 and 20:3w6 were formed from 20:3u)3 and 20:2u6, 
respectively via an active J8D. This pathway seemed 
likely as the cat has been shown to be A6D deficient 
(eg. Rivers et al 1975a and Frankel et al 1978). The 
small proportions of 18:3w6 and 18:4w3 formed with 
C1aC3-18:3w3 or C14C3-18:2u6 dosage could either reflect 
stimulation/expression of A6D, or more likely retro- 
conversion of 20:4w3 and 20;3w6, respectively. Formation 
of 18.8% u)3, and 18.1% w6, PDFA's supported J5D 
expression in these cells, but detection of small 
amounts of 22:6w3 and 22:5w6 indicated very limited 
capability to express J4D.
The finding that desaturase enzyme expression was more 
limited with p-oil compared to individual FA dosage 
(Tables 4.6.3.1. and 4.6.4.2.) supported the mediation 
of competitive interactions between p-oil FA's for these 
enzymes. However, as organisms consume mixtures rather 
than individual FA^s in the diet, the desaturase 
capability shown with p-oils probably relates closer to 
the situation in cat lung in vivo than that suggested
with single FA's.
MDA quantitation showed that cat lung fibroblasts 
exhibited the capability to produce 1ipoperoxides (Table
4.6.5.1.). This could occur either enzymatically or 
by auto-oxidation of monoenoic and/or polyenoic FA's 
when the preventative anti-oxidant mechanisms were 
saturated. Enhanced MDA measurement when cultures were 
supplemented with p-oils reflected increased unsaturated 
FA availability for oxidation, and this correlated with 
the increased 1ipoperoxide concentrations found overal1 
with the amount of p-oil supplemented (Table 4.6.5.1.). 
The quantitative variations in MDA concentrations found 
between dosed cultures, however, reflected the different 
p-oil FA compositions (Table 2.3.3.2.). The abundance 
of saturated FA's in p-CO and p-MO could well explain 
why 1ipoperoxide formation approximated to that of 
controls with incubation of these p-oils. On the other 
hand, the finding that significant increments in lipid 
peroxide levels were induced only with dosage of 40 
and/or 60mg/l of p-oils rich in monoenoic and/or 
polyenoic FA's correlated with the greater availability 
and susceptibily of the unsaturated FA's in such p-oils 
to oxidation. Lipoperoxide formation with 60mg/l p-00 
incubation confirmed the capability of 0A to undergo 
oxidation (Frankel 1984), whereas the abundance of LA in 
p-SSO and p-EPO could largely account for the lipid 
peroxides these p-oils induced. However, the small, or 
lack of, increment in cellular MDA levels induced with
20 or 40mg/l p-00, p-SSO or p-EPO dosage, despite 1arge 
amounts of OA in p-00 and LA both in p-SSO and p-EPO 
which were incorporated (Tables 2.3.3.2. and 4.6.3.1.), 
implied that these substrates for oxidation were largely 
lipid-bound and stable. Quantitation of similar MDA 
levels with p-SSO or p-EPO dosage nevertheless reflected 
the similar FA compositions of these p-oils, although 
the 1arger cellular lipoperoxide amounts 60mg/l p-EPO 
induced could have related to the presence of GLA only 
in p-EPO. ALA oxidation probably accounted largely for 
the greatest 1ipid peroxide concentrations detected 
overall with p-LO dosage, while the smaller amounts p-FO 
induced reflected the more even balance of saturated, 
monoenoic and polyenoic FA's in this p-oil.
Cat lung fibroblasts incorporated exogenous FA's (Table
4.6.3.1.), thus it seemed unlikely that spent medium 
1ipoperoxides (Table 4.6.5.1.) were primarily formed 
extrace 1 1 u 1 ar1y via auto-oxidation, particularly since 
p-oil FA's were dosed bound to albumin. The lack of 
cytotoxicity found with p-CO, p-MO, p-SSO, p-LO, p-EPO 
or p-FO dosage, and the greater amounts of cellular than 
medium MDA measured, rather suggested that medium lipid 
peroxides resulted from cellular release. Such may have 
occurred as a result of increased membrane permeability 
induced by the formation of cellular lipid peroxides, 
which others have reported (Chio et al 1969, Tappel 1980 
and Mead 1976). The similar medium lipoperoxide levels
found with p-EPO or p-SSO dosage could indeed relate to 
the similar extent to which cell viability was limited 
(Figs. 4.6.1.7. and 4.6.1.5., respectively). On the 
other hand, the finding of greater MDA amounts in the 
cells than spent medium with 60mg/l p-00 dosage, despite 
marked cytotoxicity induced (Fig 4.6.1.4.), suggested 
that most substrates for oxidation were membrane-bound.
p-CO and p-MO had little effect on MDA formation (Table
4.6.5.1.) and induced little growth limitation (Figs. 
4.6.1.2-4.6.1.3.), whereas MDA generation and cell 
viability were inversely related with p-00, p-SSO, p-LO, 
p-EPO or p-FO dosage (Figs. 4.6.1.4-4.6.1.8.). This 
suggested that lipid peroxide involvement in the 
modulation of cell growth was possible. The fact that 
the greatest cytotoxicity 60mg/l p-00 induced did not 
correlate with the highest 1ipoperoxide amounts found, 
however, indicated that 1ipoperoxides were only partly 
responsible for the modulation of cell viability, and 
alterations in membrane stability were postulated as 
also being involved.
The finding that total eicosanoid production by control 
cat lung fibroblasts only accounted for about 10'4 of all 
lipid peroxides measured (Tables 4.6.5.1. and 4.6.6.1.) 
could have related to the poor capability of such cells 
to supply eicosanoid precursors via desaturation. Thus 
lung may be reliant on an external supply of eicosanoid 
precursors. The observation that the prostanoids studied
comprised a fraction of the molar amount quantitated 
indicated that these cells were largely involved in the 
production of other eicosanoids, but nevertheless 
supported functional cyclooxygenase activity in cat lung 
fibroblasts. Mayeux et al (1989) similarly reported that 
microsomal fractions isolated from cat lung not only 
contained cyclooxygenase activity, but also prostacyc1 in 
synthetase, thromboxane synthetase and GSH-dependent
PGE2 isomerase activities. Under the experimental 
conditions employed in the present study, the enzymic
pathways for TXB2 ancj PGFfc synthesis were greatly 
favoured over those involved in PGI2 production, and it
was possible that PGH2-PGE2 , PGH1-PGE1 and PGH2-PGD2 , 
isomerases were suppressed/inhibited rather than absent
as limited PGE2 t PGEi and PGD2 formation occurred with 
p-oil dosage, respectively. Others showed the ability of
cat lung to form 1arge quantities of PGE2 f with 
considerably smaller amounts of PGI2 ancj 6-keto-PGEi 
(Ferreira et al 1967 and Forstermann et al 1983). Cat 
lung, however, has also been implicated in the marked
clearance of PGE2 > but not of PGI2 (Forstermann et al 
1983), and this could explain the absence of PGE2 in 
control and low levels of such in dosed cells, as well 
as the significantly 1arger PGI2 amounts both in control 
and dosed cells in the present study (Table 4.6.6.1.).
Supplementation of cat lung fibroblasts with p-oils 
stimulated total prostanoid production in every instance
by enhancing TXB2, PGF<*, PGI2, PGE2 , PGEi and/or PGD2 
synthesis (Table 4.6.6.1.). The extent of stimulation 
uas both p-oil and concentration dependent, but did not 
relate to the degree of p-oil unsaturation (Table
2.3.3.2.) or ability of the p-oils to provide direct 
eicosanoid precursors. Uaring et al (1988) suggested
that TXA2 t PG12 , and vasoconstr ictor prostanoids (PGF2o(,
PGD2 anc| PGE2 ) were formed in response to exogenous 
20:4u6 administration in the cat lung. p-MO contained
20:4w6 (Table 2.3.3.2.), the direct 2-series eicosanoid 
precursor, while the 1-series precursor, 20J3w6, was 
formed from 18:3u6 with p-EPO dosage (Table 4.6.3.1.), 
yet these p-oils induced no significant increase in 
prostanoid production in relation to other p-oils devoid 
of such moieties, dosed at identical concentrations. 
Even p-LO and p-FO yielded prostanoid profiles similar 
to those derived from cells incubated with corresponding 
amounts of other p-oils, despite the known inhibitory 
actions of 18:3w3 and 20:5w3 on 20?4w6 metabolism via 
cyclooxygenase, and hence 2-series prostanoid production 
(Lands et al 1971, 1973, Dyerberg et al 1978, Culp et al 
1979, Hwang et al 1980, Hamazaki et al 1982, Marshall et 
al 1982 and Nassar et al 1987). The lack of significant
differences in PGI2> TXB2 # PGFoc, PGE2 , PGEi and PGD2 
levels found with dosage of different p-oils at the same 
concentration implied that exogenous FA^s per se induced
little effect on the biosynthesis of the eicosanoids
studied, thus enhancement of prostanoid production 
related to utilisation of membrane 20:3w6 and 20:4co6, 
which were detected in cat lung fibroblasts (Table 
4.6.3.1.). However, the finding that total prostanoid 
production was slightly stimulated with 40mg/l p-oil, 
but increased about 2 fold with 20 and 60mg/l p-oil, 
implied p-oil concentration involvement in prostanoid 
synthesis. This could have influenced eicosanoid 
precursor availability, or modulated the expression of 
enzymes involved in the formation of the prostanoids 
studied, particularly at the PGH level.
The present study could not establish any correlation 
between the eicosanoid profiles (Table 4.6.6.1.) and 
cell viability changes (Figs. 4.6.1.2-4.6.1.8.) induced 
with p-oil dosage. This implied that the endogenously 
biosynthesised prostanoids studied were not directly 
involved in the modulation of cell pro1iferation, 
despite alterations in overall prostanoid production or 
the balance between individual prostanoid groups. The 
involvement of 1ipoperoxides and alterations in membrane 
physical properties were proposed as likely mechanisms.
4.7 THE EFFECTS OF PSEUDO-OILS ON CELLS
DERIVED FROM CAT SKIN.
4.7.1 Effects of pseudo-Oils on Cell Viability.
Cells were examined microscopically before, during and 
after each experiment, and at no time were changes seen 
in the morphology of control or p-oil dosed cells, 
except for cytoplasmic droplets observed with p-oil 
incubation at high concentrations in some instances.
Final medium albumin concentrations ranging from 0 to 
250mg/l were shown to have no significant effect on cell 
viability (Fig. 4.7.1.1.), nor were any synergistic 
effects induced. The cell viability changes induced with 
the p-oils were therefore a result of the exogenous FA^s 
alone, and not the albumin used as FA carrier.
The number of control cells, seeded at 10xl04/m1, at the 
end of the 24 hour— trypsinisation recovery period, was 
11.7xl04/ml. This equated to approximately 63% of the 
final control cel 1 number at the end of the 48 hour 
incubation period and represented the cytostatic number. 
Only p-oil concentrations limiting cell viability to 
significantly below 63% were thus considered cytotoxic.
The results of the incubation of cells with p-oils are 
depicted in Figs. 4.7.1•2—4.7.1.8. Cell proliferation 
was enhanced with p-MO, p-00, p-EPO or p-FO dosage, all
The results are expressed as mean percent (%) cell 
viabi1ity±standard error of the mean (s.e.m.), where "n‘ 
is the number of experiments. The concentrations given 
are as mg albumin or pseudo-oil per litre of growth 
medium. Fig. 4.7.1.1. shows the mean percent cell 
viability versus the albumin concentration (mg/1), and 
Figs. 4.7.1.2-4.7.1.8. depict the mean percent cell 
viability versus the pseudo-oil concentration (mg/1). 
Fig. 4.7.1.9. shows the mean percent cell viability 
versus the albumin concentration (mg/1) for cells dosed- 
with the amount of pseudo-oil which limits cell 
viability to 50% of the controls.
F i g .  & . 7 « 1 . 1 .
A1bumin 
Concentration 
(mg/1)
Mean ±s.e .m . n
0 100.0 5.1 12
25 102.7 5.3 12
50 101.6 5.4 12
75 102.9 3.3 12
100 100.9 7.3 12
125 98.6 2.8 12
150 100.7 5.4 12
175 97.9 5.1 12
200 98.8 4.3 12
225 95.4 4.0 12
250 101.3 2.7 12
Pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e .m . n
0 100.0 2.0 6
10 99.0 2.5 6
20 90.0 2.5 6
30 81.8 2.3 6
40 87.2 1.2 6
50 79.7 2.7 6
60 66.7 2.4 6
70 63.4 2.6 6
80 36.2 2.0 6
90 28.7 2.1 6
100 24.3 1.4 6
pseudo-Oi1 
Concentration 
< mg/1)
Mean ±s♦e ♦m . n
0 100.0 3.7 6
1.0 101.0 3.4 6
20 92.5 5.2 6
30 105.1 4.5 6
40 110.7 4.1 6
50 88.1 4.6 6
60 80.9 1.9 6
70 69.4 2.2 6
80 58.6 3.9 6
90 55.7 2.2 6
100 49.2 2.4 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e .m . n
0 100.0 4.8 6
10 92.5 5.0 6
20 102.7 5.5 6
30 90.7 4.1 6
40 103.3 3.8 6
50 112.0 1.4 6
60 122.3 6.5 6
70 107.6 4.3 6
80 79.4 4.9 6
90 55.7 5.8 6
100 33.2 5.5 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e .m . n
0 100.0 2.8 6
10 88.1 1.8 6
20 92.4 2.2 6
30 ♦00 3.0 6
40 82.5 2.1 6
50 80.8 2.6 6
60 80.7 3.8 6
70 75.2 2.9 6
80 72.4 2.7 6
90 81.9 2.6 6
100 70.6 5.0 6
Fig. 4♦7.1 ♦ 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e .m . n
0 100.0 3.2 6
10 99.2 4.4 6
20 93.2 3.2 6
30 . 89.5 5.3 6
40 103.6 4.7 6
50 86.7 4.3 6
60 81.9 2.7 6
70 70.6 5.4 6
80 50.4 3.7 6
90 32.7 3.2 6
100 17.7 3.8 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e .m . n
0 100.0 2.1 6
10 106.2 2.8 6
20 105.1 1.5 6
30 108.2 2.3 6
40 104.7 3.9 6
50 98.4 4.3 6
60 94.6 3.9 6
70 61.1 2.1 6
80 32.7 3.8 6
90 3.5 1.5 6
100 0.4 0.4 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e .m . n
0 100.0 4.6 6
10 109.1 2.3 6
20 109.1 3.2 6
30 103.4 2.6 6
40 106.0 4.1 6
50 102.3 3.5 6
60 96.3 3.7 6
70 72.4 3.4 6
80 57.6 3.3 6
90 10.5 1.8 6
100 1.4 00•o 6
Fig.  &,7 , 1,9 .
A1bumin 
Concentration 
(mg/1)
Mean ±s.e .m . n
0 100.0 4.8 6
125 49.4 5.2 6
150 56.7 4.4 6
175 49.1 4.2 6
200 52.7 4.3 6
225 54.1 3.3 6
p-oils were cytotoxic at high concentrations in the 
range dosed, although p-SSO only limited cell growth. 
The cell viability changes induced varied in magnitude 
dependent on the p-oil and concentration dosed, but p-00 
caused the greatest enhancement of cell pro 1iferation, 
whereas the overall pattern of growth inhibition was 
greatest with p-EPO or p-FO dosage.
10mg/l p-CO had little effect on cell pro 1iferation, but 
higher amounts- resulted in an overall concentration 
dependent reduction in cell viability such that cyto- 
stasis was induced with 70mg/l p-CO (Fig. 4.7.1.2.). 
10mg/l p-MO similarly had no significant effect on cell 
growth, but this was enhanced with 30 and 40mg/l p-MO to 
105.1% and 110.7%, respectively (Fig. 4.7.1.3.). p-MO 
increasingly limited the proliferative capability of the 
cells as greater concentrations were dosed, and induced 
cytotoxicity with concentrations of 80mg/l, or greater. 
Cell viability was 49.2% with 100mg/l p-MO, compared to 
24.3% with 100mg/l p-CO, and the ID50 values supported 
the greater capability of p-CO to reduce cell viability 
than p-MO (about 75mg/l and 100mg/l, respectively).
Cell proliferation was not markedly influenced with 
incubation of up to 40mg/l p-00, but was enhanced to 
112.0%, 122.3% and 107.6% with 50, 60 and 70mg/l p-00, 
respectively (Fig. 4.7.1.4.). Cell viability was limited 
to 79.4% with 80mg/l p-00, but cytotoxicity reduced cell 
viability to 50% of controls with 93mg/l p-00 (ID50) ancj
to 33.2% with 100mg/l p-00.
Dosage with increasing amounts of p-SSO limited cell 
growth marginally in an overall concentration dependent 
fashion to a minimum of 70.6% with 100mg/l p-SSO (Fig. 
4.7.1.5.). p-SSO was the only p-oil which did not induce 
cytotoxicity in these cells, thus no ID50 could be 
ca1cu1ated.
10mg/l p-LO had little effect on cell pro 1iferation 
(Fig. 4.7.1.6.), but was progressively growth limiting 
with 20 to 70mg/l p-LO, although cell growth was 
enhanced to 103.6% with 40mg/l p-LO. Cytotoxicity was 
induced with concentrations greater than 70mg/l, which 
linearly reduced cell viability to 50% with 80mg/l p-L0 
(ID5 0 ) and 17.7% with 100mg/l p-LO.
Dosage with p-EPO or p-FO enhanced cell pro 1iferation 
slightly with amounts less than 50mg/l, to a maximum of 
108.2% with 30rng/l p-EP0, and 109.1% with 10 and 20mg/l 
p-FO (Figs. 4.7.1.7. and 4.7.1.8., respectively). Cyto- 
stasis was induced with 70mg/l p-EPO, and in the range 
70 to 80mg/l p-F0, whereas cytotoxicity progressively 
reduced cell viability with higher concentrations to 
yield 0.4% and 1.4% viable cells with 100mg/l p-EP0 and 
p-FO, respectively. p-EP0 and p-F0 thus induced similar 
cell viability changes, although p-EPO was slightly more 
growth limiting and cytotoxic, which the IDso values 
supported (about 74mg/l and 82mg/l, respectively).
To exclude the possibility that any of the effects 
observed with p-oil dosage were influenced by the amount 
of albumin bound to the FA's, cells were incubated with 
a fixed amount of p-oil (74mg/l p-EPO, ID5 0) and dosed 
with varying amounts of albumin. Five points were chosen 
around which to vary the albumin concentration, keeping 
the p-oil concentration fixed, viz. 2 points above, 2 
points below, and the ID50 of p—EPO. The appropriate 
amount of albumin was added to these cultures to give 
the desired concentrations. The results shown in Fig. 
4.7.1.9. indicated that the concentration of p-EPO dosed 
reduced cell viability to approximate1y 50% of controls, 
and that such was not influenced by different albumin 
concentrations. Thus, the effects induced with the 
p-oils could be attributed solely to the exogenous FA^s, 
and synergistic effects of albumin could be excluded.
Fig. 4.7.1.10. depicts the growth of cells obtained from 
cat skin in culture medium supplemented with 10% serum 
derived from its own species compared to commercially 
available fetal calf serum (FCS) in order to extablish 
whether FCS modulated cell growth in any way. The 
cells grew from 10.0 to 14.5xl04 over a 72 hour period 
when culture medium was supplemented with 10% FCS. 
Plating efficiency was low in the presence of 10% cat 
serum (CS), however, resulting in an initial decrease in 
the number of viable cells at 24 hours to 6.6xl04, Cell 
growth increased marginally over the next 48 hours, but
The results are expressed as mean cell number±standard 
error of the mean (s.e.m.), where "n" is the number of 
experiments. The cell numbers given are xl04/ml growth 
medium. Fig. 4.7.1.10. shows mean cell numbers versus 
the incubation period (hours).
The growth of cells derived from cat skin in DMEM 
containing 10% foetal calf serum compared with 10% adult
cat serum.
Incubation Mean ±s.e.m. n
Time Cell Number
(hrs) (xlO^/ml)
Foetal calf 
serum:
24 10.8 0.3 9
48 13.6 0.4 9
72 14.5 0.3 9
Adult cat 
serum:
24 6.6 0.3 9
48 7.9 0.3 9
72 7.7 0.2 9
only 7.7xl04 viable cells were found at the end of the 
incubation period. The routine use of 10% FCS thus did 
not limit cell growth compared to 10% CS, and promotion 
of growth limitation and cytotoxicity were attributed 
solely to the exogenous FA's incorporated.
Subsequent to these studies, cat skin fibroblasts were 
plated and dosed appropriate 1y with 0, 20, 40 or 60mg 
p-oil/1 culture medium, in sufficient quantities for 
all quantitative and qualitative analyses to be carried 
out. Upon harvesting, cell viabilities were compared and 
found not to be statistically different from those in 
Figs. 4.7.1.1-4.7.1.8. All further biochemical assays 
were thus performed on these samples.
4.7.2 Effects of pseudo-Oils on Total Protein.
Table 4,7.2.1. shows the total amounts of cellular 
protein quantitated at each of the p-oil concentrations 
dosed compared to controls.
The lowest protein concentration found in dosed cells 
(304.3A19/106 cells seeded with 60mg/l p-FO) corre1ated 
with that of controls (304.5jug/106 cells seeded). All 
other dosed cells contained more protein than controls, 
although the amounts varied numerically with p-oil and 
concentration dosed, but was highest with 60mg/l p-00 
incubation (467.7jug/10& cells seeded). More protein was 
found in cells supplemented with 40 than 20 or 60mg/l 
P-MO (345.0 to 420. ljug), p~L0 (346.4 to 392.1 jag), p-EP0 
(338.1 to 383.7jug) or p-F0 (304.3 to 381.3jug). On the 
other hand, protein amounts decreased overall with 
increments in p-C0 (347.1 to 318.9jug) or p-SSO (353.7 to 
330.9jag) dosage, but the converse occurred with p-00 
incubation (326.1 to 467.7jug).
The spent incubation media derived from these cultures 
were also analysed for total protein. The values for all 
samples were summed, and a mean protein concentration of 
40.0±0.23mg/10s cells seeded obtained (n=22). However, 
statistical comparison of individual samples by analysis 
of variance showed no significant differences in the 
spent media protein levels between control and dosed
cultures (F=136.5, p=0.001)
The protein content of cells derived from cat 
expressed as jug total protein/10& cells seeded.
pseudo-
Oil
CELLS
(mg/ 1 ) 0 20 40 60
Control 304.5 -
CO 347.1 347.2 318.9
MO 345.0 420.1 348.2
00 326.1 357.3 467.7
SSO 353.7 339.3 330.9
L0 354.9 392.1 346.4
EPO 368.1 383.7 338.1
F0 372.7 381.3 304.3
skin«
4.7.3 Effects of Pseudo-Oils on the Fatty Acid
Spectrum of Cells Derived From Cat Skin.
The FA spectra for both control and cells incubated with 
20, 40 or 60mg/l p-oil are shown in Table 4.7.3.1.
The greatest proportion of any single FA in control 
cells was 21.6% 18:lu9, compared to 15.6% 16:0, 14.5%
18:0, 8.2% 20: 4w6 and 16.6% 22:4gj6. Other FA's were
detected in smaller amounts.
18:0 and 16:lu9 proportions were generally lower in 
dosed than in control cells, while 16:0 and 18:lw9 
percentages were more varied. Dosed cells generally 
contained higher 18:2u6 levels than controls, but the 
converse was found for w6 PDFA's. Similarly, w3 PUFA 
percentages were generally lower in dosed than in 
control cel Is.
A concentration dependent increase in 16:0 incorporation 
was shown when cells were incubated with 20, 40 or 
60mg/l p-C0 (21.2%, 25.2% and 28.8%, respectively vs 
15.6% in controls). 18:lw9 levels increased in a similar 
manner (23.5%, 25.0% and 28.0%, respectively vs 21.6% in 
controls), but 18:0 and 16:lw9 were parallel to controls 
(14.5% and 4.0%, respectively) or decreased (11.0 to 
16.3% and 2.5% to 4.3%, respectively). A small increment 
in 20:4u6 was found with 20mg/l p-CO incubation (9.1% vs 
8.2% in controls), whereas 20:5u3 was significantly, and
All values are tabulated as relative percent total area. 
Control values are reported as mean±s.e.m., where "n" is 
the number of experiments. "Cp-OilD" refers to the 
pseudo-oil concentration used.
The fatty acid spectrum of cells derived'from cat akin.
FATTY ACID 
SPECTRUM 
C4 )
CONTROLS 
(n=3 )
Cp-C03 
(mg/ 1 )
20 40 ! 60
Cp-MOO 
(mg/ 1)
20 ! 40 ! 60
Cp -003  
(mg/ 1)
20 ! 40 I 60
Cp-SSOH !
(m g / 1) i
20 ! 40 ! 60 1 1
Cp-LOD 
(mg/ 1)
20 ! 40 ! 60
Cp-EPOH 
(m g / 1 )
20 ! 40 ! 60 20
Cp - f o :
(mg/ 1)
! 40 ! 60
S
A
16: 0 1 5 ♦6 ±0 . 05 2 1 . 2 2 5 . 2 2 8 . 8 1 8 . 8 19 . 2 2 1 . 5 14 . 1 1 3 . 3 1 4 . 4 1 3 . 3 1 2 . 2
j
1 3 .2 !12 . 9
j
1 2.5 !1 5 . 8
1
1 1 .6 1 1 2 . 3 9 . 6 17.1 15 . 7 3 4 . 6
T
u
18: 0 1 4 .5 ±0 . 07 1 6 . 3 11 . 9 11 . 0 1 3 . 1 12. 1 11.1 10 . 0 5 . 3 4 . 4 1 1 . 0 8 . 6
1
8 . 1 111 . 5 8 .5 ! 9 . 4
l
2 2 .6 ! 8 . 8 1 3 . 7 11 . 7 7 . 7 9 . 7
R
A
20: 0 0 .2 ±0 .00 - 0 . 1 - - 0 . 2 - - - - -
111 -
1_ 1 _1
% 1_ 1 _1 - 1 - - -
T
fr
22: 0 0 .2 +0 . 0 0 0 . 1 0 . 1 0 . 2 0 . 1 0 . 2 0 . 1 - - - - 0 . 1
1
0 .1 !1 - - : o.i
1_ 1 _l1 0 . 6 - 0 . 1 -
S . 24: 0 0 .1+0 . 0 0 0 . 1 — - - 3 . 0 - — — — — 0 . 2
1_ 11j
11
0 . 1 0 .1 ! 0 . 1iiii
0 .1 ! 0 . 3  1 1 1 1
- - - -
u9
M
16:1 4 .0 ±0 . 25 2 . 5 4 . 3 3 . 3 1 . 6 2 . 1 2 . 2 1 . 8 2 . 2 1 . 9 2 . 2 1 . 8
11
2 .6 !1 2 . 3
j
1 .4 ! 1 . 0
11
1 .0 ! 1 . 6  1 0 . 6 12 . 2 18 . 9 16 . 6
0
N
18:1 2 1 .6±0 .05 2 3 . 5 25 . 0 2 8 . 0 2 2 . 1 23 . 1 2 6 . 9 4 3 . 6 5 0 . 7 5 6 . 0 2 0 . 8 1 9 . 5 2 1 .3 !18 . 6 1 7.4 !1 7 . 5 1 8 .8 !14 . 2 1 5 . 8 22 . 0 19 . 6 17 . 8
0
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1_ 11
!ii
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j
4 0 .7 !1 8 . 9
i
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u 6
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1
0 .1 !j
-
l
0 .1 ! 0 . 1
1
0 .4 ! 1 . 5  
1 3 . 5
- - -
p
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0
1
2 0 : 3 3 .6 ±0 . 07 3 . 0 2 . 4 1 . 9 2 . 9 2 . 7 2 . 3 1 . 9 1 . 5 1 . 0 2 . 8 2 . 2
1
1 .6 !1 2 . 0 1 .5 ! 1 . 1  1 4 .6 ! 5 . 4 4 . 9 2 . 1 1 . 5 0 . 7
Y
c
20: 4 8 .2±0 . 05 9 . 1 6 . 8 5 . 6 9 . 3 9 . 6 9 . 2 4 . 6 3 . 1 2 . 2 5 . 1 3 . 3 2 .7 !1 6 . 6
1
5 .6 ! 3 . 3  1 4 .2 ! 3 . 5  1 2 . 2 5 . 4 3 . 3 1.1
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1
0 .3 ! 0 . 3  1 1 . 0 0 . 7 0 . 6 0 . 4
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l
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P
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1
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1
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L
v
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1
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1
!
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1
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22:6w3 slightly, increased with p-CO supplementation 
(1.2% to 3.8* and 3.1% to 3.4* us 0.7* and 2.3* in 
controls, respectively). Percentages for other PUFA's, 
however, were parallel to controls or decreased.
Cells supplemented with 20, 40 or 60mg/l p-MO exhibited 
slightly increased 16:0 and 18:lw9 levels (18.8*, 19.2* 
and 21.5*, and 22.1*, 23.1* and 26.9*, vs 15.6* and 
21.6* in controls, respectively), 24:0 was significantly 
increased with 40mg/l p-M0 (3.0* vs 0.1* in controls), 
whereas 18:0 and 16:lw9 levels were lower than controls 
(14.5* and 4.0*, respectively). 18:2w6 was significantly 
and 20:4w6 slightly increased with p-MO dosage (6.4* to 
11.7* and 9.2* to 9.6* vs 3.9* and 8.2* in controls, 
respectively), but no significant increments in other w6 
PDFA^s were found. 20:5w3 increased approximate 1y 2 fold 
with 20mg/l p-MO incubation (1.8* vs 0.7* in controls), 
and 22:6w3 was slightly increased across the range dosed 
(2.5* to 2.7* vs 2.3* in controls), but other w3 PUFA 
levels approximated to controls or were decreased.
18:lu9 levels increased 2 to 3 fold when cells were 
fed with 20, 40 or 60mg/l p-00 (43.6*, 50.7* and 56.0*, 
respective1y vs 21.6* in controIs), whereas 16:0, 18:0 
and 16:lw9 were decreased relative to controls (15.6*, 
14.5* and 4.0*, respectively). 18:2w6 increased over the 
range dosed (7.7* to 11.0* vs 3.9* in controls), as did 
20:2w6 (3.1*, 1.8* and 2.0*, respectively vs 0.2* in 
controls), but u6 and w3 PDFA levels were parallel to
controls or decreased.
p-SSO supplementation had little effect on 18:lw9, but 
decreased 16:0, 16:lw9 and 18:0, percentages compared to 
controls (21.6%, 15.6%, 4.0% and 14.5%, respectively). 
18: 2u6 increased markedly and 20:2u)6 significantly 
(25.0%, 32.3% and 40.7%, and 1.4%, 1.4% and 1.0% with 
20, 40 and 60mg/l p-SSO us 3.9% and 0.2% in controls, 
respectiue1y), but no increments in any other u6 or w3 
series PUFA's were induced.
16:0, 16:lw9, 18:0 and 18:lw9 levels were parallel to, 
or lower than, controls (15.6%, 4.0%, 14.5% and 21.6%, 
respectively) with 20, 40 or 60rng/l p~L0 incubation, but 
18:2u6 and 18:3w3 were increased (8.9%, 11.9% and 11.2%, 
14.8%, 29.4% and 29.2% vs 3.9% and 0.7% in controls, 
respectively). However, the only significant increment 
in PDFA levels was detected for 20:5w3 with 40mg/l p-LO 
(1.4% vs 0.7% in controls).
p-EPO incubation caused 16:0, 18:0, 16:lw9 and 18:lw9 
levels to decrease, although 18:0 was increased with a 
concentration of 20mg/l (22.6% vs 14.5% in controls). 
P~EP0 induced a concentration dependent increase in 
18:2u6 uptake (23.9% with 20mg/l, 38.9 with 40mg/l, and 
39.2% with 60mg/l vs 3.9% in controls), and the levels 
of both 20:2w6 and 18:3w6 were raised (1.1% to 1.4% and 
0.4% to 3.5% vs 0.2% and 0% in controls, respectively). 
An increment in 20:3w6 was also induced (4.6%, 5.4% and
4.9% with 20, 40 or 60mg/l p-EPO, respectively vs 3.6% 
in controls), but 20:4w6 levels decreased 2 to 4 fold 
compared to controls (8.2*0, and no increments in 22:4w6 
or 22: 5w6 were found. Furthermore, all U)3 series PDFA's 
detected were lower in dosed cells than in controls.
Supplementation with 20, 40 or 60mg/l p-F0 induced an
increase in 16:lu9 (12.2%, 18.9% and 16.6%, respectively
vs 4.0% in controls), decreased 18:0 levels, but had
little effect on 18:lw9 and 16:0, although the latter
increased about 2 fold with 60mg/l p-F0 (34.6% vs 15.6%
in controls). w6 series PDFA^s were not significantly
raised, despite more 18:2w6 in dosed than control cells
(4.8% to 7.5% vs 3.9%, respectively). Raised amounts of
20:5w3 were detected (4.7%, 10.0% and 2.6% with 20, 40
and 60mg/l p-F0, respectively vs 0.7% in controls), and
22:5w3 was increased with 20 and 40mg/l p-F0 (5.3% and%
4.6%, respectively vs 3.4% in controls). However, no 
evidence to suggest increased 22:6w3 was found.
The FA spectra of the spent growth medium removed from 
each of the above cultures is shown in Table 4.7.3.2. 
The medium in which control cells had been grown 
contained 97.4% 14:0, 1.4% 17:0 and less than 0.5% each 
of 16:0, 16: lu9, 18:0, 18:lw9 and 22:4w6. Spent media 
obtained from cultures dosed with p-oils similarly 
contained at least 96% 14:0 and 1.0% to 2.0% 17:0, but 
only trace amounts of the major FA components present in
The fatty acid spectrum of the spent culture medium of 
cells derived from cat skin.
FATTY ACID 
SPECTRUM 
(*)
CONTROLS 
< n= 3 )
Cp -COD 
(mg/ 1)
20 ! 40 1 60
Cp-MOD 
(mg/ 1 )
20 ! 40 ! 60
Cp-003  
(mg /1 )
20 ! 40 ! 60
Cp-SSOD 
(mg/ 1)
20 ! 40 ! 60
Cp-L O : ! 
(mg/ 1 ) ! 
20 ! 40 ! 60 !
Cp -e p o h
(mg /1 )
20 ! 40 ! 60
Cp-FOD ! 
(m g / 1 ) ! 
20 ! 40 ! 60 !
12: 0 -
1
0 .2 !1 0 . 2 0 . 3
11
1
- -
11
1
- - -
I1
- | — -
11 11
- |
14:0 9 7 .4 ±0 . 34 9 6 .4 !9 7 . 9 9 8 . 2 9 6 .1 !9 6 . 4 9 8 . 2 9 7 .8 !9 7 . 8 9 7 . 7 9 7 . 7
l
9 7 .9 !9 7 . 7 9 7 . 0 !9 7 . 3 9 7 .2 !9 7 . 5 9 7 .1 !9 7 . 6 9 7 .7 !9 7 . 6 9 7 .4 !S 11 11 11 1 1 11
A 16:0 0 .3 ±0 . 07 0 .8 ! 0 . 1 0 . 1 0 .9 ! 1 . 3 0 . 1 0 .2 ! 0 . 1 0 . 1 0 . 2 0 .1 ! 0 . 1 0 .1 ! 0 . 2 0 .2 ! 0 . 2 0 .3 ! 0 . 1 0 .1 ! 0 . 1 0 .1 !
T 11 11 11 11 11 11
U 17: 0 1 ,4 ±0 . 07 1 .5 ! 1 . 3 1 . 0 1 .9 ! 1 . 6 1.1 1 .2 ! 1 . 2 1 . 2 1 . 3 1 .1 ! 1 . 3 2 .0 ! 1 . 6 1 .5 ! 1 . 5 1 .5 ! 1 . 5 1 .5 ! 1 . 6 1 .4 !
R 11 1 11 1 1 1
A 18: 0 0 .1±0 . 05 — | — — — | - — __ __ _ 1 __ 1 _ l
T 11 ii 1 1 1 1
E 20: 0 - — j — — - j - — — — _ 1 _ 1 __ __ 1
S . 11 ii ll 1l 11 11
2 2 : 0
1
— — i
—
1
— -
1
- ! - - [ -
1 - I
24: 0 -
1
1I
- - ii
- -
1
lI
- • -
1
1l
- ! - - i -
l
11
1
1 0 . 1 !
M 1l ii ll l1 11 1
0 16:1 0 .1±0 . 05 0 .3 ! - - 0 .3 ! - - - ! - - — - j - — J — — J — 0 .3 ! - 0 .1 ! 0 . 2 0 .3 !N 1l 11 11 11 11 1
0 . 18:1 0 .3 ±0 . 03 0 .3 !1- »
0 . 2 0 . 1 0 .4 !11
0 . 4 0 . 2 0 .4 ! 0 . 5  1 1
0 . 7 0 . 2 0 .3 ! 0 . 311
0 .3 ! 0 . 3 0 .5 ! 0 . 2 0 .3 ! 0 . 3  1 1
0 .2 ! 0 . 2  1 l
0 .3 !
18: 2 -
i
- -
1
0 .1 !1 0 . 1 0 . 1
1
0 .1 ! 0 . 1  
1 0 . 1 0 . 2
1
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11
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11
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2 0 : 2 - — J — - ; - — — J — — — _ 1 _ __ 1 _ _ l
P ii ll 11 1 1 1
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the p-oils remained in the medium following the 48 hour 
incubation period.
4 . 7.4 Incorporation of Radiolabel1ed C18 Fattv
Acids into Cells Derived from Cat Skin.
The radioactivity recovered from cultures incubated with 
2wCi C14CD-18:lu9, C14C:-18:2u6 or C14C:-18:3u3 is shown 
in Table 4 . 7 . 4 . 1.
For both C14CI1-18: lu>9 and C14C3-18 : 3u3, the equivalent 
of 4 .3xl06 cpm were dosed to the cultures, and total 
recovery approximated to 81% and 95%, respectively. For 
C14CD-18:2w6 the equivalent of 4.8xl06cpm were dosed to 
the growth medium, and the total recovery of this radio­
label after 48 hours incubation amounted 94%. The counts 
recovered from the spent incubation media ranged from 
1.8 to 2.8xlOscpm, whereas only .0.3 to 0.5xl06cpm were 
recovered from the pooled buffers after washing the 
cells, which accounted for non-specific binding. The 
amount of each of these radioisotopes incorporated into 
the cells themselves equated to 31% for both C14CD- 
18:lw9 and C14C3-18:2u6, and 23% for C14C3-18:3w3.
The percentage conversion of incorporated C14CD-18:lw9, 
C14C3—18:2u6 and C*4C3—18j3w3 to w9, u6 and w3 series 
products, respectively after 48 hours incubation with 
cat skin fibroblasts are shown in Table 4.7.4.2. As A6D 
represents the first and rate limiting enzyme in the 
desaturase cascade, total activity of this enzyme is 
reflected by the sum of al1 subsequent desaturase and 
elongase products.
The radioactivity (cpm) recovered from cat skin cultures 
incubated with radiolabel1ed C18 fatty acids. expressed as 
mean (is.e.m.). n=3.
SPENT
MEDIA
(M)
POOLED
WASHINGS
(W)
TOTAL
(M+W)
CELLS TOTAL
xl0&
Total 18:1 counts dosed to incubation medium = 4.3 x 106
1745160
(±3400)
391380
(±3660)
2136540 1343979
(±1962)
3.5
Total 18:2 counts dosed to incubation medium = 4.8 x 10s
2540660
(±10260)
491460
(±8760)
3032120 1463025
(±4281)
4.5
Total 18:3 counts dosed to incubation medium = 4.3 x 10s
2826600
(±15300)
296880
(±4800)
3123480 969108
(±573)
4.1
The counts detected for the radio1abe11ed fatty acids 
dosed and their resulting metabolites formed after 
incubation with cells derived from cat skin. expressed 
as a percentage of the total counts recovered upon GLC 
ana 1ysi s.
w9
MONOS.
c l 4 c : -
18:lw9
u6
POLYS. C14CII-18:2u6 u3POLYS. CiaCT- 18:3w3
18:1 29.9 18:2 31.0 18:3 32.0
20:1 37.3 18:3 7.7 18:4 6.4
22:1 20.5 20:2 23.2 20:3 22.5
24:1 12.4 20:3 15.9 20:4 21.4
20:4 8.5 20:5 7.3
22:4 8.4 22:5 6.2
22:5 5.2 22:6 4.3
TOTAL TOTAL TOTAL
CPM 2808 CPM 3524 CPM 1639
29.97 of the total C14C0-18Jlu9 counts derived upon GLC 
analysis (2808cpm) remained unchanged, while the amounts 
detected for the subsequent elongation products were 
37.37 20 : lw9, 20.5* 22:lu9 and 12.47. 24:lw9.
31.07 of the total C14C3-18:2u6-derived counts detected 
following GLC (3524cpm) remained unaltered, whereas 
23.27 was found as 20:2w6, but only 7.77 as 18:3w6.
15.97 20:3w6 was detected, but 20:4w6, 22:4w6 and 22:5w6 
only comprised 8.57, 8.47 and 5.27 of the total counts, 
respective!y.
1639cpm were derived upon GLC analysis of cells dosed 
with CiaC3-18:3w3, of which 32.07 remained as 18:3w3, 
22.57 was found as 20:3w3, but only 6.47 as 18:4w3. 
These amounts were similar to those detected for the 
corresponding products of C14CD-18:2w6 metabolism. 21.47 
of the total Z1aCD~18:3w3-derived counts were present as 
20:4w3, whereas the percentages for 20:5u3, 22:5u3 and 
22:6u3 were 7.37, 6.27 and 4.37, respectively. These 
post-J5D FA proportions were slightly lower than those 
detected for equivalent products in the w6 PUFA series.
4.7.5 Effects of Pseudo-Oils on Lipid Peroxide
Format i on.
Table 4.7.5.1. shows the 1ipoperoxides quantified both 
in cultured cells and their respective growth media in 
the presence and absence of dosed p-oils. The values are 
shown as nmoles MDA/106 cells, but in the case of the 
spent media, this represents the nmoles of MDA in the 
volume of medium from which lxlO6 cells were obtained.
MDA levels varied between dosed cells with p-oil, 
ranging from 0.1 to 5.8nmoles MDA/106 cells, compared to 
0.4nmoles MDA/106 control cells. Lipoperoxide amounts 
were parallel to, or lower than, controls when cells 
were supplemented with 20mg/l p-oil, but increased in an 
overall concentration dependent manner as higher p-oil 
amounts were dosed. Lipoperoxide production was low with 
p-CO, p-MO or p-00 incubation (0.1 to 0.5nmoles MDA/106 
cells). p-EPO and p-SSO induced similar amounts of lipid 
peroxides (0.3, 0.6 and 0.6 vs 0.4, 0.6 and 0.9nmoles 
MDA/106 cells with 20, 40 and 60mg/l, respectively), and 
p-FO generated significantly greater amounts only with a 
concentration of 60rng/l (4.9nmoles MDA/106 cells). p~L0, 
however, induced the highest overall levels (0.3, 1.6 
and 5.8nmoles MDA/106 cells with 20, 40 and 60mg/l,
respective!y) .
The spent medium derived from cultures incubated with 
60mg/l p-LO or p-FO contained small lipid peroxide
Lipoperoxide formation by cat skin cultures incubated 
with p-oils. expressed as nmoles MDA/106 rells.
pseudo-
Oil
(mg/1)
CELLS
0 20 40 60
Control 0.4
CO 0.1 0.3 0.5
MO 0.3 0.1 0.5
00 0.3 0.4 0.5
SSO 0.3 0.6 0.6
L0 0.3 1.6 5.8
EPO 0.4 0.6 0.9
F0 0.2 0.7 4.9
pseudo- SPENT INCUBATION MEDIUM
Oil
(mg/1) 0 20 40 60
Control -
CO - - -
MO - - -
00 - - -
SSO - - -
L0 - - 0.1
EPO - - -
F0 - - 0.3
amounts (0«1 and 0.3nmoles MDA/10^ cells, respectively), 
but these compounds were absent from the spent media of 
all other dosed cultures, as well as control medium.
4.7.6 The Eic osanoid Profile of Cells Derived 
from Cat Skin.
Table 4.7.6.1. shows the eicosanoids positively detected 
in control and dosed cat skin fibroblasts. All data is 
presented as a percentage of the total area quantitated, 
but an indication of the actual amount found is given 
for controls in '( )' as pmoles/10& control cells.
Total eicosanoid synthesis by control cells amounted to 
only 80.5pmo1es/106 cells, of which 21.0% correlated 
with the retention times of the prostanoid standards 
used. This fraction was composed of 10.7% TXB2 > 6.9%
> 1.8% PGI2 and 1.6% PGE2 . Varying proportions of 
these prostanoids were found in dosed cells, but neither
control nor dosed cells formed significant amounts of 
PGEi or PGD2 .
Total percentages for the prostanoids detected in dosed 
cells varied significantly with p-oil concentration as 
such approximated to controls (21.0%) with 40mg/l p-oil 
(15.5% to 24.9%), but were greatly increased both 
with 20mg/l (34.2% to 50.1%) and 60mg/l (32.9% to 41.8%) 
p-oil. These changes were reflected by appropriate 
alterations in individual prostanoid levels. PGI2 bio­
synthesis was increased with incubation of 40mg/l p-oil 
(3.0% to 9.5% vs 1.8% in controls), but more varied with 
20mg/l (0.8% to 6.0%) and 60mg/l (0.9% to 3.1%) p—oil. 
TXB2 levels approximated to controls (10.7%) or were
Values are tabulated as relative percent of the total 
area detected, and as pmoles total eicosanoids/106 
control cel Is.
The profile of the eicosanoids detected in extracts of 
cells derived from cat skin.
pseudo-
Oil
(mg/1)
EICOSANOIDS m
TOTAL pgi2 TXB2 (1^5 PGE2 PGEi PGD2
CONTROL 21.0 1.8 10.7 6.9 1.6 _
(80.5)
20 40.5 1.9 21.8 15.2 1.6 — —
CO 40 24.9 4.4 11.5 9.0 - - -
60 38.3 1.9 23.0 12.8 0.6 — —
20 50.1 2.9 24.1 21.3 1.8 — —
M0 40 22.0 3.0 8.7 10.3 - - -
60 41.8 2.5 24.1 14.9 0.3 —
20 37.2 2.6 19.8 13.3 1.5 — —o*3Oo 23.7 7.9 8.5 7.3 - - -
60 38.7 3.1 24.3 10.2 0.8 0.3 —
20 39.7 6.0 18.3 13.8 1.6 — —
SSO 40 20.0 9.5 5.8 4.7 - - -
60 34.2 1.3 19.3 13.2 0.1 0.3
20 38.8 2.9 21.2 13.1 1.6 — —oo—I 15.5 5.0 7.6 2.9 - - -
60 38.9 1.0 24.5 12.9 0.5 — —
20 34.2 0.8 17.2 14.5 1.7 — —
EP0 40 23.5 6.2 9.3 8.0 - - -
60 32.9 1.5 17.2 13.9 0.3 — —
20 42.4 3.0 23.1 14.8 1.5 — —
F0 40 16.6 4.7 8.9 3.0 - - -
60 34.7 0.9 23.9 9.0 0.9
decreased with dosage of 40mg/l p-oil (5.8% to 11.5%), 
but increased approximate!y 2 fold with 20 or 60mg/l 
p-oil (17.2% to 24.5%). Similarly, the changes in PGF^ 
production were smallest with incubation of 40mg/l p-oil 
(2.9% to 10.3% us 6.9% in controls), but were greater 
with 20mg/l (13.1% to 21.3%) and 60mg/l (9.0% to 14.9%)
p oil. PGE2 production approximated to that of controls 
(1.6%) when cells were supplemented with 20mg/l p-oil 
(1.5% to 1.8%), but was suppressed in the presence of 
60mg/l p-oil (0.1% to 0.9%) and inhibited with 40mg/l 
p-oi 1 .
4.7.7 D i scussi on.
p-Oil supplementation of cultured cat skin fibroblasts 
induced effects ranging from stimulation to inhibition 
of cell proliferation, and the different cell viability 
changes reported (Figs. 4.7.1.2-4.7.1.8.) reflected the 
unique FA composition of each p-oil (Table 2.3.3.2.) and 
the concentration dosed. The pronounced differences in 
cell viability induced with p-00, p~SS0 or p-LO dosage 
probably related to the abundance of OA, LA and ALA in 
these p-oils, respectively. It was apparent that OA 
exhibited the potential to stimulate cell proliferation 
when dosed at intermediate concentrations in the range
used, unlike LA and ALA, whereas the cytotoxic potential
/of ALA was greater than OA, followed by LA when these 
p-oils were dosed at high concentrations. The marked 
variations in cell viability induced with p-EPO or p-SSO 
dosage, despite similar FA compositions, could have 
related to the presence of GLA in p-EPO only. This FA 
appeared to stimulate cell growth with low, and inhibit 
such with high, concentrations of p-EPO dosed, compared 
only to growth limitation induced by LA with p-SSO 
feeding. It was also apparent that GLA (in p-EPO) was 
more effective in mediating cytotoxicity than ALA 
(in p-LO) at high concentrations, and such may relate to 
the fact that GLA is a PDFA. Indeed, PDFA involvement 
in the modulation of cytotoxicity seemed likely as 
dosage with high concentrations of p-EPO or p-FO, which
contained significant PDFA amounts, were most effective 
as cytotoxic agents, while their absence led to less 
effective cell killing. However, the enhancement of cell 
viability reported with supplementation of p-MO, p-00, 
P“EP0 or p-FO, but not with p-CO, p-SSO or p-LO, 
correlated with the presence of EFA desaturation and/or 
elongation products in the former p-oils only, and also 
suggested involvement of such FA's in the stimulation of 
cell growth with low and/or intermediate concentrations 
of p-oils. Dosage with p-00 or p-MO, each containing 
about 2%, 20:2u6 or 20:4u6, respectively, enhanced cell 
viability to a greater extent than did p-EPO or p-FO, 
containing 9% 18:3w6 and 18% 20:5w3, respectively. Small 
amounts of exogenous EFA desaturation and/or elongation 
products thus seemed more effective in the stimulation 
of cell proliferation.
The different cell viability changes which the p-oil 
FA's appeared to induce could have related to structural 
variations between different moieties. It should be kept 
in mind, however, that synergistic or antagonistic 
interactions between different p-oil FA's could also 
have played a role in the modulation of cell viability. 
This may explain why cell viability changes did not 
always correlate linearly with the amount of p-oil 
supp1emented.
The finding that only trace amounts of the major FA
components present in the p-oils remained in the spent 
medium following the 48 hour incubation period (Table 
4.7.3.2.) indicated the capability of these cells to 
incorporate exogenous FA's, even in the presence of high 
14:0 levels derived from the culture medium itself 
(Table 2.3.3.3.). The FA spectra of dosed cells (Table
4.7.3.1. ) supported p-oil FA uptake from the culture 
medium. A mechanism whereby p-oils affected cell growth 
may therefore relate to differential exogenous FA uptake 
and alterations in membrane stability, dependent on 
p-oil FA composition and concentration dosed. Pronounced 
distortions of membrane fluidity would indeed support 
the limitation and inhibition of cell proliferation 
found when 1arge quantities of saturated or unsaturated 
FA-rich p-oils were fed (Figs. 4.7.1.2-4.7.1.8.).
p-Oil supplementation of cat skin fibroblasts induced 
concentration changes in total cellular protein (Table
4.7.2.1. ) which generally reflected the cell viability 
changes induced (Figs. 4.7.1.2-4.7.1.8.). The largest 
amount of total protein quantitated indeed corresponded 
to the greatest stimulation of cell viability found with 
60mg/l p-00 dosage. However, the finding that protein 
increased about 50% compared to a 22% increment in cel 1 
viability indicated that such protein changes did not 
relate solely to increased cell numbers,' particularly 
since increased protein was found in cells dosed with 
p-oils that caused growth limitation, eg. p-CO or p-SSO.
This indicated p-oil FA involvement in the stimulation 
of protein synthesis, which may reflect enhanced enzyme 
expression to metabolise the incorporated p-oil FA's. 
The fact that the extent of protein stimulation varied 
when supplementation with identical concentrations of 
different p-oils yielded similar cell numbers suggested 
that the capability to modulate protein biosynthesis 
related to differences in FA structure. Whether this 
related to specific FA's in any p-oil, or to synergistic 
effects between p-oil FA's, was unknown, although a 
combination of such effects seemed most likely. However, 
as the protein concentrations in spent media derived 
from dosed cultures were not statistically different 
from controls (section 4.7.2), medium protein itself 
probably did not contribute significantly to the changes 
demonstrated in cellular protein (Table 4.7.2.1.).
The literature does not describe the desaturation 
capability of cat skin either in vivo or in vitro. The 
results obtained from the incubation of cat skin 
fibroblasts with p-oils showed that such cells exhibited 
very little potential to desaturate or elongate FA's, 
despite significant p-oil FA uptake (Tables 4.7.3.1. and 
4.7.3.2.). No significant 18:4w3 or 18:3w6 formation 
occurred, even with p-LO or p-SSO supplementation, 
respectively, implying impaired A6D capability. This was 
consistent with reports which have indicated an overal1 
lack or suppression of A6D capability in the cat (eg.
Rivers et al 1975a, Frankel et al 1978, Sinclair 1979, 
Sinclair et al 1981 and Davidson et al 1990a). Thus 
20:3w6 formation only with p-EPO dosage more than likely 
related to elongation of incorporated 18:3w6, while the 
presence of small 20:2w6 amounts with p-SSO or p-EPO 
dosage reflected limited elongation of incorporated 
18:2w6 which could not be further desaturated. However, 
no evidence for 20?3w6 desaturation via J5D was shown. 
Limited elongation of 20:5w3 incorporated with p^FO 
incubation occurred, but this was not converted to 
22:6w3 via J4D. On the other hand, p-CO dosage induced 
significantly increased cellular 20:5w3 and 22:6w3 
levels. This p-oil was PUFA-deficient (Table 2.3.3.2.), 
thus it was possible that such enhanced desaturation 
and/or elongation of cellular PDFA/s in an attempt to 
maintain membrane fluidity? this indeed correlated with 
decreased cellular 18:4w3 and 20:4w3 levels.
The overall lack or suppression of desaturase cascade 
enzyme capability in these cells (Table 4.7.3.1.) did 
not relate to the mediation of growth limitation induced 
with p-oil supplementation (Figs. 4.7.1.2-4.7.1.8.) as 
enzyme capability was not improved even when p-oils 
stimulated cell proliteration. Impairment of enzyme 
expression may rather be a characteristic of cat skin, 
implying a requirement for preformed PDFA's from the 
diet or other cat tissues, particularly for eicosanoid 
production.
p-0il desaturation was compared with that of individual 
C18 FA's (Table 4.7.4.2.) to assess whether FA mixtures 
modulated the pattern of p—oil desaturation reported 
(Table 4.7.3.1.). Cat skin fibroblasts were unable to 
effic iently desaturate 18:lw9 when such was supplemented 
with p-oils or individually. Elongation was induced with 
C14C3-18:lu9 feeding, however, and such was possibly 
suppressed with p-oil, or enhanced with C14CD-18:lu9, 
supplementation. On the other hand, the pattern of 
radioactivity derived from the incubation of cells with 
C14CD~18:2w6 or C14C3-18!3w3 was consistent with both 
desaturation and elongation of these moieties. However, 
PDF A formation from C14CI1-18: 2u6 and C14C3-18:3u3 via 
an active A6D was unlikely since expression of this 
enzyme is impaired in the cat (eg. Rivers et al 1975a 
and Frankel et al 1978). The data rather suggested that 
C14C3-18 J 2to6 and C14C3-18s 3u3 were directly elongated to 
20:2u6 and 20:3w3, followed by J8~desaturation to 20:3w6 
and 20:4w3, respectively. The small 18:3u6 and 18:4w3 
amounts detected may therefore reflect 20:3w6 and 20:4to3 
retroconversion. The formation of about 20^ post-J5D 
PUFA's nevertheless supported the capability for .45D 
expression. However, the apparent accumulation of 20:3w6 
and 20!4u3 may have been an indication that the rate of 
their formation was greater than the rate of their 
conversion to post-J5D products and/or that A5D activity 
was not fully expressed. This could account for the
small amounts of radioactivity detected for 22*5w6 and 
22:6w3, although it was also apparent that these cells 
exhibited very limited .44D capability.
The findings above indicated that desaturase cascade 
enzyme expression was more 1imited in the presence 
of p-oils than individual FA's (Tables 4.7.3.1. and 
4.7.4.2). This could have related to the mediation of 
competitive interactions between p-oil FA's for the 
desaturase and elongase enzymes by complex mechanisms, 
which are documented (Brenner et al 1966, Mohrhauer et 
al 1967, Ullman et al 1971a, de Schriver et al 1982, 
Holman 1986a, Nassar 1986 and Cook et al 1987). Similar 
effects probably occur in vivo when dietary oils are 
fed, thus p-oil desaturation may be a better indicator 
of such enzyme capability in cat skin in vivo than that 
suggested with individual FA's, particularly since FA's 
are presented to the organism as mixtures.
Cellular MDA detection both in the presence and absence 
of dosed p-oils (Table 4.7.5.1.) indicated that cat skin 
fibroblasts exhibit enzymic and/or non-enzymic pathways 
for the oxidation of monoenoic and/or polyenoic FA's. 
MDA detection in control cells was not surprising, 
since these cells contained FA's which were potential 
candidates to act as substrates for the formation of 
1ipoperoxides (Table 4.7.3.1.). Measurement of small, or 
no, increments in MDA concentration with p-CO or p-MO 
dosage reflected the abundance of saturated FA's in
these p-oils (Table 2.3.3.2.). However, the formation of 
relatively small cellular 1ipoperoxide amounts also with 
p-00, p-SSO or p-EPO dosage implied that the substrates 
for 1ipoperoxidation were not so readily accessible 
to oxidation, possibly because they were present as 
components of complex membrane lipids, eg. PGL's. This 
could also explain the lower MDA levels measured in some 
dosed cells than in controls (Table 4.7.5.1.), despite 
the presence of unsaturated FA's in the p-oils. It was 
also possible that incubation with p-00, p-SSO or p-EPO 
decreased the rate of PGL turnover and therefore the 
size of the FFA pool. The converse, however, could 
explain the highest cellular 1ipoperoxide concentrations 
induced with 40 or 60mg/l p-LO or p-FO supplementation, 
which probably related to the amount of ALA and EPA in 
these p-oils, respectively (Table 2.3.3.2.), as well as 
their susceptibility to oxidation.
The absence of significant 1ipoperoxide amounts in the 
spent media derived from dosed cultures (Table 4.7.5.1.) 
supported cellular uptake of supplemented p-oil FA's 
(Tables 4.7.3.1. and 4.7.3.2.). This was also consistent 
with the lack of cytotoxicity found with 20, 40 or 
60mg/l p-oil dosage, and therefore retension of cellular 
FA s, 1ipoperoxides and peroxidising enzymes.
Supplementation of cat skin fibroblasts with 20, 40 
or 60mg/l p-oil stimulated and/or limited, but never
inhibited, cell liability (Figs. 4.7.1.2-4.7.1.8.), thus 
no correlation between lipid peroxide formation and 
cytotoxicity could be established. These compounds 
should, however, be considered as a possible mechanism 
involved in the modulation of cell death with higher 
p-oil concentrations. On the other hand, comparison of 
MDA amounts with the growth limitation induced with 
20, 40 and/or 60mg/l p-oil dosage indicated that lipid 
peroxides were not solely involved in the modulation of 
growth limitation. It was likely, therefore, that other 
mechanisms, such alterations in membrane fluidity, were 
also involved.
The finding that total eicosanoid formation accounted
for 20^ of the 1ipoperoxides quantified in control
cat skin fibroblasts (Tables 4.7.5.1. and 4.7.6.1.)
reflected the poor capability of such cells to form 
eicosanoid precursors via desaturation (Table 4.7.3.1). 
It seemed likely therefore that skin was reliant on an 
external supply of eicosanoid precursors. The fact that 
the eicosanoids studied comprised a fraction of the 
molar amount quantified indicated that these cells were 
largely involved in the production of other eicosanoids. 
Prostanoid detection nevertheless supported functional 
cyclooxygenase expression in cat skin fibroblasts under 
the experimental conditions employed, although it was
apparent that PGHi-pg^j ancj PGH2-PGD2 isomerases were 
suppressed/inhibited since no significant PGEi or PGD2
formation was shown, even with p—oil supplementation. 
A1ternatively, it was possible that these PG's were 
degraded at a faster rate than other prostanoids by 
cytoplasmic enzymes such as 15-hydroxy PG dehydrogenase. 
On the other hand, the finding that the rate of TXB2 ancj 
PPPrur0: biosynthesis were considerably greater than that
r  n p nor rut2 and PGl2 could have been the result of increases 
in the activity/expression of enzymes forming TXB2 and
and/or relative decreases in PGH2-PGE2 isomerase 
and prostacyclin synthetase.
The eicosanoid spectra obtained from dosed cells (Table 
4.7.6.1.) were consistent with the ability of the p-oils 
to modulate prostanoid production. This, however, did 
not correlate in any way with the degree of p-oil 
unsaturation or the ability of the p-oils to provide 
direct eicosanoid precursors (Table 2.3.3.2.). Cells 
enriched with p-EPO elongated incorporated 18:3w6 to the 
1-series eicosanoid precursor, 20:3u6 (Table 4.7.3.1.), 
p-MO contained 20:4w6, the direct 2-series precursor, 
whereas 2-series prostanoid inhibitors were present in 
p~F0 and p-LO (20:5u3 and 18:3u>3, respectively). The 
prostanoid changes these p-oils induced, however, were 
not significantly different, even when compared to those 
mediated with identical concentrations of other p—oils. 
These findings implied that exogenous FA/s per se 
induced little effect on the production of the 
eicosanoids studied, and suggested that any enhancement
of prostanoid production related to utilisation of 
endogenous membrane 20:3w6 and/or 20:4w6, which were 
detected in cat skin fibroblasts (Table 4.7.3.1.). The 
fact that supplementation with 40mg/l p-oil had little 
effect on, or suppressed, prostanoid formation, whereas 
20 and 60mg/l p-oil stimulated eicosanoid production 
nearly 2 fold primarily by enhancing TXB2 ancj PGFa 
synthesis (Table 4.7.6.1.), nevertheless implied p-oil 
concentration involvement in the modulation of 
prostanoid synthesis. This could have influenced the 
release of 1- and 2-series eicosanoid precursor FA's 
from membrane lipids, or the expression of enzymes 
involved in the formation of the prostanoids studied 
from PGH. However, the fact that no correlation could be 
found between the eicosanoid profiles (Table 4.7.6.1.) 
and cell viability changes (Figs. 4.7.1.2-4.7.1.8.) 
induced with p-oil dosed was in v i tro evidence against 
the concept that the endogenously generated prostanoids 
studied played a direct role in the modulation of cell 
proliferation. It was more likely that such related to 
alterations in membrane physical properties and possibly 
the generation of FA oxidation products.
4.8 THE EFFECTS OF PSEUDO-OILS ON CELLS
DERIVED FROM CAT ADIPOSE TISSUE.
4.8.1 Effects of pseudo-Qils on Cell Viability.
Microscopic 
exper i ment 
control or 
cytoplasmic 
at high con
examination before, during 
showed no changes in the 
p-oil dosed cells at any 
droplets were observed with p 
centrations in some instances.
and after each 
morphology of 
t i me, a 1 though 
-oil incubation
Investigation of the effects of albumin with final 
medium concentrations ranging from 0 to 250mg/l showed 
no significant effect on cell viability (Fig. 4.8.1.1.). 
The effects induced with the dosed p-oils were therefore 
a result of the FA's in the p-oil mixture and not the 
albumin used as FA carrier.
The number of control cells, seeded at 10xl04/ml, at the 
end of the 24 hour post-trypsinisation recovery period, 
was 10.1xl04/ml. This equated to about 92% of the final 
control cel 1 number at the end of the 48 hour incubation 
period, and represented the cytostatic number. Only 
p-oil concentrations limiting cell viability to 
significantly below 92% were thus considered cytotoxic.
Figs. 4.8.1.2—4.8.1.8. depict the cell viability changes 
induced with p—oil incubation. Cell growth was enhanced 
with low concentrations of p-00 and p-FO, but was both
The results are expressed as mean percent (%) cell 
viabi1ity±standard error of the mean (s.e.m.), where "n" 
is the number of experiments. The concentrations given 
are as mg albumin or pseudo-oil per litre of growth 
medium. Fig. 4.8.1.1. shows the mean percent cell 
viability versus the albumin concentration (mg/1), and 
Figs. 4.8.1.2~4.8.1.8. depcit the mean percent cell 
viability versus the pseudo-oil concentration (mg/1). 
Fig. 4.8.1.9. shows the mean percent cell viability 
versus the albumin concentration (mg/1) for cells dosed 
with the amount of pseudo-oil which limits cell 
viability to 50^ of the controls.
A 1 b u m in 
Concentration 
(m g / 1 )
Mean ± s .e .m . n
0 100.0 2.7 12
25 98.5 4.0 12
50 102.6 3.9 12
75 102.4 3.8 12
100 102.4 2.5 12
125 103.1 3.6 12
150 100.4 2.2 12
175 100.9 2.5 12
200 101.7 3.1 12
225 101.3 2.5 12
250 99.6 3.6 12
pseuso-Oi1 
Concentration 
(mg/1)
Mean ±s.e .m . n
0 100.0 3.9 6
10 100.5 3.3 6
20 103.3 3.1 6
30 101.6 3.8 6
40 89.7 2.8 6
50 83.7 4.1 6
60 75.5 3.9 6
70 42.4 3.5 6
80 37.5 3.2 6
90 28.3 1.8 6
100 22.8 3.5 6
pseuso-Oi1 
Concentration 
< mg/1)
Mean ±s.e .m . n
0 100.0 3.7 6
10 98.8 7.1 6
20 00•o 4.8 6
30 92.4 2.7 6
40 90.4 1.8 6
50 84.5 2.0 6
60 79.6 2.2 6
70 69.7 2.0 6
80 76.1 2.1 6
90 71.7 2.1 6
100 58.4 2.1 6
pseuso-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 2.8 6
10 98.0 4.7 6
20 100.2 5.3 6
30 75.1 1.9 6
40 111.3 2.1 6
50 72.7 2.1 6
60 63.8 2.5 6
70 64.4 3.3 6
80 53.7 1.5 6
90 14.7 2.3 6
100 2.5 00♦o 6
pseuso-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 5.2 6
10 105.0 3.1 6
20 95.2 4.7 6
30 90.3 1.7 6
40 91.9 2.1 6
50 94.4 3.8 6
60 88.7 2.1 6
70 81.8 5.7 6
80 81.4 2.7 6
90 72.4 1.9 6
100 41.8 3.2 6
pseuso-Oi1 
Concentration 
(mg/1 )
Mean ±s.e .m . n
0 100.0 3.4 6
10 99.6 3.7 6
20 100.4 3.5 6
30 91.0 4.5 6
40 102.3 3.0 6
50 92.5 2.1 6
60 92.0 4.4 6
70 80.8 3.5 6
80 82.7 3.4 6
90 83.1 2.6 6
100 68.1 2.4 6
pseuso-Oi1 
Concentration 
( m g / 1 )
Mean ±s.e .m . n
0 100.0 1.9 6
10 101.3 3.4 6
20 93.7 2.5 6
30 92.4 2.6 6
40 86.1 2.6 6
50 76.0 2.9 6
60 84.0 2.2 6
70 76.8 3.0 6
80 71.7 2.2 6
90 57.8 2.2 6
100 40.1 h* 00 6
pseuso-Oi1 
Concentration 
(mg/1)
Mean ±s.e .m . n
0 100.0 4.1 6
10 93.3 3.7 6
20 95.5 5.2 6
30 110.9 3.8 6
40 117.8 2.6 6
50 107.2 3.6 6
60 89.9 3.7 6
70 81.8 1.9 6
80 27.9 3.1 6
90 4.6 2.4 6
100 4.4 1.6 6
Fi g ♦ 4 ♦ 8 ♦ 1.9
A1bumin 
Concentration 
(mg/1)
Mean ±s.e .m . n
0 100.0 4.1 6
150 49.9 2.0 6
175 49.1 1.8 6
200 53.1 2.0 6
225 45.0 1.8 6
250 50.1 1.9 6
limited and inhibited with all p-oils, although the 
magnitude thereof varied greatly dependent on the p-oil 
and concentration dosed. The overall pattern of growth 
inhibition was least with p-LO or p-MO, and greatest 
with p-CO, p-00 or p-FO, dosage.
Dosage with up to 30mg/l p—CO had little effect on cell 
growth (Fig. 4.8.1.2.), but cytostasis was induced with 
40mg/l p-CO as cell viability (89.7%) approximated to 
the cytostatic number. Concentrations greater than 
40mg/l p-CO were cytotoxic, and progressively reduced 
cell viability to 50% of controls with about 68mg/l p-CO 
(ID5 0), and to 22.8% with 100mg/l p-CO.
Cell proliferation was not significantly different from 
controls with 10 or 20mg/l p-MO dosage, cytostasis was 
induced with 30mg/l p-MO, and cytotoxicity was prominent 
with concentrations greater than 40mg/l (Fig. 4.8.1.3.).
No ID50 yalue was found, however, as 58.4% of cells were 
viable with 100mg/l p-MO.
Cell growth mirrored that of controls with up to 20mg/l 
p-00 incubation (Fig. 4.8.1.4.). Cytotoxicity increased 
progressively with higher concentrations, reducing cell 
viability to 75.1% and 72.7% with 30 and 50mg/l p-00, 
respectively, although cell proliferation was enhanced 
with 40mg/l p—00 to 111.3%. Concentrations greater than 
70mg/l p-00 induced marked cell death as cell viability 
was 50% with 81mg/l p-00 ( I D50) ,  and only 2.5% with
100mg/l p-00.
10mg/l p-SSO enhanced cell proliferation to 105.0%, but 
20 to 60mg/l p-SSO induced cytostasis (Fig. 4.8.1.5.). 
Cytotoxicity reduced cell viability to 81.4% with 80mg/l 
p-SSO, but more markedly to 41.8% with 100mg/l p-SSO. 
10 and 20mg/l p-EPO had little effect on cell growth, 
while 30mg/l p-EPO induced cytostasis (Fig. 4.8.1.7.). 
Higher concentrations were progressively cytotoxic, and 
resulted in 40.1% viable cells with 100mg/l p-EPO. The 
cell viability changes p-SSO and p-EPO induced were thus 
similar, and this was supported by the IDso values 
(approximately 98mg/l and 95mg/l, respectively).
Dosage with up to 40mg/l p-LO generally had little 
effect on cell growth, while cytostasis was induced with 
30, 50 or 60mg/l p-LO (Fig. 4,8.1.6.). Concentrations 
greater than 60mg/l p-L0 were only slightly cytotoxic, 
and cell viability ranged from 80.8% to 83.1% with 70 to
90mg/l p-LO. No ID50 value could be calculated as 68.1% 
viable cells were found with 100mg/l p-LO.
No marked cell viability changes were induced with 10 or 
20mg/l p-FO, while cell proliferation was enhanced to 
110.9%, 117.2% and 107.2% with 30, 40 and 50mg/l p-F0 
(Fig. 4.8.1.8.). 60mg/l p-FO induced cytostasis, while 
cytotoxicity reduced cell viability to 81.8% with 70mg/l 
P-FO and to 50% with 76mg/l P-F0 (ID50), Cytotoxicity 
was considerably greater with higher concentrations, and
Trypan blue uptake uas about 95% with 90 and lOOmg/1 
P-FO.
Ce11s were incubated with p-00 to correspond with i ts
ID50 (about 81mg/l) and dosed with varying amounts of
albumin to exc1ude the possibility that any cel 1
viability changes induced with p-oil incubation were 
influenced by the amount of albumin bound to the FA's. 
Five points were chosen around which to vary the albumin 
concentration, keeping the p-oil level fixed, viz. two 
points above, two points below, and the ID50 Qf p-0 0. 
The appropriate amount of albumin was added to these 
cultures to give the desired concentrations. The results 
are shown in Fig. 4.8 .1.9., and indicated that the 
p-00 concentration supplemented reduced cell viability 
to approximately 50% of controls, and that such was not 
significantly influenced by different concentrations of 
albumin. Exclusion of the synergistic involvement of 
albumin therefore implied that the effects induced with 
the p-oi1s were attributed solely to the exogenous FA's.
Subsequent to these studies, cells derived from cat 
adipose tissue were plated and dosed appropriately with 
0, 20, 40 or 60mg p-oi1/1 culture medium in sufficient 
amounts for all quantitative and qualitative analyses to 
be carried out. Upon harvesting, cell viabilities were 
compared and found not to be statistically different 
from those in Figs. 4.8 .1 .1-4.8 .1 .8 ., hence all further 
biochemical assays were performed on these samples.
4.8.2 Effects of pseudo-Oils on Total Protein.
The total cellular protein content determined at each of 
the 3 p-oil concentrations dosed are shown in Table 
4.8.2.1. in relation to controls, expressed as Mg total 
protein/106 cells seeded.
475.3^9 protein/106 control cells seeded was measured, 
while concentrations were considerbly greater in cells 
supplemented with 20, 40 or 60mg/l p-oil, ranging from 
533.0 to 774.2,ug/106 cells seeded. The protein in crement 
was greater with supplementation of 20 than 40 or 60mg/l 
p-CO (681.3, 668.0 and 664.9;ug> respectively) or p-EP0 
(638.9, 575.4 and 533.7jug> respectively), but did not 
vary significantly with p-SSO dosage (668.5 to 673.6jug). 
On the other hand, the protein increment was noticeably 
greater with supplementation of 40 than 20 or 60mg/l 
p-00 (695.3, 609.8 and 533.0jU9» respectively) or p-FO 
(774.2, 694.0 and 681.3jug> respectively), while the 
converse was found with p-MO (668.5, 708.9 and 694.0jug> 
respective!y).
The protein content of cells derived from cat adipose 
tissue. expressed as jug total protein/10s cells seeded.
pseudo-
Oil
CELLS
(mg/1) 0 20 40 60
Control 475.3
CO 681.3 668.0 664.9
MO 708.9 668.5 694.0
00 609.8 695.3 533.0
SSO 672.2 673.6 668.5
L0 740.2 767.0 763.3
EPO 638.9 575.4 533.7
F0 694.0 774.2 681.3
4.8.3 Effects of pseudo-Qils on the Fatty Acid
Spectrum of Cells Derived From Cat 
Adipose Tissue.
The FA spectra for cells incubated with 20, 40 or 60mg/l 
p~oil are shown in Table 4.8.3.1. in relation to 
contro1s.
Control cells exhibited a FA spectrum in which 18:lw9 
comprised 21.6% of all FA's detected, compared to 18.1% 
16:0, 12.7% 18:0, 9.0% 20:4w6, 15.5% 22:4w6 and smaller 
percentages of other FA's.
In general, 16:0, 18:0, 16:lw9 and 18:lu)9 percentages 
approximated to that of controls, or were decreased, in 
dosed cells. Similarly, u6 PDFA levels were generally 
decreased in dosed cells, despite increments in 18:2w6. 
u3 PUFA levels in dosed cells were generally parallel 
to controls, or decreased, although small increments in 
some higher w3 PDFA^s were detected.
Supplementation with 20, 40 or 60mg/l p-C0 resulted in 
increased percentages of 16:0 (22.7%, 25.4% and 25.6%,
respectively vs 18.1% in controls), 18:lu9 (23.8%, 25.4% 
and 26.8% vs 21.6% in controls), and 16:lw9 (3.5%, 5.7% 
and 10.1%, respectively vs 4.7% in controls), while 18:0 
proportions approximated to controls (12.7%). Slightly 
increased levels of 20:5w3 (1.1% to 1.7% vs 0.8% in 
controls) and 22:6w3 (2.6% to 2.8% vs 1.9% in controls)
All values are tabulated as relative percent total 
Control values are reported as mean±s.e.m., where * 
the number of experiments. ‘Cp-OilD' refers to 
pseudo—oi1 concentration used.
area 
n " i 
th
The fatty acid spectrum of cells derived from cat
adipose tissue.
!FATTY ACID 
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(n =3 )
Cp-COD 
(mg/ 1 )
20 ! 40 ! 60
Cp-MOO 
(mg/ 1)
20 ! 40 ! 60
C p - o o n
(mg/ 1)
20 ! 40 ! 60
Cp-SSOO 
(m g / 1)
20 1 40 ! 60
Cp-L03 T
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Cp-EPOH 
(m g / 1 )
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were found, but all other PUFA proportions were parallel 
to controls, or significantly decreased.
The levels of 16:0 and 18:lu9 increased slightly with 
p-MO dosage (20.5% to 23.7% and 23.0% to 26.7% vs 18.1% 
and 21.6% in controls, respectively), 18:0 mirrored 
controls (12.7%), while 16:lu9 decreased about 2 fold 
compared to controls (4.7%). No significant increments 
in u6 PDFA's were detected, despite slightly increased 
18:2w6 levels (6.3% to 9.2% vs 4.3% in controls). 20:5w3 
increased approximately 2 fold with 20mg/l p-M0 dosage 
(1.9% vs 0.8% in controls), while 22:6w3 was slightly 
increased with all concentrations dosed (2.4% to 2.5% vs 
1;9% in controls).
20, 40 or 60mg/l p-00 supp1emenation increased cellular 
18:lw9 levels (38.2%, 45.3% and 50.4%, respectively vs 
21.6% in controls), but decreased 16:0, 18:0 and 16:lw9 
percentages. p-00 dosage induced significant increments 
in 18:2w6 (7.3% to 9.6% vs 4.3% in controls) and 20:2w6 
(1.1% to 1.7% vs 0.1% in controls), but not in other w6 
or u3 PDFA's, which levels either mirrored, or were 
lower than, their respective controls.
Supplementation of cells with p-SSO caused 16:0, 18:0 
and 16:lw9 levels to decrease, but had no effect on 
18:lw9. A concentration dependent increased in 18:2w6 
was induced with 20, 40 and 60mg/l p~SS0 (19.9%, 26.6% 
and 35.2%, respectively vs 4.3% in controls), and 20:2u6
levels increased over the same range (1.1%, 1.3% and 
1.4%, respectively vs 0.1% in controls). 18:3w6 was only 
slightly increased with 20mg/l p-SSO dosage (1.2% vs 0% 
in controls), but other w6 and w3 PDFA's were found in 
proportions similar to, or lower than, controls.
An overall decrease in 16:0, 16:lw9, 18:0 and 18:lw9 was 
detected when p-LO was dosed, although 18:0 was slightly 
increased with 20mg/l p-L0 (17.1% vs 12.7% in controls). 
u)6 and u)3 PDFA percentages were parallel to controls, or 
significantly decreased, despite increases in 18:2w6 
(7.9%, 10.0% and 11.4% with 20, 40 and 60mg/l p-LO 
respectively vs 4.3% in controls) and 18:3w3 (10.5%, 
20.9% and 29.8% with 20, 40 or 60mg/l p-LO, respectively 
vs 0.7% in controls).
Feeding cells p-EPO had little effect on, or decreased, 
16:0, 18:0, 16:lw9 and 18:lu9 proportions in relation to 
controls. Dosage with 20, 40 or 60mg/l p-EPO resulted in 
increased detection of 18:2u6 (20.0%, 29.1% and 34.5%, 
respectively vs 4.3% in controls), but small increments 
in 18:3w6 (0.3%, 1.0% and 1.3%, respectively) and 20:2w6 
(0.7% to 1.1% vs 0.1% in controls). 20:3u6 percentages 
nearly doubled over the same range (5.1%, 5.4% and 5.0%, 
respectively vs 2.9% in controls), but higher u6 PDFA 
amounts were significantly decreased in relation to 
controls. Furthermore, u3 PUFA levels were parallel to 
controls, or decreased.
Supplementation of cells with 20, 40 or 60mg/l p-FO had 
no significant effect on 16:0 and 18:lw9 levels, but 
caused a decrease in 18:0, and significant increases in 
16:Iw9 (9.7%, 13.8% and 20.4%, respectively vs 4.7% in 
controls) and 22:0 with 20mg/l p-F0 (2.3% vs 0.1% in 
controls). No significant increments in u6 PDFA levels 
were found, despite increased 18:2w6 detection (6.0% to 
7.5% vs 4.3% in controls). Dosage with 20, 40 or 60rng/l 
p-FO raised the levels of cellular 20:5w3 (4.9%, 7.1% 
and 9.4%, respectively vs 0.8% in controls) and 22:5w3 
(5.34, 3.84 and 4.74, respectively vs 2.8% in controls), 
but not 22:6u3 (1.8%, 0.1 % and 1.6%, respectively vs
1.9% in controls).
4.8.4 Incorporation of Radio1abe11ed C18 Fatty
Acids into Cells Derived from Cat Adipose 
T i ssue.
Table 4.8.4.1. shows the radioactivity recovered from 
cultures incubated with 2juCi C 14CD~18 J lu)9, C14CJ-18:2w6 
or C14CD-18:3w3.
The total counts recovered in the spent incubation media 
ranged from 2.7 to 3.2xl06Cpm, while only 0.5xl0Gcpm was 
recovered from the pooled buffers after washing the 
cells, which accounted for non-specific binding. For 
both C14C3-18:lu9 and C14C3-18J3w3, the equivalent of 
4.3xl06cpm were dosed to the incubation medium, and 
total recovery of radiolabel from these cultures was 
approximately 91%. For 0inCJ~13:2u6, the equivalent of 
4.8xl06cpm were dosed to the incubation medium, and the 
total recovery of this radioisotope from the cultures 
was similarly about 92%. However, the total amount of 
each of these radioisotopes incorporated into the cells 
equated to 16% for C14C3-18: lu9, 14% for C14C3-18: 2u>6 
and 9% for C14C3-18:3u3.
Table 4.8.4.2. shows the percentage conversion of each 
of the incorporated radio1abe11ed C18 FA's above to u9, 
u6 or w3 series products after 48 hours incubation with 
cells derived from cat adipose tissue.
32.1% of the total C14CD-18Jlw9 counts derived upon GLC
The radioactivity (cpm) recovered from cat adipose cultures 
incubated uiith radiolabel1ed C18 fatty acids. expressed as 
mean (±s.e.m»). n=3.
-SPENT
MEDIA
(M)
POOLED
WASHINGS
(U)
TOTAL
(M+U)
CELLS TOTAL
xlO6
Total 18;1 counts dosed to incubation medium = 4.3 x 106
2730200
(±16020)
509275
(±7735)
3239475 665235
(±1740)
3.9
Total 18:2 counts dosed to incubation medium = 4.8 x 10s
3195893
(±8035)
524588
(±5039)
3720481 646281
(±894)
4.4
Total 18:3 counts dosed to incubation medium = 4.3 x 106
3101520
(±5900)
450320
(±6435)
3551840 368823
(±1113)
3.9
The counts detected for the radiolabelled fatty acids 
dosed and their resulting metabolites formed after 
incubation with cells derived from cat adipose tissue, 
expressed as a percentage of the total counts recovered 
upon GLC analysis.
w9
MONOS.
L iaCU- 
18:lu9
u6
POLYS.
CiaC3-
18:2u6
u3
POLYS. C14CD-18:3u3
18:1 32.1 18:2 27.5 18:3 19.5
20:1 34.3 18:3 8.4 18:4 9.2
22:1 30.8 20:2 19.1 20:3 30.0
24:1 2.8 20:3 23.9 20:4 19.6
20:4 10.2 20:5 8.0
22:4 7.6 22:5 - 9.2
22:5 3.3 22:6 4.7
TOTAL
CPM 1300
TOTAL
CPM 2823
TOTAL
CPM 905
analysis (1300cpm) remained as 18:lw9, with similar 
amounts shown ' for the subsequent elongation products, 
20:lw9 (34.3%) and 22;lw9 (30.8%). However, only 2.8% 
24 : lco9 was detected.
27.54 of the total C14CD~18:2w6-derived counts detected 
(2823cpm) remained unchanged, while 8.4% was detected 
for 18:3w6, compared to 19.1% 20:2w6 and 23.9% 20:3w6. 
Approximately 20% of the total counts detected were 
converted to post-J5D PUFA's, comprising 10.2% 20:4w6 
and 7.6% 22:4w6, but only 3.3% 22:5w6.
The total counts derived following GLC analysis of cells 
incubated with CiaC3-18:3w3 were 905cpm, of which 19.5% 
remained as 18:3u3. Only 9.2% 18:4w3 was detected, 
compared to 30.0% 20:3w3 and 19.6% 20:4w3, while 8.0% of 
the recovered radiolabel was shown as 20:5u)3 and 9.2% as 
22:5w3, but only 4.7% as 22:6u3.
As J6D represents the first and rate limiting enzyme in 
the desaturase cascade, total activity of this enzyme is 
reflected by the sum of all subsequent desaturase and 
elongase products.
4,8.5 Effects of Pseudo-Oils on Lipid Peroxide
Format i on♦
The 1ipoperoxides measured in dosed cat adipose cells 
and their respective growth media are shown in Table 
4.8.5.1. in relation to controls. The data is expressed 
as nmoles MDA/106 cells, but in the case of the spent 
media, this represents the nmoles of MDA in the volume 
of medium from which lxlO6 cel Is were obtained.
0.4nmoles MDA/106 control cells were quantitated, while 
concentrations in dosed cells varied with the p-oil 
supplemented, ranged from 0.5 to 4.5nmoles MDA/106 cells 
and increased in an overal1 concentration dependent 
manner. Cells incubated with p-CO, p-MO or p-00 induced 
similar lipoperoxide amounts (0.5 to 0.9nmoles MDA/106 
cells), while 1arger concentrations were measured with 
dosage of p-oils more abundant in PUFA's. Comparable 
lipoperoxide amounts were induced with 20, 40 or 60mg/l 
p-EP0 or p-SSO supplementation (0.9, 1.0 and 1.2 vs 0.9, 
1.2 and 1.3nmoles MDA/106 cells, respectively), while 
p-FO generated significantly greater amounts only with a 
concentration of 60mg/l (2.2nmoles MDA/106 cells). p-LO, 
however, induced the greatest amounts of cellular lipid 
peroxides at the p-oil concentrations studied (1.1, 1.9 
and 4.5nmo1es MDA/106 cells with 20, 40 and 60mg/l, 
respectively).
Lipoperoxides were absent in spent control media, and in
pseudo-
Oil
(mg/1)
CELLS
0 20 40 60
Control 0.4
CO 0.5 0.7 0.8
MO 0.8 0.9 0.9
00 0.7 00o 0.9
SSO 0.9 1.2 1.3
L0 1.1 1.9 4.5
EPO 0.9 1.0 1.2
F0 0.8 0.8 2.2
pseudo- SPENT INCUBATION MEDIUM
Oil
(mg/1) 0 20 40 60
Contro1 -
CO - - -
MO - - 0.6
00 - - 2.2
SSO - - 1.7
L0 0.8 2.1 2.5
EPO - - 2.1
F0 - - 1.9
that derived from cultures incubated with p-CO. On the 
other hand, small lipoperoxide amounts were measured in 
spent medium with 60mg/l p-MO dosage (0.6nmoles MDA/106 
cells). Higher concentrations were found with 60mg/l 
p-00, p-SSO, p-EPO or p-FO incubation (2.2, 1.7, 2.1 and 
1.9nmoles MDA/10& cells, respectively), whereas spent 
medium lipid peroxide levels were greatest with p-LO 
dosage (0.8, 2.1 and 2.5nmoles MDA/106 cells with 20, 40 
and 60mg/l, respectively).
4.8.6 The Eicosanoid Profile of Cells Derived
from Cat Adipose Tissue.
Table 4.8.6.1. shows the eicosanoids positively detected 
in cells supplemented with 0, 20, 40 or 60mg/l p-oil. 
All data is presented as a percentage of the total area 
quantitated, but an indication of the actual eicosanoid 
concentration found is given for controls in "( )" as
pmoles total eicosanoids/106 cells.
Total eicosanoid production by control cells amounted to 
208.Opmo1es/10s cells, of which 19.3% correlated with 
the retention times of the prostanoid standards used. 
This fraction was largely composed of PGFq, 4%), with
smaller amounts of PGI2 (1.2%), TXB2 (3.6%) and PGE2 
(0.1%), but no PGEi or PG02 were found in control cells.
The percentage of total prostanoids detected in dosed 
cells varied significantly with p-oil concentration, as 
such was decreased in relation to controls (19.3%) with 
dosage of 40mg/l p-oil (11.7% to 16.8%), comparable to 
controls or slightly increased with 60mg/l p-oil (17.0% 
to 25.4%), but significant increased with 20mg/l p-oil 
(28.3% to 32.9%). Such changes related to alterations in 
the production of individual prostanoids in these cells.
PGI2 production varied with supplementation of 20mg/l 
p-oil (0.4% to 1.7%), but increased slightly with 60mg/l 
p-oil (2.0% to 3.3%), and considerably with 40mg/l p-oil 
(3.8% to 5.2%) in relation to controls (1.2%). Every
Values are tabulated as relative percent of the total 
area detected, and as pmoles total eicosanoids/106 
contro1 cells.
The profile of the eicosanoids detected in extracts of 
cells derived from cat adipose tissue.
pseudo-Oil
(mg/1)
EICOSANOIDS m
!TOTAL pgi2 TXB2 (l+2<5 PGE2 PGEi PGD2
CONTROL ! 19.3 1.2 3.6 14.4 0.1
(208.0)
20 : 30.4 1.7 18.3 9.2 1.2 _ _CO 40 : 1 2 . 8 4.7 4.2 3.8 0.1 - -
60 ! 21.0 2.8 10.4 6.2 0.6 0.8 0.2
20 : 29.3 0.9 17.9 9.9 0.6 — —
MO 40 : 1 5 . 1 3.8 6.2 5.0 0.1 - -
60 ! 23.5 2.8 11.3 6.7 1.2 1.3 0.2
20 : 29.5 0.7 17.4 10.5 0.9 — —
00 40 1 11.7 5.2 3.8 2.6 0.1 - -
60 ! 19.6 2.0 9.1 6.1 1.2 1.0 0.2
20 ! 32.9 0.8 18.6 12.7 0.8 — —
SSO 40 ! 12.5 4.5 4.6 3.1 0.3 - -
60 : i7.o 2.0 8.9 5.4 0.5 0.1 0.1
20 : 28.3 0.4 16.8 10.3 0.8 — —oo : 16.8 4.4 7.6 4.7 0.1 - -■
60 1 19.4 2.6 8.9 5.6 0.9 1.3 0.1
20 : 29.5 0.5 16.2 12.1 0.7 — —
EPO 40 ! 11.8 3.9 3.7 4.0 0.2 - -
60 : 20.7 3.2 10.3 5.8 1.2 0.1 0.1
20 : 29.2 1.6 17.4 9.3 0.9 — —
FO 40 : 14.7 4.1 6.4 3.9 0.3 - -
60 : 25.4 3.3 13.4 7.6 0.6 0.3 0.2
p-oil concentration dosed enhanced TXB2 biosynthesis, 
but this was greatest with a concentration of 20mg/l 
(16.2% to 18.6% os 3.6% in controls) and least with 
40mg/l (3.7% to 7.6%). In contrast, p-oil incubation
decreased PGFa production (14.4% in controls), with
concentrations of 20mg/l being least (9.2% to 12.7%),
and 40mg/l most (2.6% to 5.0%), effective. Dosage with
40mg/l p-oil had little effect on cellular PGE2 levels
(0.1% in controls), but such was increased with 20 and
60mg/l p—oil (0.5% to 1.2%). PGEi _nri Pfsn? _i_ +.1 ana ruuz were absent
in control cells, but trace amounts were detected only 
with 60mg/l p-oil supplemenation.
4.8.7 Discussion.
The effect of FA's on cat adipocyte growth has not
been described in the literature. Ue demonstrated that
the viability of cultured cells derived from cat adipose
tissue was affected when subjected to supplementation
with p-oils for 48 hours (Figs. 4.8.1.2-4.8.1.8.), and
it was apparent that the modulation of cell viability
related to p-oil FA composition and concentration dosed,
rather than the overall degree of p-oil unsaturation
(Table 2.3.3.2.). Thus, the similar extent of growth
limitation and cytotoxicity induced with p-EPO or p-SSO
dosage was not surprising as the FA compositions of both
p-oils were similar. The presence of 9*4 GLA in p-EPO,
but not in p-SSO, seemed to have had little additional
influence on cell proliferation, and the effects induced
seemed more likely to relate to the abundance of LA in
these p-oils (approximately 704). Comparison with the
cell viability changes p-LO induced, however, indicated
♦
that LA exhibited greater growth 1imiting and cytotoxic 
potential than ALA, the u3 series EFA abundant in p-LO. 
On the other hand, the marked cytotoxicity p-00 induced 
with high concentrations in the range dosed implied 
greater OA involvement in the modulation of cytotoxicity 
than LA or ALA, although the increased cell viability 
40mg/l p-00 induced also supported OA involvement in the 
stimulation of cell proliferation. The different effects 
these FA's appeared to induce probably related to
variations in FA structure between such moieties, and 
this indicated that FA's of different structures could 
modulate cell proliteration in different ways. The cell 
viability changes which p-FO induced, however, could not 
be related to any individual FA as this p-oil contained 
a more even balance of saturated, monounsaturated and 
polyenoic FA's rather than a single FA which contributed 
to the bulk of the spectrum. Although the modulation of 
cell growth could be related in some cases to particular 
p-oil FA's, every FA in a p-oil had the potential to 
induce an effect on cell viability to a greater or 
lesser extent. The possibility exists, therefore, that 
p-oil FA's operated either in concert with each other to 
enhance, or antagonistically to suppress, the effects 
induced by individual FA's. This could explain the 
greater stimulation of cell growth found with 40mg/l 
p-00 or p-FO dosage than with other concentrations of 
these p-oils, as well as the dramatic reduction in cell 
viability observed over small increments of certain 
p-oils at high concentrations dosed.
Supplementation of the culture medium for 48 hours with 
p-oils resulted in exogenous FA incorporation into the 
cells, which generally increased with the amount of 
p—oi1 dosed and altered the FA composition of these 
cells compared to controls (Table 4.8.3.1.). Thus it was 
possible that membrane fluidity was altered to a greater 
or 1eser extent, and such was involved in the modulation
of growth limitation and cytotoxicity, particularly when 
large amounts of p-oil were dosed. Whereas an increased 
complement of membrane unsaturated FA's could explain 
the marked cytotoxicity induced with p-00 or p-FO 
supplementation, the modulation of growth inhibition 
with p-CO dosage, in contrast, may well relate to 
rigidification of cell membranes.
p-Oil supplementation enhanced the total protein content 
of cat adipose cells (Table 4.8.2.1.). However, it was 
apparent from comparison with the cell viability changes 
induced (Figs. 4.8.1.2-4.8.1.8.) that increased cellular 
protein did not reflect increments in cell number alone, 
particularly since the amount of protein/cell increased 
significantly even when growth limitation and/or cyto­
toxicity were induced. These findings supported p-oil FA 
involvement in the stimulation of protein synthesis. As 
the extent of protein stimulation varied quantitatively 
when dosage with identical amounts of different p-oils 
yielded similar cell numbers, it was suggested that FA's 
vary in their capability to modulate protein synthesis, 
and that this related to variations in FA structure. The 
enhancement of protein synthesis could nevertheless 
represent increased production of 1ipid metabolising 
enzymes such as lipases or enzymes related to protection 
against lipid peroxidation, particularly in the light of 
p-oil FA's incorporated (Table 4.8.3.1.) and involvement 
of adipocytes in lipid metabolism (Lehninger 1982).
It was unlikely that absolute increases in cellular 
protein related to increased expression of desaturase 
cascade enzymes as the FA spectra of dosed cat adipose 
cells indicated that such exhibited relatively little 
capability for FA desaturation or elongation (Table
4.8.3.1.). Saturated and monoenoic FA's were neither 
desaturated nor elongated, although the potential for 
16:0 and 18:0 desaturation (suggested with p-CO or p-MO 
dosage) could not be excluded. The finding that cellular 
18:3u6 and 18:4u3 levels were not significantly raised, 
even with p-EPO, p-SSO or p-LO incubation, supported the 
lack or suppression of A6D activity in these cells. Even 
direct 18:2u6 elongation to 20:2w6 was limited, despite 
substrate availability with p-SSO or p-EPO incubation in 
particular. These findings indicated that the formation 
of 20:3w6 only with p-EPO dosage more than likely 
represented elongation of incorporated 18:3u6, but the 
inability to induce increased post-J5D FA levels implied 
that 20:3u6 was not desaturated. It was also apparent 
that the small 20:4w6 amounts incorporated with p-MO 
supplementation could not be elongated. This elongation 
step, however, was shown when 20:5w3 was incorporated 
with p-FO dosage, but no evidence was found to suggest 
that this moiety was converted to 22:6u3 via J4D. On the 
other hand, the slightly increased 20:5u3 and 22:6u3 
levels found in cells dosed with p-CO or p-MO suggested 
limited J5D and J4D potential. These p-oils did not
contain u3 PUFA's (Table 2.3.3.2.)* thus the increases 
in post~J5D FA's reported must represent desaturation 
and elongation of cellular (membrane) u3 PUFA's; the 
significantly decreased 18:4u3 and 20:4w3 levels found 
suggested utilisation of these moieties as substrates. 
It was theoretically possible that incorporation of 
saturated FA's present in these p-oils, as well as 
prolonged EFA/PDFA deprivation, enhanced J5D, subsequent 
elongase and J4D expression in an attempt to maintain 
membrane fluidity. In contrast, PUFA incorporation from 
more unsaturated p-oils may have suppressed expression 
of such enzymes to preserve membrane fluidity. Previous 
studies from our 1aboratory showed that cats fed a diet 
deficient in u)3 and w6 PDFA's contained no post-J5D FA 
products in adipose tissue. However, PUFA levels in 
these cells were maintained by incorporation of greater 
amounts of 18:2u6 compared to cats fed diets sufficient 
in w3, w6, or all PDFA's (Davidson et al 1989, 1990a). 
Such also reflected an attempt to maintain membrane 
fluidity. The finding that w3 PDFA's were desaturated 
and elongated to a greater extent than those of the 
u6 series (Table 4.8.3.1.) nevertheless confirmed the 
substrate preference established by others (Brenner et 
al 1966, Brenner 1974, 1982, Mead et al 1976 and Kanau 
et al 1977).
The impairment of J6D, and potential for J5D, expression 
we demonstrated above correlated with similar findings
which others have reported in this species (eg. Rivers 
et al 1975a, Frankel et al 1978, Sinclair 1979, Sinclair 
et al 1981 and Davidson et al 1989, 1990a). The present 
study also indicated the potential for J4D expression in 
cat adipocytes, while in vivo studies have been unable 
to demonstrate either its presence or absence in this 
tissue (Davidson et al 1989, 1990a). Our data indicated 
that the inability of cat adipose cells to efficiently 
express desaturase cascade enzymes (Table 4.8.3.1.) did 
not relate to limitation or inhibition of cell viability 
induced with p-oil supplementation, as such enzyme 
capability did not improve even when p-oils enhanced 
cell proliteration (Figs. 4.8.1.2-4.8.1.8.). Impaired 
desaturase cascade enzyme expression may rather be a 
characteristic of this tissue, implying a requirement of 
preformed PDFA's from the diet or other cat tissues to 
maintain normal physiology.
Comparison of p-oil desaturation (Table 4.8.3.1.) with 
that of individual FA's (Table 4.8.4.2.) was assessed to 
establish whether the pattern of p-oil desaturation 
reported above was modulated by the presence of FA 
mixtures. The pattern of radioactivity derived from 
cells supplemented with C14C3-18:3u3 or CiaC3-18;2u6 
was consistent with desaturation and elongation of 
these moieties (Table 4.8.4.2.). However, conversion of 
incorporated CiaCD-18i3w3 and DiaCD-18:2u6 to PDFA's 
via A6 D was unlikely as the cat lacks significant A6D
capability (eg. Rivers et al 1975a, Frankel et al 1978, 
Sinclair 1979, Sinclair et al 1981 and Davidson et al 
1989, 1990a). Instead, the data suggested that C14C3- 
18:3w3 and C14C3-18:2w6 were directly elongated to 
20:3w3 and 20:2u6, and such converted to 20:4w3 and 
20:3w6, respectively via an active J8D. As elongase 
reactions are reversable, it was possible that 20:4u3 
and 20*3u6 retroconversion accounted for the small 
amounts of 18:4u3 and 18:3w6 detected, respectively, 
although such could also theoretically relate to A 6D 
expression with EFA incorporation and/or prolonged PDFA 
deprivation. Nevertheless, conversion of approximately 
20% CiaC3-18:3w3 and C14C3-18:2u6 each to post-J5D FA's 
was evidence for J5D activity. However, the apparent 
accumulation of 20:4w3 and 20:3u6 may reflect that the 
rate of their formation was greater than the rate of 
their conversion to post-J5D products and/or that J5D 
activity was not fully expressed. Indeed, this would 
support 20:4u3 and 20:3u6 retroconversion. Although 
20:5u3 and 20*4u6 were elongated, the formation of less 
than 5% 22:6w3 and 22:5u6 indicated that J4D was not
significantly expressed. The lack of desaturation found 
with C14CD-18:lu9 supplementation supported impaired J6D 
capability, whereas 22*lw9 formation was consistent with 
expression of elongases.
The above findings indicated that capability for 
desaturation and elongation not only varied numerically
with dosage of individual C18 FA's or p-oils (Tables
4.8.3.1. and 4.8.4.2.), but such was also more limited 
with p-oils. Competitive interactions between FA's for 
desaturase cascade enzymes are well known (eg. Brenner 
et al 1966, 1967, 1969 and Brenner 1974, 1982), and 
similar reactions may have occurred between p-oil FA's 
which could explain the data. However, as p-oil FA 
composition mirrored that of similar dietary oils, the 
desaturase capability shown with p-oils probably related 
closer to the situation in cat adipocytes in vivo than 
that suggested with single FA/s.
MDA measurement in control and p-oil dosed cat adipose 
cells (Table 4.8.5.1.) supported the capability of those 
cells to generate 1ipoperoxides by auto-oxidation or 
enzymatically. This could have occurred when the 
availability of unsaturated FA's outweighed the amount 
of vitamin E which serves as anti-oxidant. Both the 
p-oils and cells themselves contained FA's which were 
potential candidates to act as substrates for cellular 
1ipoperoxide formation (Tables 2.3.3.2. and 4.8.3.1.). 
However, the presence of albumin as FA carrier and 
abundance of saturated FA's in new culture medium (Table 
2.3.3.3.), as well as the ability of these cells to 
incorporate p-oil FA's (Table 4.8.3.1.), supported the 
likelyhood that most 1ipoperoxides found in the spent 
media of dosed cultures originated intracel1ularly. 
Reports that cellular 1ipoperoxides disrupt biological
membranes and increase their permeability (Chio et al 
1969, Mead 1976, Tappel 1975, 1980, Gavino et al 1981c, 
Morisaki et al 1982b and Frankel 1984) supported the 
transfer of these compounds into the incubation medium 
through the plasma membrane, eg. with p-LO, 60mg/l p-SSO 
or 60mg/l p-FO supplementation, or as a direct result of 
p-oi1-induced cytotoxicity, eg. with 60mg/l p-MO, p-00 
or p-EPO dosage. Cellular peroxidising enzymes and FFA's 
could also have been released into the culture.medium 
in this process, thus the possiblity that further FA 
oxidation occurred extracel1ularly, and contributed to 
the spent medium 1ipoperoxides measured, could not be 
ignored. Such may well account for the greater MDA 
amounts found in the spent medium of cultures enriched 
with 60mg/l p-00, p-SSO or p-EPO, or 40rng/l p-LO than in 
the cells themselves.
The quantitative variations in MDA levels found between 
cultures incubated with identical p-oil concentrations 
reflected the different p-oil FA compositions (Table
2.3.3.2.). This related not only to the amount of 
unsaturated FA's present in any p-oil, but also to their 
availability and susceptibility to oxidation. The small 
lipoperoxide amounts induced with p-CO or p-MO dosage 
reflected the abundance of saturated FA's in these 
p-oils, and probably related to oxidation of their small 
amounts of unsaturated FA's and/or cellular FA's 
released during PGL turnover. The finding that p-00 also
induced small cellular 1ipoperoxide amounts when dosed, 
despite significant OA uptake (Table 4.8.3.1.), and the 
capability of OA to undergo oxidation (Frankel 1984), 
implied that such was largely lipid-bound and thus not 
readily accessible to oxidation, although 1ipoperoxide 
release into the medium with 60mg/l p-00 supplementation 
could explain the low cellular levels. The greater 
1ipoperoxide amounts induced overal1 with dosage of 
p-SSO, p-EPO, p-FO or p-LO than with p-CO, p-MO or p-00, 
was consistent with the presence of 1arger amounts 
polyenoic FA's in the former. The similar 1ipoperoxide 
amounts p-EPO and p-SSO induced, which probably related 
to oxidation of free LA, reflected their similar FA 
compositions and effect on cell viability. The similar 
EFA levels present in p-EPO, p-SSO and p-LO (about 
73% LA, 70% LA and 63% ALA, respectively) and greater 
1ipoperoxide amounts induced with dosage of p-LO than 
p-EPO or p-SSO, however, indicated that ALA was more 
susceptible to oxidation than LA, probably relatable to 
the greater number of double bonds in ALA. The presence 
of 5 double bonds in EPA compared to 3 in ALA implied 
greater susceptiblity of the former to oxidation. 
However, the considerably lower amount of EPA in p-FO 
(about 18%) than ALA in p—LO was consistent with lower 
1ipoperoxide levels induced with p—FO dosage. Such could 
also reflect a faster rate of PGL cycling and therefore 
FFA release into the cellular pool from membrane lipids 
with p-LO incubation.
Total 1ipoperoxide formation by cultures supplemented 
with p-oils was directly related to the amount of p-oil 
dosed (Table 4.8.5.1.), and generally inversely related 
to changes in cell viability (Figs. 4.8.1.2-4.8.1.8.). 
Thus, it was possible that 1ipoperoxides were involved 
in the modulation of cell proliferation. The finding 
that the greatest cytotoxicity 60mg/l p-00 induced did 
correlate with the highest 1ipoperoxide amount found 
(with 60mg/l p-LO dosage), however, indicated that other 
mechanisms were also involved in the modulation of cell 
growth. It was possible that the 1ipoperoxide levels 
reported in dosed cultures induced cell damage/death 
only once membrane fluidity had been significantly 
altered. Thus, the modulation of cell proliferation with 
p-oil supplementation may relate both to alterations in 
membrane stability and 1ipoperoxidation.
Control cat adipose cells produced a significant amount 
of total eicosanoids, which accounted for approximately 
50^ of all 1ipoperoxides quantitated (Tables 4.8.5.1. 
and 4.8.6.1.). This was rather surprising in the light 
of the poor capability for p-oil desaturation reported 
(Table 4.8.3.1.), but could well reflect a requirement 
for eicosanoids in cat adipocytes, which may, for 
example, relate to the control of lipid metabolism or 
mobilisation of storred FA's (Mayes 1981). Control cells 
indeed contained PUFA's which were potential candidates 
to act as substrates for the formation of eicosanoids
(Table 4.8.3.1.), but the finding that the prostanoids 
studied comprised only a fraction (19.3J£) of the molar 
amount quantitated indicated that these cells were 
primarily involved in the making of other eicosanoids. 
Prostanoid detection nevertheless supported cyclo­
oxygenase expression, and it was apparent that the 
enzymic pathways for PGPq, biosynthesis were greatly 
favoured over those involved in TXB2 f PGI2 or PGE2 
production. Furthermore, the small PGEi ancj PQD2 amounts 
produced by dosed cells, but not in controls, suggested
that PGHi-pqej an(j PGH2-PGD2 isomerases were suppressed 
or inhibited rather than absent.
Supplementation of cat adipose cultures with p-oils for 
48 hours influenced the rate of prostanoid production in 
these cells (Table 4.8.6.1.), but such was independent 
upon the degree of p-oil unsaturation or ability of the 
p-oils to provide eicosanoid precursor PUFA's (Table
2.3.3.2.). Indeed, incorporation of 20:4w6, the direct 
2-series eicosanoid precursor, with p-MO incubation, and 
formation of the 1-series precursor, 20:3u6, from'18:3w6 
incorporated with p-EPO dosage (Table 4.8.3.1.), had no 
significant effect on prostanoid production compared to 
other p-oils supplemented at the same concentrations. 
This phenomneon was also found with p-LO or p-FO dosage, 
which contained significant amounts of 18:3w3 and 20:5w3 
that normally inhibit 2-series prostanoid production 
by preferential1y occupying the active site on cyclo­
oxygenase (Lands et al 1973, 1977, Hamazaki et al 1982, 
Corey et al 1983, Fischer et al 1983, 1984 and Nassar et 
al 1987). The inability to induce significant changes
in TXB2 , PGFa, PGI2, PGE2 , PGEi or PGD2 levels with 
dosage of different p-oils at the same concentration
implied that exogenous FA's per se had little effect on 
prostanoid production, and detection of 20:4w6 and 
smaller 20:3w6 levels in control cells (Table 4.8.3.1.) 
rather supported endogenous PUFA utilisation for 
prostanoid formation. On the other hand, the finding 
that total prostanoid production was suppressed with 
40mg/l p-oil, unaltered overall with 60mg/l p-oil, and 
stimulated with 20mg/l p-oil, supplementation primarily 
due to changes in PGFa , TXB2 and/or PGl2 1eVels, implied 
p-oil concentration involvement in the modulation of 
prostanoid biosynthesis. This could have influenced 
eicosanoid precursor availability or the expression of 
enzymes involved in prostanoid formation from PGH. The 
prostanoid changes induced with p-oil supplementation of 
cells were nevertheless found not to correlate with the 
changes reported in cell viability (Figs. 4.8.1.2- 
4.8.1.8.), total protein (Table 4.8.2.1.), 1ipoperoxides 
(Table 4.8.5.1.), or desaturation capability (Table 
4.8.3.1.). This implied that while p-oil supplementation 
influenced eicosanoid production, or the balance between 
individual prostanoid groups, the endogenously generated 
prostanoids studied were probably not directly involved
in the modulation of effects demonstrated. Indeed, this 
mechanism could not explain the growth limitation and 
cytotoxicity induced with p-oils rich in saturated or 
monounsaturated FA's, which could not be metabolised to 
eicosanoids. Alterations in membrane physical properties 
and the generation 1ipoperoxides were proposed as more 
likely mechanisms involved in the modulation of cell 
pro!iferation.
4.9 General Discussion.
The effect of p-oil supplementation on the viability 
of different types of cultured normal cat cells was 
presented in this chapter. The capability of each cell 
type to incorporate, desaturate and elongate FA's, the 
formation of lipid peroxides and eicosanoids and the 
possible roles these compounds played in the modulation
of cell viabi 1i ty, were a 1 so exam i ned.
The cat i s a model for many human diseases (O'Brien
1986) , yet the 1i terature indicates that re 1 atively
1ittle work has been conducted in this spec i es,
particularly with regard to lipid metabolism. The lack 
of commercially available cat cell lines (Flow 1984 and 
Gibco 1984) possibly explains why tissue culture has not 
been used as a tool to study aspects of 1ipid metabolism 
in the cat in vitro. To the best of our knowledge, this 
study was the first to use a range of normal cat cells 
in tissue culture to investigate the above parameters. 
This therefore permitted valid comparisons to be made 
between different cat cell types under standard 
experimental conditions.
p-Oils had the capability to modulate cat cell viability 
when dosed for 48 hours, but the effects induced and 
magnitude thereof varied to a greater or lesser 
extent between different cat cell types. All p-oils 
were cytotoxic to cat erythrocytes and lymphocytes,
except p-CO which induced no effect on the 
erythocytes. In general, suspension cultures of 
erythrocytes and lymphocytes were killed with very low 
(sections 4.1.1 and 4.2.1, respectively), adipose and 
brain cells with intermediate (sections 4.8.1 and 4.5.1, 
respectively), and endothelium, skeletal muscle, lung 
and skin cells only with high (sections 4.3.1, 4.4.1, 
4.6.1 and 4.7.1, respectively), p-oil concentrations in 
the range dosed. Adherent cells were thus more resistent 
to cytotoxicity than suspension cultures, and such may 
relate to the fact that the adherent cells used divided 
in culture without prior stimulation. It was also 
clear that the threshold for cytotoxicity varied with 
different adherent cells. This was found to be relatable 
to cell population doubling times (Table 2.3.1.1.) as 
relatively slow dividing cells, eg. brain and adipose, 
required lower p-oil concentrations to induce growth 
limition and/or cytotoxicity than cells with shorter 
population doubling times, eg. lung and skin. The lower 
cytostatic number established with faster, than with 
slower, replicating cells, was consistent with the 
broader growth limiting range the former induced. This 
range is nevertheless important and should always be 
defined as it distinguishes the p-oil concentration(s) 
which induce mere growth limitation or cytostasis from 
those promoting cell pro 1iferation or cytotoxicity. In 
this regard, the data presented therefore has practical
applications for those wishing to modulate cell growth 
with p-oils* single FA's or other agents to achieve a 
specific effect, and also allows for valid comparisons 
to be made between cells of different growth rates.
Previous work from our 1 aboratory showed that both U)6 
and w3 PDFA's were required for normal cat growth. 
Feeding with diets deficient in either w3 or u)6 PDFA's 
limited the rate of growth significantly, while the 
poorest growth rate was observed when fed a diet 
deficient both in u3 and w6 PDFA's (Davidson et al 1989,
t  J
1990a). No consistent correlation between cell viability 
and p-oil PDFA levels were found in the present study. 
Dosage with low to intermediate concentrations of p-oils 
containing EFA's and/or PDFA's, however, induced less 
growth limitation than p-CO, which was deficient in all 
PUFA's. Furthermore, EFA and/or PDFA containing p-oils 
enhanced cell proliteration significantly in numerous 
instances, whereas such was never mediated with p-CO 
feeding. These findings therefore suggested a PUFA 
requirement for normal proliferation of cat cells and 
tissues.
The data presented supported the involvement of dietary 
FA's in the modulation of- cat cell growth, and the 
different cell viability changes found between the cat 
cell types studied to dosage with identical p-oils may 
well relate to the different physiology of these tissues 
in v i vo. Careful consideration should therefore be
given to the selection of cat tissues for experimental 
purposes, and extrapolation of cell viability results 
from one cat cell type to another should therefore be 
avoided to ensure valid interpretation of data.
The present chapter provided substancial evidence to 
support the incorporation of exogenous FA's by cat 
cells in vitro. The resulting FA modifications induced 
in the cells led to the proposal that differential 
uptake of exogenous FA's caused alterations in membrane 
physical properties such as fluidity, and this was 
a mechanism whereby p-oils reduced cell viability, 
particularly with high concentrations in the range 
dosed.
Total protein concentrations varied considerably between 
the different cat cell types studied (sections 4.1.2,
4.2.2, 4.3.2, 4.4.2, 4.5.2, 4.6.2, 4.7.2 and 4.8.2). 
Protein amounts in control adherent cells were greatest 
in adipose and aortic endothelium, intermediate in skin 
and skeletal muscle, and lowest in lung and brain 
(475.3, 424.4, 304.5, 300.1, 230.4 and 175.1M9/106 cells 
seeded, respectively). The finding that control adherent 
cells exhibited markedly more protein than suspension 
cultures of erythrocytes or lymphocytes (12.3 and 6.4jjg 
per 10s cells seeded, respectively) could have related 
to the ability of the former to replicate in culture 
without prior stimulation. Control cell protein levels,
however, showed no clear correlation with the 
proliferation rate of these cells (Table 2.3.1.1.), and 
probably reflected variations in morphology, physiology 
and rate of protein turnover (Lehninger 1982) with cell 
type in vivo. Total protein measurement in dosed cells 
reflected the relative changes induced in cell number to 
a greater or lesser extent, but such also provided 
evidence implicating exogenous FA involvement in the 
stimulation of protein synthesis in nucleated cells. 
This varied in magnitude with cat cell type, p-oil 
FA composition and concentration supplemented. It was 
suggested that absolute increases in cellular protein 
induced with p-oil dosage related to increased synthesis 
of membrane proteins, particularly if the integrity of 
such was threatened by growth 1imiting and/or cytotoxic 
p-oil concentrations. Increased expression of lipid 
metabolising enzymes were also proposed, although it was 
apparent that such probably did not represent increased 
desaturase and elongase enzyme production.
The FA spectra derived from the incubation of cat cells 
with p-oils provided a means of assessing the capability 
of those cells to desaturate and elongate FA's. Studies 
investigating the capability of the domestic cat to 
desaturate FA's have primarily been limited to liver and 
monitoring serum FA profiles subsequent to dietary oil 
or FA supplementation (Rivers et al 1975a, 1976, Frankel 
et al 1978, Sinclair 1979, MacDonald et al 1983a and
Davidson et al 1990a). The present study, in contrast, 
examined the in vitro desaturase capability of a variety 
of cat tissues not previously examined by other workers. 
Neither cat erythrocytes nor lymphocytes exhibited any 
significant capability for FA desaturation or elongation 
(Tables 4.1.3.1. and 4.2.3.1., respectively). Similarly, 
no significant desaturase enzyme expression occurred 
overall with p-oil dosage to cat skeletal muscle, lung, 
skin or adipose cells, and PUFA metabolism was primarily 
limited to elongation of 18’2u6, 18:3w6 and 20:5w3 
(Tables 4.4.3.1., 4.6.3.1.* 4.7.3.1. and 4.8.3.1., 
respecitve1y ). Cat brain cells exhibited elongation, 
retroconversion, 48- and 45-desaturation, but not 46- 
or 44-desaturation, potential (Table 4.5.3.1.), whereas 
48D, 45D, 44D and elongase, but not 46D, activity was 
suggested in cat endothelial cells (Table 4.3.3.1.). The 
above findings clearly demonstrated that desaturase 
cascade enzyme capability varies between different cat 
tissues. It also supported current evidence indicating 
that the domestic cat is 46D-deficient (eg. Rivers et al 
1975a, 1976, Frankel et al 1978 and MacDonald et al 
1983a). The results obtained by Sinclair (1979) after 
supplementing cat diets with 18:2u>6 similarly showed 
that cat tissues do not exhibit significant 46D 
capability, even in liver. When cats were fed diets 
either sufficient in all PDFA's, or deficient in w6, w3 
or all PDFA's, Davidson et al (1989, 1990a) failed to 
detect in different tissues 20:3w9, the unusual FA
considered indicative of PUFA deficiency in other 
mammals (Holman 1977 and Sprecher 1977); this also 
confirmed the lack or suppression of A 6D activity in 
the cat. In contrast* J5D expression was demonstrated by 
both Sinclair (1979) and Davidson et al (1989, 1990a), 
although the presence or absence of ^4D could not be 
proven. There is evidence, however, that this species 
probably has the capability to express both J5D and J4D 
(Kane et al 1981 and MacDonald et al 1983a), although 
enzyme activity appears to vary with experimental 
conditions.
The pattern of radioactivity shown with C14CD-18:2w6 or 
C14C3-1853u3 dosage to cat lung, skin or adipose cells 
(Tables 4.6.4.2., 4.7.4.2. and 4.8.4.2., respectively) 
was consistent with impaired J6D capability, but 
supported the expression of elongases, J8D and J5D for 
which adipose cells exhibited slightly greater potential 
than skin or lung fibroblasts. When Sinclair et al 
(1981) fed cats EFA-deficient diets, they detected 
20:3u9 in various tissues and also proposed that such 
was formed by an active J8D and J5D. MacDonald et al 
(1983a) similarly demonstrated the capability of cat 
liver to elongate 18:2w6 to 20*2u6 and desaturate such 
to 20:3w6 via J8D when SSO was fed in the absence of 
18:2u6 desaturation. Cat testes were also shown to use 
the A 8 D f rather than the A 6D, route to convert 18:2u6 to 
22;5u6 (MacDonald et al 1984). This could well be a
mechanism whereby the cat is able to form PDFA's even 
when EFA desaturation is impaired, and thus provide 
20:3w6, 20:4u6 and 20:5w3 as substrates for eicosanoid 
production.
The more limited desaturation capability we found with
p-oil than single FA dosage in al 1 cat cel 1 types
studied indicated differences in the metabolism of
single and mixtures of FA's, which probably re 1ated to
the mediation of competitive interactions between p-oil 
FA's for such enzymes. Similar reactions probably occur 
in vivo when cats ingest dietary oils, although FA's 
of the same and different series/positions in the 
desaturase cascade, as well as the cellular demand for 
PDFA's, will modulate desaturase/elongase expression, 
the maximum potential which is genetically determined. 
The fact that the cat cel 1 types studied exhibited 
different capabilities to desaturate and elongate PDFA's 
implied in vivo dependence of some cat tissues on others 
as a source of higher PDFA's, particularly under
iconditions of limiting dietary supply. Nevertheless, the 
variations in desaturation capability found between the 
cat cell types studied, whether dosed with single FA's 
or p-oils, may well relate to the different physiology 
of these tissues in vivo. ' Extrapolations in this regard 
to other cat cell types should therefore be avoided.
Comparison of the MDA amounts quantitated between the
cat cell types studied indicated varying capabilities to 
generate 1ipoperoxides. These compounds were absent from 
control erythrocytes (section 4.1,4), but were formed by 
all nucleated control cat cells, although relative 
amounts were low in brain (0.Inmoles MDA/105 cells), 
intermediate in lymphocytes, lung, skin and adipose (0.3 
to 0.4nmoles MDA/105 cells), and greatest in skeletal 
muscle and endothelium (0.6 to 0.8nmoles MDA/105 cells) 
(sections 4.5.4, 4.2.4, 4.6.5, 4.7.5, 4.8.5, 4.4.4 and 
4.3.4, respectively). Others found that FA oxidation 
occurred more rapidly in cat adipose than liver 
slices (Richard et al 1989). These findings supported 
variations in the rates of FA oxidation, the content of 
vitamin E as cellular anti-oxidant and/or the efficiency 
of enzymes such as catalase, peroxidase and superoxide 
dismutase in the removal of different species of 
activated oxygen that promote 1ipoperoxidation between 
different cat tissues. The fact that control cell lipid 
peroxide concentrations showed no clear correlation with 
the total unsaturated FA contents or population doubling 
times (Table 2.3.1.1.) of these cel Is, however, could 
well have related to the different physiology and rates 
of PGL turnover with cell type (Lehninger 1982).
Incubation of cat cultures with p-oils for 48 hours 
induced the formation of 1ipoperoxides from exogenous 
unsaturated FA's, although the magnitude thereof once 
again varied quantitatively between the different cell
types studied even when identical p-oils were dosed. 
Lipoperoxide concentrations greater than 5nmoles MDA/106 
cells were rarely found in dosed adherent cells or the 
corresponding spent medium (Tables 4.3.4.1., 4.4.4.1., 
4.5.4.1, 4.6.5.1, 4.7.5.1. and 4.8.5.1.), while the 
range was considerably wider (0 to 73nmoles MDA/106 
cells) for dosed erythrocyte or lymphocyte cultures 
(Tables 4.1.4.1. and 4.2.4.1.), The overall increment in 
cellular lipoperoxide formation found when cat cultures 
were enriched with increasing amounts of p-oil supported 
exogenous FA incorporation from the growth medium. The 
variations found in 1ipoperoxide concentrations between 
the dosed cat cell types studied, however, could have 
related to alterations in the rate of cellular FA 
uptake and release induced with p-oil supplementation. 
p-0i1-induced 1ipoperoxidation was also shown to relate 
to the amount of unsaturated FA's present in the p-oils 
(Table 2.3.3.2.) and their susceptibility to oxidation, 
dependent on FA structure and availability of these 
moieties in the free form. These factors could indeed 
explain the greater lipoperoxide amounts induced in all 
cells with dosage of p-FO or p-LO than other p-oils. The 
evidence we presented in this chapter indicated that the 
p-oils induced the spent medium 1ipoperoxides found 
occasionally in dosed cultures, but that these compounds 
largely originated intrace 11u1ar1y and were released as 
a result of p-oil-induced cytotoxicity or increased 
plasma membrane permeabi1ity. Both intracel1ular and
extracellular 1ipoperoxides could nevertheless have 
induced cellular damage, and the involvement of these 
compounds in the modulation of cell viability was 
proposed.
Eicosanoid quantitation supported the ability of cat 
lung, skin and adipose cells to generate such compounds 
(Tables 4.6.6.1, 4.7.6.1 and 4.8.6.1, respectively). 
This correlated with the detection of 20:4w6, 20:3io6 and 
20:5u3 in control cells as eicosanoid precursors (Tables 
4.6.3.1., 4.7.3.1. and 4.8.3.I., respectively). It was 
also possible that 22*4u6 and 22*5u3 retroconversion 
provided 2- and 3-series eicosanoid substrates, 
respectively, particularly since PDFA formation was 
limited by impaired J6D expression. Ue showed that total 
molar eicosanoid production varied considerably between 
different cat cells, being greatest for control adipose, 
while skin and lung formed considerably smaller amounts 
(208.0, 80.5 and 32.9pmoles/10s cells, respectively). 
The finding that these cells produced similar amounts of 
lipid peroxides (0.3 to 0.4nmoles MDA/106 cells) thus 
implied greater potential to synthesise eicosanoids in 
cat adipose, than in skin or lung under the experimental 
conditions used. This probably related to the different 
physiology, eicosanoid requirements, and activities of 
enzymes involved in eicosanoid formation/inactivation 
between such cells. The lower molar eicosanoid amounts 
generated by lung than skin or adipose cells could also
have related to a greater incorporation of FA's into the 
TAG rather than the PGL pool.
Control cat lung, skin and adipose cells differed in the
relative amounts of PGI2> TXB2 , PGFa and PGE2 they 
formed (Tables 4,6.6.1., 4.7.6.1. and 4.8.6.1.), and it
was apparent that enzymic pathways for the synthesis of
T v pAD2 in lung and skin fibroblasts, and PGFa in adipose 
cells, were preferred to that of other prostanoids. This
implied differences in the expression and activity of 
enzymes involved in prostanoid synthesis between cat 
tissues and/or modulation by other eicosanoids. PGEi 
for example, is partly responsible for the control of 
cAMP levels, a potent inhibitor of phospholipase and 
thus AA release (Feinstein et al 1977, Minkes et al 1977 
and Horrobin 1980b). Low PGEt > as a resuit Qf impaired 
LA desaturation for example, will cause low cAMP levels, 
and thus increased AA mobilisation. As control lung, 
skin and adipose cells did not produce PGEif such may 
explain the production of 2-series prostanoids (Tables 
4.6.6.1., 4.7.6.1. and 4.8.6.1.). In the light of this 
phenomenon, it was possible that a greater proportion of
the PGFft fraction detected in these cells was composed 
of PGF2ct rather than PGFioc.
Cat lung, skin and adipose prostanoid synthesis was 
modulated with p-oil dosage (Tables 4.6.6.1., 4.7.6.1. 
and 4.8.6.1., respectively), and its relationship with
the p—oi1 amount incubated suggested a preference for 
certain p-oil concentrations to selectively modulate 
enzyme activity involved in the synthesis of these 
compounds. The finding that the modulation of prostanoid 
production did not correlate with p-oil FA composition, 
however, suggested sufficient endogenous PUFA's in the 
precursor pool, or an unavailability of incorporated 
p-oil FA's, for prostanoid production. The prostanoid 
profiles of dosed cat lung, skin and adipose cells also 
showed no p-oil concentration dependent correlation with 
cell viability, desaturation capability or 1ipoperoxide 
production, thus we proposed that the endogenously
produced prostanoids studied were not directly involved
*
in, or responsible for, the effects induced with p-oil 
supplementation; these compounds may rather be involved 
in the overall regulation of cellular metabolism.
To sum up, comparative data on a range of cell 
parameters for different cultured cat tissues were 
presented in this chapter. Ue showed that control cells 
from different cat tissues varied with respect to their 
rates of cell proliferation, FA and eicosanoid profiles, 
total protein concentrations, and molar 1ipoperoxide and 
eicosanoid production. In addition, variations in cell 
viability, total protein and 1ipoperoxide formation, FA 
and eicosanoid profiles, and desaturation capability 
were demonstrated between different cat cells dosed with 
p-oils, although the impairment of A6D expression was
common to all cat cells studied. The data implied that 
variations in FA metabolism between different cat 
tissues were important in the modulation of the effects 
reported. Care should therefore be taken when selecting 
cat tissues for experimental purposes, and extrapolation 
of findings from one cat cell type to another should be 
avoided to ensure valid interpretation of data.
